Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,A1BG,Alpha-1B-glycoprotein,19494,1852,1.43 [1.10-1.87],0.0083352503242925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AAMDC,Mth938 domain-containing protein,18968,1809,1.03 [0.95-1.13],0.4432783231405841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AARSD1,Alanyl-tRNA editing protein Aarsd1,22222,2129,1.03 [0.96-1.10],0.4032627171997699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ABCA2,ATP-binding cassette sub-family A member 2,18799,1796,1.32 [1.17-1.49],4.333512882507211e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ABHD14B,Protein ABHD14B,22079,2126,1.02 [0.95-1.09],0.6369906998217069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ABL1,Tyrosine-protein kinase ABL1,22222,2129,1.13 [1.07-1.20],2.1885894282538523e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ABO,Histo-blood group ABO system transferase,19470,1855,1.02 [0.99-1.05],0.1632743381309832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ABRAXAS2,BRISC complex subunit Abraxas 2,18799,1796,1.05 [0.98-1.13],0.132332564313737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",21834,2088,1.33 [1.27-1.39],7.216950196746845e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",19109,1826,1.00 [0.94-1.07],0.8931273738756332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",19462,1849,1.03 [0.98-1.09],0.2133357869405227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACAN,Aggrecan core protein,22107,2112,0.47 [0.41-0.54],1.918401258585996e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACE,Angiotensin-converting enzyme,19470,1855,1.70 [1.45-1.99],5.728747877068359e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACE2,Angiotensin-converting enzyme 2,21913,2105,1.76 [1.66-1.86],7.731169426272672e-85
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACHE,Acetylcholinesterase,19045,1813,1.28 [1.12-1.46],0.0003053407826821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACOT13,Acyl-coenzyme A thioesterase 13,19369,1846,1.04 [1.00-1.08],0.0565260668672632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,22331,2138,1.09 [1.01-1.17],0.0200628826502649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACP1,Low molecular weight phosphotyrosine protein phosphatase,18885,1799,0.90 [0.81-1.00],0.0413300369858215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACP5,Tartrate-resistant acid phosphatase type 5,22448,2148,1.96 [1.78-2.15],8.943956885286186e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACP6,Lysophosphatidic acid phosphatase type 6,22470,2148,0.99 [0.94-1.04],0.6709761904641083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACRBP,Acrosin-binding protein,19371,1841,1.04 [0.93-1.17],0.4726005471430797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACRV1,Acrosomal protein SP-10,18885,1799,1.06 [1.01-1.12],0.0199900313696187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACSL1,Long-chain-fatty-acid--CoA ligase 1,18799,1796,0.96 [0.84-1.09],0.5509096319352836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACTA2,"Actin, aortic smooth muscle",21913,2105,1.05 [0.96-1.15],0.2660754273652459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACTN2,Alpha-actinin-2,18799,1796,1.07 [0.99-1.15],0.0840427820893071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACTN4,Alpha-actinin-4,21900,2081,1.02 [0.91-1.15],0.7546129010726108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACVRL1,Serine/threonine-protein kinase receptor R3,22101,2129,1.21 [1.05-1.40],0.0103607512513407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACY1,Aminoacylase-1,22331,2138,1.85 [1.76-1.96],3.102019106997164e-110
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,18799,1796,1.59 [1.48-1.70],9.12707020095118e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACYP1,Acylphosphatase-1,18972,1808,1.01 [0.94-1.08],0.7660390413732421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADA,Adenosine deaminase,22551,2158,1.26 [1.14-1.40],6.989636830381748e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADA2,Adenosine deaminase 2,22230,2119,1.96 [1.81-2.13],1.4163174365619574e-58
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,18885,1799,1.35 [1.18-1.54],1.1667022604084793e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,21913,2105,1.27 [1.12-1.44],0.0001431790181466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,22137,2130,1.03 [0.93-1.14],0.5864896646183895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,22551,2158,1.03 [0.92-1.14],0.6362744069500383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,22468,2154,1.38 [1.21-1.56],9.32368459593714e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,19369,1846,1.48 [1.29-1.70],2.101784200547832e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,18885,1799,1.14 [0.99-1.32],0.0744860008711124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,22606,2166,2.20 [1.87-2.59],1.8608546186983018e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,22222,2129,1.23 [1.12-1.35],7.963858583230269e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,21913,2105,1.06 [0.94-1.19],0.3573324060603855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,18885,1799,1.17 [1.03-1.33],0.0164679354041855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,22422,2149,0.84 [0.77-0.92],6.829882354422715e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTSL2,ADAMTS-like protein 2,19475,1856,3.13 [2.83-3.46],1.4907715955438425e-111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTSL4,ADAMTS-like protein 4,18968,1809,1.15 [0.95-1.39],0.1517300281375359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTSL5,ADAMTS-like protein 5,19462,1849,0.87 [0.77-0.97],0.0143957272887794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,21834,2088,1.01 [0.91-1.12],0.8536300354385175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADD1,Alpha-adducin,19045,1813,1.00 [0.94-1.07],0.8818177084921983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRB3,Adhesion G protein-coupled receptor B3,22101,2129,1.26 [1.12-1.41],6.857681446021463e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRD1,Adhesion G-protein coupled receptor D1,19045,1813,1.87 [1.67-2.08],6.267988565326525e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRE1,Adhesion G protein-coupled receptor E1,19369,1846,1.18 [1.09-1.27],3.744108270419099e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRE2,Adhesion G protein-coupled receptor E2,22429,2152,1.81 [1.59-2.06],4.582637616712277e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRE5,Adhesion G protein-coupled receptor E5,22515,2156,1.82 [1.64-2.03],3.183037233562391e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRF5,Adhesion G protein-coupled receptor F5,19462,1849,1.22 [1.04-1.43],0.0171972690966954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRG1,Adhesion G-protein coupled receptor G1,22222,2129,1.50 [1.45-1.55],7.778057630146173e-120
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRG2,Adhesion G-protein coupled receptor G2,22331,2138,0.42 [0.36-0.48],6.850584794538575e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRV1,Adhesion G-protein coupled receptor V1,18824,1792,1.01 [0.94-1.08],0.8192972773362912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADH1B,All-trans-retinol dehydrogenase,19045,1813,1.37 [1.30-1.45],7.13500357932264e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,21913,2105,1.47 [1.41-1.54],2.393762999057881e-62
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADIPOQ,Adiponectin,19494,1852,0.54 [0.51-0.58],5.08969122126903e-79
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADM,Pro-adrenomedullin,22508,2152,1.50 [1.29-1.74],8.970400158239796e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADRA2A,Alpha-2A adrenergic receptor,18799,1796,0.92 [0.86-0.99],0.0228314703364956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AFAP1,Actin filament-associated protein 1,19045,1813,1.00 [0.95-1.06],0.9456904850924444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AFM,Afamin,19494,1852,3.68 [2.95-4.58],2.81540360305313e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AFP,Alpha-fetoprotein,22060,2123,0.90 [0.85-0.96],0.0010555705670899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGBL2,Cytosolic carboxypeptidase 2,18824,1792,0.97 [0.93-1.02],0.2736732042411312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGER,Advanced glycosylation end product-specific receptor,22291,2137,0.91 [0.83-1.00],0.0435339037085901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGR2,Anterior gradient protein 2 homolog,21647,2071,1.18 [1.14-1.23],3.211365540079603e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGR3,Anterior gradient protein 3,21787,2083,1.35 [1.28-1.44],1.6997419155643e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGRN,Agrin,22429,2152,1.77 [1.62-1.94],1.371736171408658e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGRP,Agouti-related protein,22551,2158,1.31 [1.22-1.41],4.811035158444993e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGT,Angiotensinogen,19470,1855,1.23 [1.02-1.49],0.0309047103606983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGXT,Serine--pyruvate aminotransferase,22331,2138,1.39 [1.33-1.46],1.6891446389091066e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AHCY,Adenosylhomocysteinase,22331,2138,1.05 [0.99-1.11],0.0899453846689634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AHNAK,Neuroblast differentiation-associated protein AHNAK,18968,1809,0.94 [0.81-1.09],0.423047696135408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AHNAK2,Protein AHNAK2,18968,1809,1.04 [0.89-1.21],0.6084668326463144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,19371,1841,0.99 [0.92-1.06],0.7397900149450659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AHSG,Alpha-2-HS-glycoprotein,19470,1855,1.58 [1.34-1.86],5.6110942702928615e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AHSP,Alpha-hemoglobin-stabilizing protein,22312,2144,1.05 [1.00-1.10],0.0339192951377967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AIDA,"Axin interactor, dorsalization-associated protein",18933,1813,0.98 [0.93-1.04],0.541127584541419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AIF1,Allograft inflammatory factor 1,21834,2088,1.01 [0.94-1.09],0.7245148413458284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AIF1L,Allograft inflammatory factor 1-like,18968,1809,0.97 [0.89-1.06],0.5051386285044868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",22189,2127,1.14 [1.10-1.18],8.025601673897648e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AK1,Adenylate kinase isoenzyme 1,22331,2138,0.99 [0.93-1.05],0.6841890328026394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AK2,"Adenylate kinase 2, mitochondrial",19425,1849,1.01 [0.96-1.05],0.7967019481697404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKAP12,A-kinase anchor protein 12,19045,1813,0.58 [0.46-0.73],2.492908916773596e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKR1B1,Aldo-keto reductase family 1 member B1,21834,2088,1.04 [0.99-1.10],0.1175762118886662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKR1B10,Aldo-keto reductase family 1 member B10,18933,1813,1.35 [1.28-1.43],8.296040825633781e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKR1C4,Aldo-keto reductase family 1 member C4,21913,2105,1.17 [1.10-1.25],1.537815177411306e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKR7L,Aflatoxin B1 aldehyde reductase member 4,18885,1799,1.38 [1.31-1.45],1.9387891283897984e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKT1S1,Proline-rich AKT1 substrate 1,21826,2083,1.08 [1.02-1.15],0.0107071580693165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKT2,RAC-beta serine/threonine-protein kinase,19419,1844,1.00 [0.97-1.04],0.9813106896653828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKT3,RAC-gamma serine/threonine-protein kinase,21745,2080,0.99 [0.93-1.07],0.8830295649197479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALCAM,CD166 antigen,22606,2166,2.28 [1.89-2.74],3.1884819449672825e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALDH1A1,Retinal dehydrogenase 1,22355,2147,1.48 [1.39-1.57],6.424530692795225e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALDH2,"Aldehyde dehydrogenase, mitochondrial",19371,1841,1.10 [1.02-1.19],0.01320825172337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",22234,2132,1.29 [1.24-1.34],4.0436209083744207e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",19419,1844,1.19 [1.09-1.30],0.0001896980852929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALMS1,Alstrom syndrome protein 1,19109,1826,0.93 [0.84-1.04],0.1932926850248027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALPI,Intestinal-type alkaline phosphatase,18885,1799,1.07 [1.03-1.11],0.0004443808507981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALPP,"Alkaline phosphatase, placental type",22222,2129,1.11 [1.07-1.16],1.907809693960683e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMBN,Ameloblastin,21900,2081,0.88 [0.77-1.02],0.0901394546284157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMBP,Protein AMBP,22471,2151,2.16 [1.80-2.59],1.3746882726701181e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,19475,1856,1.07 [0.90-1.28],0.4308947994525095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMFR,E3 ubiquitin-protein ligase AMFR,21826,2083,1.09 [1.02-1.16],0.0066861121981019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMIGO1,Amphoterin-induced protein 1,18933,1813,0.90 [0.81-0.99],0.0352942082092693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMIGO2,Amphoterin-induced protein 2,22222,2129,1.79 [1.51-2.11],5.413756581962485e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMN,Protein amnionless,21900,2081,1.16 [1.07-1.26],0.0002957775526155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMOT,Angiomotin,19045,1813,1.54 [1.38-1.72],1.9143524116361964e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMOTL2,Angiomotin-like protein 2,19286,1828,0.97 [0.88-1.07],0.5033258618535896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMPD3,AMP deaminase 3,19425,1849,1.06 [1.00-1.13],0.0629935100240571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,18219,1739,0.78 [0.71-0.86],3.677706416105521e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMY2A,Pancreatic alpha-amylase,21444,2052,0.76 [0.70-0.83],7.978666803571491e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMY2B,Alpha-amylase 2B,20800,1990,0.75 [0.69-0.81],3.992862591844653e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANG,Angiogenin,22310,2134,1.32 [1.18-1.48],6.41137196126973e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPT1,Angiopoietin-1,22238,2138,1.04 [0.99-1.08],0.1275763196385574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPT2,Angiopoietin-2,22508,2152,1.83 [1.67-2.01],2.3992873185927863e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL1,Angiopoietin-related protein 1,22016,2100,1.17 [1.02-1.34],0.024872195758115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL2,Angiopoietin-related protein 2,22358,2148,1.68 [1.53-1.84],1.0556708786074048e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL3,Angiopoietin-related protein 3,22375,2141,0.46 [0.41-0.51],7.341399664977051e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL4,Angiopoietin-related protein 4,22391,2150,1.31 [1.21-1.43],4.897062872217617e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL7,Angiopoietin-related protein 7,22508,2152,1.82 [1.66-2.01],8.497842276242405e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANK2,Ankyrin-2,18799,1796,1.00 [0.94-1.06],0.9681835429771732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,18885,1799,1.01 [0.96-1.07],0.6247961325201689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANKRA2,Ankyrin repeat family A protein 2,18754,1788,0.95 [0.87-1.03],0.2235960905624539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANKRD54,Ankyrin repeat domain-containing protein 54,21834,2088,1.03 [0.97-1.10],0.3296955145731011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,18968,1809,0.99 [0.89-1.11],0.9027992011844326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANPEP,Aminopeptidase N,22427,2137,1.44 [1.26-1.64],5.1156267989497616e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANXA1,Annexin A1,18936,1804,1.10 [0.99-1.22],0.082556657115613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANXA10,Annexin A10,21826,2083,1.14 [1.09-1.19],1.9686777750595744e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANXA11,Annexin A11,22249,2134,1.06 [1.00-1.13],0.0427026830990328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANXA2,Annexin A2,18665,1782,1.13 [1.06-1.20],0.0001402533104293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANXA3,Annexin A3,22468,2154,1.06 [1.00-1.12],0.0426055450780467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANXA4,Annexin A4,22237,2128,1.00 [0.95-1.06],0.8614519639917995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANXA5,Annexin A5,21756,2077,1.22 [1.07-1.39],0.0026346529009583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AOC1,Amiloride-sensitive amine oxidase [copper-containing],21900,2081,1.03 [0.96-1.10],0.3943882342519852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AOC3,Membrane primary amine oxidase,22460,2144,2.60 [2.29-2.94],2.3119937450363943e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AP1G2,AP-1 complex subunit gamma-like 2,19371,1841,1.09 [1.03-1.15],0.0024990693917989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AP2B1,AP-2 complex subunit beta,18933,1813,1.01 [0.91-1.11],0.8961374513146235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AP3B1,AP-3 complex subunit beta-1,19369,1846,1.06 [1.00-1.13],0.0373668009912746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AP3S2,AP-3 complex subunit sigma-2,19425,1849,1.07 [0.98-1.18],0.1220876474085091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,22222,2129,1.20 [1.10-1.30],1.266485176599742e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APCS,Serum amyloid P-component,19303,1831,0.93 [0.81-1.06],0.2692401043860364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,22428,2147,1.13 [1.06-1.20],0.0001903276862493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APLP1,Amyloid-like protein 1,22331,2138,0.81 [0.75-0.87],6.165737855616293e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOA1,Apolipoprotein A-I,19494,1852,0.41 [0.34-0.49],3.0277460383491705e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOA2,Apolipoprotein A-II,19470,1855,0.91 [0.83-0.99],0.0363006826439237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOA4,Apolipoprotein A-IV,19494,1852,1.53 [1.38-1.71],5.307270220760566e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOB,Apolipoprotein B-100,19470,1855,0.95 [0.78-1.15],0.5873183702087723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOBR,Apolipoprotein B receptor,18968,1809,0.87 [0.78-0.96],0.007283304388869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOC1,Apolipoprotein C-I,19460,1848,0.37 [0.33-0.42],9.886819353401606e-57
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOD,Apolipoprotein D,18662,1767,0.33 [0.29-0.38],6.292257518197226e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOE,Apolipoprotein E,19494,1852,0.85 [0.78-0.92],2.969225925429712e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOF,Apolipoprotein F,19470,1855,0.49 [0.45-0.53],5.309270295649516e-75
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOH,Beta-2-glycoprotein 1,22355,2147,1.18 [1.07-1.30],0.0014014318837142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOL1,Apolipoprotein L1,19470,1855,0.87 [0.81-0.95],0.0008747676001621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOM,Apolipoprotein M,22412,2141,0.32 [0.28-0.36],3.975738709355709e-73
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APP,Amyloid-beta precursor protein,22329,2143,1.06 [1.00-1.13],0.0349405766825713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APPL2,DCC-interacting protein 13-beta,19045,1813,1.01 [0.97-1.05],0.6526038725414931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APRT,Adenine phosphoribosyltransferase,22087,2128,1.10 [1.02-1.20],0.0199812076592443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARAF,Serine/threonine-protein kinase A-Raf,19109,1826,1.04 [0.97-1.11],0.2318602261232664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AREG,Amphiregulin,22222,2129,1.92 [1.78-2.07],6.682549709224162e-67
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARF6,ADP-ribosylation factor 6,19369,1846,1.05 [1.01-1.10],0.014452077451691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARFIP1,Arfaptin-1,19419,1844,1.00 [0.93-1.07],0.9418549400096954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARG1,Arginase-1,22173,2112,0.98 [0.91-1.05],0.5660529994116332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARG2,"Arginase-2, mitochondrial",19371,1841,0.97 [0.88-1.08],0.5996312178751743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARHGAP1,Rho GTPase-activating protein 1,21834,2088,0.91 [0.84-1.00],0.0429224938677861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARHGAP25,Rho GTPase-activating protein 25,21834,2088,1.02 [0.96-1.09],0.4653886107127049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARHGAP30,Rho GTPase-activating protein 30,19109,1826,0.89 [0.78-1.01],0.0773365580593945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARHGAP45,Rho GTPase-activating protein 45,19045,1813,1.02 [0.96-1.07],0.5898662221824542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARHGAP5,Rho GTPase-activating protein 5,18754,1788,1.01 [0.95-1.06],0.8492437223961106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARHGEF1,Rho guanine nucleotide exchange factor 1,19425,1849,1.07 [1.02-1.13],0.0058127995574056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARHGEF10,Rho guanine nucleotide exchange factor 10,19419,1844,1.03 [0.98-1.08],0.1940158001396945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARHGEF12,Rho guanine nucleotide exchange factor 12,22279,2137,1.05 [1.01-1.09],0.0147657599102089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARHGEF5,Rho guanine nucleotide exchange factor 5,18824,1792,1.03 [0.96-1.09],0.4386535877266916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARID3A,AT-rich interactive domain-containing protein 3A,18824,1792,0.89 [0.80-1.01],0.0630522928098718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARID4B,AT-rich interactive domain-containing protein 4B,21826,2083,1.00 [0.91-1.09],0.9642109252231952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARL13B,ADP-ribosylation factor-like protein 13B,18799,1796,0.99 [0.93-1.06],0.8704696005691241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,18799,1796,0.95 [0.84-1.06],0.3677604450657008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARMCX2,Armadillo repeat-containing X-linked protein 2,18824,1792,0.89 [0.82-0.97],0.0063139128461944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARNT,Aryl hydrocarbon receptor nuclear translocator,21900,2081,0.90 [0.80-1.01],0.0771813393186059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,18799,1796,1.02 [0.94-1.11],0.6652513515656671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARSA,Arylsulfatase A,22355,2147,1.35 [1.25-1.46],2.603524567597506e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARSB,Arylsulfatase B,22222,2129,1.16 [1.08-1.24],2.9032396592456723e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ART3,Ecto-ADP-ribosyltransferase 3,22460,2144,0.80 [0.72-0.89],3.914210776706873e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ART5,Ecto-ADP-ribosyltransferase 5,18824,1792,0.96 [0.89-1.04],0.3233578030014173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARTN,Artemin,21900,2081,1.01 [0.93-1.11],0.7356306774532753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASAH1,Acid ceramidase,19269,1841,1.28 [1.19-1.39],9.225329830451644e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASAH2,Neutral ceramidase,22137,2130,1.64 [1.50-1.78],5.23218378252431e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASGR1,Asialoglycoprotein receptor 1,22137,2130,2.68 [2.40-2.98],1.9963045786479936e-72
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASGR2,Asialoglycoprotein receptor 2,19470,1855,1.12 [0.95-1.31],0.1824275376467401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASPN,Asporin,19462,1849,1.08 [0.92-1.26],0.3597757666783027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASPSCR1,Tether containing UBX domain for GLUT4,19419,1844,1.06 [0.99-1.13],0.107749156181066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASRGL1,Isoaspartyl peptidase/L-asparaginase,18968,1809,0.98 [0.94-1.03],0.4704286440943027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASS1,Argininosuccinate synthase,18799,1796,1.31 [1.24-1.39],1.0721539171002944e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATF2,Cyclic AMP-dependent transcription factor ATF-2,21826,2083,0.98 [0.92-1.04],0.491801264880673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATF4,Cyclic AMP-dependent transcription factor ATF-4,18754,1788,1.15 [1.01-1.30],0.0368802586987829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATG16L1,Autophagy-related protein 16-1,19369,1846,1.07 [1.02-1.13],0.0086278937741158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATG4A,Cysteine protease ATG4A,21834,2088,1.01 [0.95-1.08],0.6591093583966278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATOX1,Copper transport protein ATOX1,22422,2149,1.09 [1.03-1.15],0.0036023727648849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,18799,1796,0.99 [0.90-1.09],0.7749035761545517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,18799,1796,0.96 [0.84-1.10],0.5669108463704619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,18799,1796,1.03 [0.91-1.15],0.6784773077048871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP1B4,Protein ATP1B4,18754,1788,0.96 [0.86-1.07],0.4884894202212515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP2B4,Plasma membrane calcium-transporting ATPase 4,18799,1796,0.91 [0.84-0.99],0.0247740856030062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP5F1D,"ATP synthase subunit delta, mitochondrial",18799,1796,0.93 [0.85-1.02],0.1389366361186124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP5IF1,"ATPase inhibitor, mitochondrial",22429,2152,1.02 [0.99-1.06],0.1915912489029544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP5PO,"ATP synthase subunit O, mitochondrial",21826,2083,0.91 [0.83-1.01],0.0653921189046146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP6AP2,Renin receptor,21834,2088,1.14 [1.04-1.25],0.004853134935108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP6V1D,V-type proton ATPase subunit D,22222,2129,1.03 [0.89-1.19],0.6932197925733519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP6V1F,V-type proton ATPase subunit F,21793,2082,1.04 [0.98-1.10],0.2093198210262149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP6V1G1,V-type proton ATPase subunit G 1,18968,1809,1.05 [0.99-1.12],0.1259021794322373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP6V1G2,V-type proton ATPase subunit G 2,18799,1796,1.00 [0.95-1.05],0.9655848836969692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATRAID,All-trans retinoic acid-induced differentiation factor,19369,1846,1.17 [1.01-1.35],0.0306600350183377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATRN,"Attractin, Isoform 2",19494,1852,3.49 [2.72-4.47],5.674876128226133e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATXN10,Ataxin-10,21826,2083,1.05 [1.00-1.11],0.0569593196590088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATXN2,Ataxin-2,18824,1792,1.02 [0.98-1.06],0.237684906709259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATXN2L,Ataxin-2-like protein,19419,1844,1.11 [1.02-1.22],0.0181031242088363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATXN3,Ataxin-3,19425,1849,1.01 [0.94-1.08],0.787708078908129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AXIN1,Axin-1,22279,2137,1.06 [1.02-1.10],0.0058644289702793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AXL,Tyrosine-protein kinase receptor UFO,22460,2144,1.28 [1.12-1.47],0.0003808242897247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AZI2,5-azacytidine-induced protein 2,19419,1844,1.10 [1.02-1.20],0.0157990496318463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AZU1,Azurocidin,21650,2086,1.06 [1.01-1.11],0.0244071610971393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,B2M,Beta-2-microglobulin,19494,1852,1.21 [1.08-1.35],0.0012203129932435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,18799,1796,0.88 [0.70-1.10],0.2567063038555934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",18968,1809,2.35 [2.07-2.66],3.6649108002316927e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",22429,2152,1.57 [1.37-1.79],3.78459645882992e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,B4GAT1,"Beta-1,4-glucuronyltransferase 1",22355,2147,0.88 [0.75-1.04],0.1317350513238369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BABAM1,BRISC and BRCA1-A complex member 1,18885,1799,0.96 [0.81-1.13],0.5980747278916947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BACH1,Transcription regulator protein BACH1,22279,2137,1.09 [1.03-1.15],0.0020174597024685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAG3,BAG family molecular chaperone regulator 3,22101,2129,0.85 [0.78-0.93],0.0004418838286682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAG4,BAG family molecular chaperone regulator 4,18885,1799,1.07 [0.97-1.17],0.1575612019017661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAG6,Large proline-rich protein BAG6,21913,2105,1.03 [0.92-1.15],0.6137511219891245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,21834,2088,1.52 [1.44-1.59],2.2592669921424693e-59
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,21834,2088,1.18 [1.03-1.34],0.0140253980324524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BANK1,B-cell scaffold protein with ankyrin repeats,22279,2137,1.07 [1.03-1.11],0.0003343282563557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAP18,Chromatin complexes subunit BAP18,19425,1849,1.10 [1.04-1.17],0.0017956204205679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BATF,Basic leucine zipper transcriptional factor ATF-like,18933,1813,1.02 [0.97-1.08],0.3620167063597117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAX,Apoptosis regulator BAX,21793,2079,1.04 [0.99-1.08],0.1133184499869044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCAM,Basal cell adhesion molecule,22355,2147,1.37 [1.18-1.59],3.226493716682821e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCAN,Brevican core protein,22137,2130,0.52 [0.47-0.58],6.604404153554097e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",19462,1849,1.10 [0.95-1.27],0.2037310571362446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",18824,1792,0.93 [0.85-1.02],0.1097247699161358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCHE,Cholinesterase,19109,1818,1.73 [1.45-2.05],8.376883834056115e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCL2,Apoptosis regulator Bcl-2,19369,1846,0.99 [0.91-1.07],0.818956522102409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCL2L1,Bcl-2-like protein 1,19425,1849,1.02 [0.98-1.07],0.3152009754322573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",22279,2137,1.16 [1.05-1.27],0.0026566795629137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCL2L15,Bcl-2-like protein 15,18885,1799,1.19 [1.10-1.28],2.829160982451917e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCL7A,B-cell CLL/lymphoma 7 protein family member A,18754,1788,0.99 [0.92-1.07],0.856068353242242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCL7B,B-cell CLL/lymphoma 7 protein family member B,19371,1841,0.92 [0.83-1.02],0.1195203385912111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCR,Breakpoint cluster region protein,22279,2137,1.07 [1.02-1.11],0.0024647585292621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BDNF,Brain-derived neurotrophic factor,19475,1856,1.04 [0.98-1.09],0.1970164740927931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BECN1,Beclin-1,18968,1809,1.14 [1.06-1.23],0.0007578962727551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BEX3,Protein BEX3,18754,1788,1.01 [0.92-1.11],0.8065371660055505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BGLAP,Osteocalcin,19475,1856,0.83 [0.79-0.87],7.528122849458095e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BGN,Biglycan,21790,2086,1.00 [0.97-1.04],0.9232862911461448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BHLHE40,Class E basic helix-loop-helix protein 40,18824,1792,1.00 [0.94-1.07],0.9202391750628522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,18799,1796,1.02 [0.85-1.22],0.8391156779905344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BID,BH3-interacting domain death agonist,22279,2137,1.07 [1.01-1.13],0.0151070970217461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BIN2,Bridging integrator 2,22355,2147,1.05 [1.00-1.09],0.0379194568147487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BIRC2,Baculoviral IAP repeat-containing protein 2,21834,2088,1.03 [0.96-1.09],0.4083073564861222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BLMH,Bleomycin hydrolase,22606,2166,0.85 [0.75-0.95],0.0063740722966021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BLNK,B-cell linker protein,18885,1799,1.02 [0.91-1.15],0.6773942815549723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,18824,1792,0.96 [0.90-1.02],0.2240085221068999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,19425,1849,1.00 [0.89-1.12],0.9556503709977968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BLVRB,Flavin reductase,22355,2147,1.04 [0.99-1.10],0.1493085489813097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BMP10,Bone morphogenetic protein 10,19045,1813,1.09 [0.93-1.28],0.2701429657136892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BMP4,Bone morphogenetic protein 4,22101,2129,1.23 [1.14-1.33],3.415249944608451e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BMP6,Bone morphogenetic protein 6,21885,2103,1.25 [1.14-1.38],3.519544169614684e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BMPER,BMP-binding endothelial regulator protein,19045,1813,2.95 [2.49-3.50],2.546169192435986e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,19462,1849,0.96 [0.84-1.10],0.6029103935445582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,18885,1799,1.12 [1.01-1.24],0.0389014387181745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BOC,Brother of CDO,21913,2105,1.19 [1.01-1.41],0.0432498392922688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BOLA1,BolA-like protein 1,18824,1792,1.07 [0.98-1.16],0.1306390040163816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BOLA2_BOLA2B,BolA-like protein 2,18968,1809,1.00 [0.92-1.09],0.987300121948362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BPIFA2,BPI fold-containing family A member 2,18299,1743,0.97 [0.93-1.01],0.1691631664243124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BPIFB1,BPI fold-containing family B member 1,22277,2136,0.84 [0.79-0.89],6.489887904188456e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BPIFB2,BPI fold-containing family B member 2,19420,1848,1.24 [1.17-1.32],1.1662060340551344e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BRAP,BRCA1-associated protein,19199,1826,1.05 [1.01-1.10],0.0226508155203033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BRD1,Bromodomain-containing protein 1,19109,1826,1.02 [0.88-1.18],0.7714438641093688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BRD2,Bromodomain-containing protein 2,18824,1792,0.99 [0.86-1.13],0.8440265844260139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BRD3,Bromodomain-containing protein 3,18799,1796,1.02 [0.93-1.12],0.643401280018984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BRDT,Bromodomain testis-specific protein,18799,1796,1.14 [1.01-1.28],0.0370850961014306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BRK1,Protein BRICK1,21826,2083,0.95 [0.87-1.04],0.239877524613003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BRME1,Break repair meiotic recombinase recruitment factor 1,18824,1792,0.93 [0.83-1.04],0.1908401335235045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BRSK2,Serine/threonine-protein kinase BRSK2,19419,1844,1.03 [0.91-1.15],0.6785553568458713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BSG,Basigin,22519,2155,1.13 [0.95-1.36],0.1707566401623238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BSND,Barttin,18754,1788,0.99 [0.87-1.14],0.926738361583687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,22509,2156,1.16 [1.06-1.27],0.0011376818443624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BST2,Bone marrow stromal antigen 2,22509,2156,1.39 [1.30-1.47],4.4303216505960216e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BTC,Probetacellulin,21834,2088,0.94 [0.89-0.99],0.0238511763094208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BTD,Biotinidase,19494,1852,1.98 [1.58-2.48],2.165083197419782e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BTLA,B- and T-lymphocyte attenuator,18754,1788,1.03 [0.98-1.08],0.2378259534675729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BTN1A1,Butyrophilin subfamily 1 member A1,19331,1839,0.97 [0.86-1.09],0.5959153924436711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BTN2A1,Butyrophilin subfamily 2 member A1,22429,2152,1.55 [1.36-1.77],5.38691534402716e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BTN3A2,Butyrophilin subfamily 3 member A2,22279,2137,1.20 [1.09-1.32],0.0001135018984383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BTNL10,Butyrophilin-like protein 10,18754,1788,0.93 [0.82-1.05],0.2239003196130957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C19orf12,Protein C19orf12,21826,2083,1.34 [1.28-1.41],4.795431833596804e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1GALT1C1,C1GALT1-specific chaperone 1,18799,1796,1.12 [0.98-1.29],0.0892289374466092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1QA,Complement C1q subcomponent subunit A,22450,2151,1.19 [1.00-1.42],0.0443588722161155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",19419,1844,0.99 [0.93-1.06],0.7361671326481978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1QL2,Complement C1q-like protein 2,18885,1799,0.90 [0.81-0.99],0.0377693769227439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,22460,2144,1.88 [1.74-2.02],5.2258178472080923e-61
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,19045,1813,1.07 [0.95-1.21],0.2814775734850169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,19419,1844,1.12 [0.99-1.28],0.0766048084118811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,19009,1810,0.84 [0.77-0.92],0.0001626059656481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1R,Complement C1r subcomponent,19494,1852,1.11 [0.87-1.42],0.3924134334990338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1RL,Complement C1r subcomponent-like protein,19456,1849,1.59 [1.26-2.00],8.333661188656452e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1S,Complement C1s subcomponent,19494,1852,1.09 [0.88-1.35],0.4287861835505967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C2,Complement C2,22412,2141,3.18 [2.62-3.87],1.959258472865784e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C2CD2L,Phospholipid transfer protein C2CD2L,21793,2082,1.11 [1.01-1.21],0.0230054328397449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C2orf69,UPF0565 protein C2orf69,18933,1813,0.95 [0.87-1.03],0.1782512869835013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C3,Complement C3,18470,1746,1.48 [1.36-1.60],8.013075338793527e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C4BPB,C4b-binding protein beta chain,22422,2149,0.83 [0.75-0.91],0.0001173903283016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C5,Complement C5,19494,1852,1.46 [1.08-1.97],0.0131060556291658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C7,Complement component C7,19008,1806,2.51 [2.19-2.89],3.6850274515461e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C7orf50,Uncharacterized protein C7orf50,19425,1849,1.05 [0.87-1.28],0.6037509275299486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C8B,Complement component C8 beta chain,19494,1852,1.00 [0.86-1.16],0.991330465323255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C9,Complement component C9,19470,1855,0.77 [0.72-0.83],5.2814127316728814e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C9orf40,Uncharacterized protein C9orf40,19369,1846,1.00 [0.95-1.06],0.899030575704827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA1,Carbonic anhydrase 1,21868,2102,1.02 [0.96-1.09],0.5033202359147744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA11,Carbonic anhydrase-related protein 11,21834,2088,1.01 [0.90-1.13],0.9006391001913995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA12,Carbonic anhydrase 12,22222,2129,1.49 [1.33-1.67],8.344277413167917e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA13,Carbonic anhydrase 13,22103,2114,1.01 [0.98-1.05],0.4669099772362209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA14,Carbonic anhydrase 14,22508,2152,0.48 [0.43-0.53],3.7871149181118135e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA2,Carbonic anhydrase 2,22267,2140,1.04 [0.99-1.10],0.1359739444220215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA3,Carbonic anhydrase 3,22571,2164,1.08 [1.02-1.15],0.0118262387742153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA4,Carbonic anhydrase 4,22606,2166,0.87 [0.74-1.01],0.0749804241661812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA5A,"Carbonic anhydrase 5A, mitochondrial",21913,2105,1.21 [1.17-1.26],8.066324107779739e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA6,Carbonic anhydrase 6,22291,2138,0.85 [0.80-0.90],1.274146168691649e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA7,Carbonic anhydrase 7,19109,1826,1.00 [0.88-1.14],0.9723494305100618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA8,Carbonic anhydrase-related protein,18885,1799,1.09 [0.92-1.28],0.3169961853616938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA9,Carbonic anhydrase 9,22508,2152,1.31 [1.22-1.41],3.651702547825978e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CABP2,Calcium-binding protein 2,18933,1813,0.97 [0.90-1.05],0.4344570215087763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,18824,1792,0.91 [0.79-1.05],0.2066331145028884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,18799,1796,0.94 [0.87-1.02],0.1389193569285668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,18824,1792,1.00 [0.93-1.08],0.9431872725796724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,19419,1844,1.07 [1.02-1.13],0.010758798575033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CACYBP,Calcyclin-binding protein,19017,1812,1.05 [1.00-1.10],0.0315930588801503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CADPS,Calcium-dependent secretion activator 1,18933,1813,0.93 [0.83-1.04],0.2081640604794477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CALB1,Calbindin,22222,2129,1.07 [0.98-1.16],0.1308927077409928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CALB2,Calretinin,21826,2083,1.23 [1.12-1.35],1.80694476133854e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CALCA,Calcitonin,22104,2129,1.23 [1.16-1.29],2.2415399987742194e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CALCB,Calcitonin gene-related peptide 2,19425,1849,0.98 [0.87-1.09],0.6741210311977506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,22431,2144,1.03 [1.00-1.07],0.0792425676644019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,18968,1809,1.09 [1.03-1.16],0.0052523138215313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CALY,Neuron-specific vesicular protein calcyon,18799,1796,1.00 [0.88-1.13],0.9883544761419166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,21834,2088,1.04 [0.95-1.13],0.4440459361368113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,18933,1813,0.95 [0.87-1.03],0.2282282158136044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,19419,1844,1.05 [1.00-1.09],0.0399132716438522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CANT1,Soluble calcium-activated nucleotidase 1,22253,2132,1.62 [1.34-1.95],3.50181685796434e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CAPG,Macrophage-capping protein,22131,2118,1.11 [1.04-1.19],0.0013472154590064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CAPN3,Calpain-3,19371,1841,1.04 [0.92-1.17],0.5540117577981067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CAPS,Calcyphosin,19425,1849,0.99 [0.95-1.04],0.7284843895730708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CARHSP1,Calcium-regulated heat-stable protein 1,21826,2083,1.01 [0.93-1.08],0.8926421906274068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CASC3,Protein CASC3,18933,1813,1.04 [0.93-1.16],0.4979317757355738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CASP1,Caspase-1,21826,2083,1.04 [0.98-1.10],0.172596880554315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CASP10,Caspase-10,21826,2083,1.05 [0.99-1.11],0.114443902034958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CASP2,Caspase-2,22279,2137,1.07 [1.01-1.13],0.0180099429241796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CASP3,Caspase-3,22606,2166,1.02 [0.98-1.07],0.3567410506609028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CASP4,Caspase-4,19109,1826,1.00 [0.98-1.03],0.7174536015764967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CASP7,Caspase-7,19425,1849,1.00 [0.95-1.06],0.9570398325466098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CASP8,Caspase-8,22433,2147,0.95 [0.89-1.01],0.1019506154022209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CASP9,Caspase-9,18885,1799,0.91 [0.85-0.99],0.0204119534842805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CASQ2,Calsequestrin-2,18799,1796,0.87 [0.78-0.96],0.0084641704648074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CAT,Catalase,19190,1825,1.03 [0.95-1.12],0.4173568527711002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CBLIF,Cobalamin binding intrinsic factor,22288,2136,1.24 [1.18-1.30],8.1683313147079e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CBLN1,Cerebellin-1,18824,1792,0.96 [0.91-1.01],0.1369287992984874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CBLN4,Cerebellin-4,22508,2152,1.38 [1.24-1.53],2.777193922005157e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CBS,Cystathionine beta-synthase,18968,1809,1.45 [1.36-1.56],3.783290610560096e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CBX2,Chromobox protein homolog 2,18799,1796,0.87 [0.77-0.98],0.0247817301816207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,22137,2130,1.07 [1.02-1.13],0.0083702167583058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCAR2,Cell cycle and apoptosis regulator protein 2,19425,1849,1.02 [0.94-1.10],0.7199321287884255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCDC134,Coiled-coil domain-containing protein 134,19371,1841,1.06 [0.97-1.16],0.2045076812010074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCDC28A,Coiled-coil domain-containing protein 28A,18933,1813,0.95 [0.81-1.11],0.5074607643240504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCDC50,Coiled-coil domain-containing protein 50,19419,1844,0.95 [0.89-1.01],0.0851191179055894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCDC80,Coiled-coil domain-containing protein 80,22331,2138,1.13 [1.02-1.25],0.0224220619543857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,18968,1809,0.96 [0.89-1.03],0.2889260324554171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL11,Eotaxin,22551,2158,1.50 [1.35-1.66],1.8748425589223733e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL13,C-C motif chemokine 13,22516,2155,1.07 [1.01-1.13],0.0175751215062695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL14,C-C motif chemokine 14,22310,2134,0.99 [0.90-1.09],0.8079964386959967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL15,C-C motif chemokine 15,22606,2166,1.79 [1.65-1.93],1.5754056354425138e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL16,C-C motif chemokine 16,22606,2166,1.43 [1.33-1.54],2.932842059892725e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL17,C-C motif chemokine 17,22294,2139,1.03 [0.99-1.08],0.1158425023808727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL18,C-C motif chemokine 18,22049,2114,1.05 [1.00-1.11],0.0574361827235808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL19,C-C motif chemokine 19,22509,2156,1.07 [1.04-1.10],8.49499901538448e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL2,C-C motif chemokine 2,22101,2129,1.01 [0.94-1.09],0.6921487038972937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL20,C-C motif chemokine 20,22551,2158,1.23 [1.19-1.28],9.928311118647102e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL21,C-C motif chemokine 21,22429,2152,1.35 [1.26-1.44],3.989271933923503e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL22,C-C motif chemokine 22,22138,2124,1.19 [1.11-1.28],1.1293958572675898e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL23,C-C motif chemokine 23,22429,2152,0.94 [0.86-1.03],0.1634464954832827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL24,C-C motif chemokine 24,22391,2150,1.00 [0.96-1.05],0.8840969422796394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL25,C-C motif chemokine 25,22551,2158,1.31 [1.21-1.41],2.363603052114868e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL26,C-C motif chemokine 26,22279,2137,0.99 [0.95-1.03],0.6168393207438935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL27,C-C motif chemokine 27,22331,2138,0.97 [0.91-1.03],0.3458643428932548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL28,C-C motif chemokine 28,22197,2127,1.08 [1.01-1.15],0.0239988022748846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL3,C-C motif chemokine 3,22279,2137,1.17 [1.12-1.23],9.138899181039368e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL4,C-C motif chemokine 4,22364,2145,1.09 [1.03-1.14],0.0011003025886512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL5,C-C motif chemokine 5,22460,2144,1.07 [1.03-1.11],0.0002951143861321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL7,C-C motif chemokine 7,22279,2137,1.22 [1.15-1.29],6.409521725967459e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL8,C-C motif chemokine 8,22471,2151,0.96 [0.90-1.02],0.2027897559983918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCN1,CCN family member 1,22178,2127,1.13 [1.08-1.20],3.728771635526346e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCN2,CCN family member 2,22301,2141,1.04 [0.97-1.11],0.3106282280770357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCN3,CCN family member 3,22567,2159,1.15 [1.04-1.28],0.0092194737912204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCN4,CCN family member 4,22508,2152,1.45 [1.32-1.58],2.171723003516984e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCN5,CCN family member 5,22355,2147,1.25 [1.13-1.37],1.0767637777869524e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCND2,G1/S-specific cyclin-D2,19109,1826,0.98 [0.87-1.10],0.7116651174539008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCNE1,G1/S-specific cyclin-E1,18885,1799,0.98 [0.93-1.04],0.5091156884767041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCS,Copper chaperone for superoxide dismutase,22137,2130,0.94 [0.86-1.02],0.1223539546515572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCT5,T-complex protein 1 subunit epsilon,21834,2088,1.06 [0.98-1.16],0.1547406089240608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD101,Immunoglobulin superfamily member 2,19369,1846,1.29 [1.16-1.43],2.246583174358349e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD109,CD109 antigen,22355,2147,1.56 [1.39-1.75],3.2794717581624546e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD14,Monocyte differentiation antigen CD14,21936,2109,1.26 [1.15-1.38],1.0055014140059612e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD160,CD160 antigen,22551,2158,1.13 [1.05-1.22],0.0013697701664988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,22460,2144,1.61 [1.49-1.75],7.911917617359849e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD164,Sialomucin core protein 24,22355,2147,1.41 [1.29-1.55],1.5656629682419157e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD164L2,CD164 sialomucin-like 2 protein,18933,1813,0.83 [0.73-0.94],0.0036852789280463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD177,CD177 antigen,22321,2143,1.01 [0.98-1.04],0.3962117181324619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD1C,T-cell surface glycoprotein CD1c,22422,2149,0.66 [0.57-0.77],5.97609559662644e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD2,T-cell surface antigen CD2,18799,1796,1.19 [1.08-1.31],0.0005291949034689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD200,OX-2 membrane glycoprotein,22279,2137,0.82 [0.71-0.94],0.0053052035162965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD200R1,Cell surface glycoprotein CD200 receptor 1,22212,2130,1.22 [1.09-1.36],0.0003171199186874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD207,C-type lectin domain family 4 member K,21827,2092,1.32 [1.20-1.46],4.0036422285689626e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD209,CD209 antigen,22400,2149,0.80 [0.73-0.88],1.0613443051208603e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD22,B-cell receptor CD22,22551,2158,1.35 [1.25-1.47],4.3318088996001554e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD226,CD226 antigen,18885,1799,1.07 [0.96-1.19],0.2435067672172025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD244,Natural killer cell receptor 2B4,22551,2158,1.56 [1.36-1.78],3.1983108884251993e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD248,Endosialin,19475,1856,0.58 [0.52-0.65],8.544201420567087e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD27,CD27 antigen,22422,2149,1.41 [1.30-1.54],1.5251945755156072e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD274,Programmed cell death 1 ligand 1,22137,2130,1.36 [1.22-1.51],9.650380141333197e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD276,CD276 antigen,22325,2139,1.68 [1.50-1.87],7.036812579383595e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD28,T-cell-specific surface glycoprotein CD28,21834,2088,1.42 [1.30-1.56],8.160266377731533e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD2AP,CD2-associated protein,22331,2138,1.12 [1.06-1.19],0.0001382262811099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD300A,CMRF35-like molecule 8,19045,1813,1.31 [1.14-1.52],0.0002007985104377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD300C,CMRF35-like molecule 6,22509,2156,1.43 [1.30-1.59],3.088044153808304e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD300E,CMRF35-like molecule 2,22435,2146,1.24 [1.14-1.36],1.1936809948293829e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD300LF,CMRF35-like molecule 1,22508,2152,1.04 [0.97-1.10],0.2603161958094538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD300LG,CMRF35-like molecule 9,22355,2147,0.57 [0.51-0.63],9.429160735029154e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD302,CD302 antigen,22222,2129,1.48 [1.32-1.66],2.0974445226261143e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD33,Myeloid cell surface antigen CD33,22422,2149,1.09 [1.04-1.15],0.0004972793307897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD34,Hematopoietic progenitor cell antigen CD34,22449,2154,0.49 [0.42-0.57],1.2845392572683033e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD36,Platelet glycoprotein 4,18885,1799,1.13 [1.03-1.25],0.0115057514674118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,22222,2129,1.34 [1.19-1.50],6.08661931757569e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD3D,T-cell surface glycoprotein CD3 delta chain,18824,1792,0.97 [0.85-1.11],0.6732032707730509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD3E,T-cell surface glycoprotein CD3 epsilon chain,19109,1826,0.93 [0.82-1.06],0.2755627234950436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD3G,T-cell surface glycoprotein CD3 gamma chain,18885,1799,0.98 [0.93-1.03],0.3841327667463798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD4,T-cell surface glycoprotein CD4,22242,2132,1.51 [1.36-1.67],7.444044442801928e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD40,Tumor necrosis factor receptor superfamily member 5,22326,2143,1.18 [1.10-1.28],1.3537850175360876e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD40LG,CD40 ligand,22551,2158,1.01 [0.96-1.06],0.7855362374756215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD46,Membrane cofactor protein,22238,2125,1.27 [1.12-1.45],0.0002814634960591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD48,CD48 antigen,22391,2150,1.59 [1.41-1.79],8.625388145569383e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD5,T-cell surface glycoprotein CD5,22471,2151,1.49 [1.37-1.62],5.709176435467913e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD55,Complement decay-accelerating factor,21582,2059,0.90 [0.77-1.04],0.1506784020058754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD58,Lymphocyte function-associated antigen 3,22296,2136,0.79 [0.64-0.98],0.0313350495795115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD59,CD59 glycoprotein,21568,2053,1.46 [1.25-1.70],1.447919486754102e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD5L,CD5 antigen-like,19380,1838,0.92 [0.84-1.02],0.1031154662288182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD6,T-cell differentiation antigen CD6,22519,2155,1.17 [1.09-1.26],1.165963896679002e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD63,CD63 antigen,22101,2129,1.27 [1.18-1.37],1.2938311613173075e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD69,Early activation antigen CD69,22240,2128,1.07 [1.02-1.11],0.0046359739037822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD7,T-cell antigen CD7,18840,1793,1.18 [1.06-1.30],0.0020189283297824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD70,CD70 antigen,22279,2137,0.98 [0.90-1.07],0.6609980205325721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD72,B-cell differentiation antigen CD72,19045,1813,1.30 [1.18-1.44],2.5717211248580776e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD74,HLA class II histocompatibility antigen gamma chain,22509,2156,1.58 [1.43-1.75],3.600662468667532e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,22551,2158,1.21 [1.12-1.31],1.5118660637272075e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD80,T-lymphocyte activation antigen CD80,19462,1849,2.11 [1.89-2.36],2.007976246383939e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD82,CD82 antigen,19109,1826,1.07 [0.96-1.19],0.2007081149773887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD83,CD83 antigen,22279,2137,1.58 [1.42-1.75],1.4669474742401904e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD84,SLAM family member 5,22279,2137,1.02 [0.91-1.16],0.7110156119029298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD86,T-lymphocyte activation antigen CD86,19369,1846,0.88 [0.76-1.03],0.1056338725300208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD8A,T-cell surface glycoprotein CD8 alpha chain,22509,2156,1.32 [1.23-1.42],7.569247809401888e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD93,Complement component C1q receptor,21533,2078,0.83 [0.73-0.94],0.0032744126546246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD99,CD99 antigen,22355,2147,0.88 [0.73-1.07],0.203127714859172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD99L2,CD99 antigen-like protein 2,22355,2147,0.89 [0.76-1.04],0.1412338356266242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDA,Cytidine deaminase,19417,1845,1.14 [1.04-1.25],0.0044414690465622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDAN1,Codanin-1,19425,1849,1.00 [0.84-1.20],0.9704663064957606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDC123,Cell division cycle protein 123 homolog,18754,1788,1.05 [0.97-1.12],0.2158589414124535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDC25A,M-phase inducer phosphatase 1,18754,1788,0.99 [0.88-1.11],0.8288993755437757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDC26,Anaphase-promoting complex subunit CDC26,19325,1840,1.04 [0.97-1.11],0.2743834030786524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDC27,Cell division cycle protein 27 homolog,21834,2088,1.11 [1.04-1.18],0.0010771294209151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDC37,Hsp90 co-chaperone Cdc37,22422,2149,1.03 [0.98-1.07],0.2621668561390334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDC42BPB,Serine/threonine-protein kinase MRCK beta,19369,1846,1.04 [0.99-1.08],0.0890302111339931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDCP1,CUB domain-containing protein 1,22137,2130,1.47 [1.38-1.57],8.068020346578909e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH1,Cadherin-1,21625,2059,1.76 [1.64-1.90],2.459277958175366e-51
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH15,Cadherin-15,22476,2155,1.36 [1.30-1.43],1.194389043725158e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH17,Cadherin-17,22331,2138,1.43 [1.36-1.51],2.5639579464182644e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH2,Cadherin-2,22331,2138,2.48 [2.24-2.74],3.9778312424168114e-70
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH22,Cadherin-22,19109,1826,1.09 [0.93-1.27],0.2690850816607433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH23,Cadherin-23,19425,1849,0.88 [0.74-1.05],0.1562568906511466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH3,Cadherin-3,22509,2156,0.97 [0.88-1.08],0.6307605867264702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH4,Cadherin-4,18824,1792,0.96 [0.88-1.06],0.4399054603530299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH5,Cadherin-5,22606,2166,0.90 [0.79-1.02],0.0944757441958304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH6,Cadherin-6,22331,2138,1.31 [1.19-1.44],7.524198002050243e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDHR1,Cadherin-related family member 1,21826,2083,1.11 [1.02-1.21],0.0204414615038517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDHR2,Cadherin-related family member 2,22222,2129,1.48 [1.40-1.57],5.655084170444245e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDHR5,Cadherin-related family member 5,22331,2138,1.24 [1.12-1.38],2.741754993837925e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDK1,Cyclin-dependent kinase 1,18754,1788,1.23 [1.09-1.40],0.0009545221414335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,19419,1844,1.05 [0.97-1.13],0.2115874124126822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDKL5,Cyclin-dependent kinase-like 5,18824,1792,0.92 [0.84-1.01],0.0692496618388418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDKN1A,Cyclin-dependent kinase inhibitor 1,22222,2129,1.08 [1.04-1.12],1.602721756672825e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,22222,2129,1.02 [0.98-1.06],0.3384393127231355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDNF,Cerebral dopamine neurotrophic factor,22222,2129,0.98 [0.87-1.10],0.7125376223413658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,22359,2146,1.57 [1.36-1.83],3.1888981825117387e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDSN,Corneodesmosin,22483,2147,0.83 [0.76-0.91],3.7704567469978495e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,22385,2142,1.81 [1.53-2.14],2.803233307295392e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,19369,1846,1.20 [1.13-1.27],6.71088753948031e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,19109,1826,1.02 [0.96-1.09],0.4779261026407546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,19369,1846,0.94 [0.84-1.05],0.2492608202593207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,19109,1826,1.26 [1.16-1.37],1.081868834484972e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,22279,2137,1.06 [1.02-1.11],0.0066878899265865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,21834,2088,0.98 [0.91-1.07],0.679137418602899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,21570,2065,1.21 [1.14-1.28],1.6947474313297387e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,19475,1856,1.31 [1.19-1.45],5.064511972298815e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,21913,2105,1.21 [1.13-1.31],4.352425306709671e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEBPA,CCAAT/enhancer-binding protein alpha,18885,1799,1.08 [0.95-1.23],0.2440950409887414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEBPB,CCAAT/enhancer-binding protein beta,21913,2105,1.12 [1.02-1.24],0.0189850380252288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CELA2A,Chymotrypsin-like elastase family member 2A,19475,1856,0.90 [0.84-0.96],0.0029704687895667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CELA3A,Chymotrypsin-like elastase family member 3A,22573,2164,0.90 [0.85-0.96],0.0020919092346229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,19045,1813,0.99 [0.85-1.15],0.8859341157086804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEMIP2,Cell surface hyaluronidase,18885,1799,1.45 [1.33-1.59],8.50610765121042e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEND1,Cell cycle exit and neuronal differentiation protein 1,18824,1792,1.01 [0.94-1.09],0.7186994331383869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CENPF,Centromere protein F,19109,1826,1.03 [0.95-1.11],0.501014436356407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CENPJ,Centromere protein J,19109,1826,1.02 [0.96-1.09],0.4873627697709017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEP112,Centrosomal protein of 112 kDa,18799,1796,0.98 [0.88-1.08],0.6863982093710831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEP152,Centrosomal protein of 152 kDa,18754,1788,0.95 [0.85-1.06],0.3856946197544744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEP164,Centrosomal protein of 164 kDa,21900,2081,1.02 [0.96-1.08],0.5915973707226572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEP170,Centrosomal protein of 170 kDa,18968,1809,1.03 [0.97-1.09],0.367428088372459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEP20,Centrosomal protein 20,21834,2088,1.10 [1.05-1.16],0.0001578582121531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEP290,Centrosomal protein of 290 kDa,19109,1826,1.00 [0.92-1.09],0.9735458216221864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEP350,Centrosome-associated protein 350,18754,1788,0.92 [0.81-1.03],0.1474363442590698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEP43,Centrosomal protein 43,21740,2092,1.11 [1.05-1.17],0.0003851196836643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEP85,Centrosomal protein of 85 kDa,21834,2088,1.09 [1.03-1.16],0.0036206120584108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CERT,Ceramide transfer protein,21826,2083,1.02 [0.95-1.08],0.6466364571141279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CES1,Liver carboxylesterase 1,22407,2150,1.43 [1.38-1.49],8.181194225373878e-71
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CES2,Cocaine esterase,22222,2129,1.42 [1.34-1.51],2.764769780126706e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CES3,Carboxylesterase 3,22222,2129,1.19 [1.13-1.25],4.838178105685762e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CETN2,Centrin-2,21826,2083,1.09 [1.03-1.15],0.0043731010681779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CETN3,Centrin-3,19369,1846,1.03 [0.98-1.10],0.2571326881418959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFB,Complement factor B,19140,1808,2.11 [1.83-2.43],1.9531881649345893e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFC1,Cryptic protein,21834,2088,1.30 [1.20-1.41],1.466487709213054e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFD,Complement factor D,19494,1852,0.66 [0.53-0.82],0.0002247264098652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFH,Complement factor H,18338,1727,2.82 [2.30-3.46],2.090305518002238e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFHR2,Complement factor H-related protein 2,19344,1832,1.06 [0.98-1.15],0.1531554762235161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFHR4,Complement factor H-related protein 4,19458,1849,0.85 [0.80-0.91],1.2690446184015609e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFHR5,Complement factor H-related protein 5,19208,1828,0.85 [0.77-0.95],0.0027792526437284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFI,Complement factor I,19494,1852,4.10 [3.26-5.15],1.1701693080996821e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFP,Properdin,19494,1852,0.94 [0.76-1.16],0.5801868857133512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CGA,Glycoprotein hormones alpha chain,22355,2147,1.07 [1.01-1.14],0.0260330345065242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,19470,1855,0.96 [0.85-1.08],0.5022367254764191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CGN,Cingulin,18933,1813,1.04 [0.93-1.15],0.5224791579644439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CGREF1,Cell growth regulator with EF hand domain protein 1,22331,2138,1.44 [1.32-1.58],2.3551506204190554e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,21834,2088,1.01 [0.95-1.08],0.7093361688638194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHAD,Chondroadherin,19045,1813,0.52 [0.48-0.57],8.135785986183001e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",19425,1849,1.65 [1.51-1.80],7.04517552693958e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHCHD6,MICOS complex subunit MIC25,19371,1841,1.49 [1.31-1.70],1.266113053599523e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHEK2,Serine/threonine-protein kinase Chk2,21913,2105,0.96 [0.85-1.08],0.5045324336406588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHGA,Chromogranin-A,19475,1856,1.12 [1.08-1.17],6.131287773523111e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHGB,Secretogranin-1,22441,2149,1.03 [0.95-1.13],0.4638147183958558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHI3L1,Chitinase-3-like protein 1,21891,2088,1.27 [1.21-1.32],6.010904742144634e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHIT1,Chitotriosidase-1,22434,2148,1.00 [0.97-1.02],0.7524724575119023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHL1,Neural cell adhesion molecule L1-like protein,22428,2141,0.65 [0.57-0.74],1.4781586102139055e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHM,Rab proteins geranylgeranyltransferase component A 1,18933,1813,1.00 [0.93-1.08],0.992798182762885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHMP1A,Charged multivesicular body protein 1a,22137,2130,1.00 [0.96-1.06],0.843333161084468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHMP6,Charged multivesicular body protein 6,19462,1849,1.08 [1.00-1.17],0.0614502893035302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHP1,Calcineurin B homologous protein 1,18824,1792,0.95 [0.89-1.02],0.1382565432066105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHRDL1,Chordin-like protein 1,22391,2150,1.02 [0.90-1.15],0.7704723953900868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHRDL2,Chordin-like protein 2,22331,2138,1.34 [1.24-1.46],3.704597725536936e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHRM1,Muscarinic acetylcholine receptor M1,18933,1813,0.89 [0.78-1.01],0.0728006099850609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CIAPIN1,Anamorsin,22422,2149,1.05 [0.99-1.12],0.0973455324694533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CILP,Cartilage intermediate layer protein 1,19475,1856,1.66 [1.52-1.82],4.182561970156854e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CINP,Cyclin-dependent kinase 2-interacting protein,19109,1826,1.01 [0.92-1.12],0.7955977656458942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CIRBP,Cold-inducible RNA-binding protein,19369,1846,1.02 [0.97-1.07],0.4805951511540224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CIT,Citron Rho-interacting kinase,18933,1813,1.03 [0.94-1.14],0.5219949412723421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CKAP4,Cytoskeleton-associated protein 4,22455,2149,1.38 [1.22-1.57],5.803371699189289e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CKB,Creatine kinase B-type,19475,1856,0.58 [0.53-0.62],5.550534572487459e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",22263,2133,1.19 [1.12-1.26],2.36166126429025e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLASP1,CLIP-associating protein 1,18754,1788,1.00 [0.94-1.07],0.9839785791350724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLC,Galectin-10,22292,2135,1.04 [0.99-1.10],0.1464926015034779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC10A,C-type lectin domain family 10 member A,22137,2130,0.99 [0.89-1.10],0.864406190708042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC11A,C-type lectin domain family 11 member A,22322,2146,1.01 [0.93-1.09],0.8873553794081243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC12A,C-type lectin domain family 12 member A,18885,1799,1.25 [1.00-1.55],0.0468498374551116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC14A,C-type lectin domain family 14 member A,22355,2147,1.11 [0.98-1.24],0.088672433370877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC1A,C-type lectin domain family 1 member A,21913,2105,0.92 [0.82-1.04],0.1709474310165258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC1B,C-type lectin domain family 1 member B,22509,2156,1.06 [1.02-1.11],0.0022848421856925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC2L,C-type lectin domain family 2 member L,18933,1813,0.93 [0.84-1.03],0.1466340996026651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC3B,Tetranectin,19030,1800,0.35 [0.28-0.43],2.2624289529309297e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC4A,C-type lectin domain family 4 member A,22279,2137,0.66 [0.60-0.73],1.503229717660878e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC4C,C-type lectin domain family 4 member C,22279,2137,0.95 [0.88-1.03],0.2081952238814299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC4D,C-type lectin domain family 4 member D,22279,2137,1.24 [1.17-1.32],4.799968238293765e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC4G,C-type lectin domain family 4 member G,22279,2137,1.11 [0.99-1.25],0.0661791632485572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC4M,C-type lectin domain family 4 member M,19440,1854,0.75 [0.68-0.82],5.98356771063958e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC5A,C-type lectin domain family 5 member A,22268,2132,1.18 [1.04-1.34],0.0106853097890663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC6A,C-type lectin domain family 6 member A,21834,2088,1.23 [1.14-1.34],2.0517362695049106e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC7A,C-type lectin domain family 7 member A,22551,2158,1.08 [1.01-1.16],0.0232528794556604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLGN,Calmegin,18933,1813,1.04 [0.95-1.15],0.4116037245585042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLIC5,Chloride intracellular channel protein 5,18933,1813,0.88 [0.76-1.02],0.0936857322634146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLINT1,Clathrin interactor 1,18754,1788,0.93 [0.83-1.03],0.1541182984283508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLIP2,CAP-Gly domain-containing linker protein 2,22279,2137,1.06 [1.02-1.09],0.0020304661718787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLMP,CXADR-like membrane protein,22508,2152,0.97 [0.81-1.16],0.7411865541367103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLNS1A,Methylosome subunit pICln,18933,1813,0.98 [0.86-1.12],0.767204667499447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",22104,2129,1.07 [1.03-1.12],0.0006716937519372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLPS,Colipase,22312,2144,0.94 [0.89-0.99],0.0255113044502074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLSPN,Claspin,21793,2082,1.04 [0.94-1.16],0.4656247285803705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLSTN1,Calsyntenin-1,21826,2083,1.07 [1.00-1.15],0.0608278770804059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLSTN2,Calsyntenin-2,22551,2158,1.47 [1.34-1.60],1.2124108530548008e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLSTN3,Calsyntenin-3,19425,1849,1.50 [1.30-1.72],1.2176770097703604e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLTA,Clathrin light chain A,21913,2105,1.05 [0.97-1.14],0.2101363511516437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLU,Clusterin,19494,1852,1.11 [0.96-1.28],0.1681178253802729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLUL1,Clusterin-like protein 1,22295,2134,0.72 [0.66-0.79],8.218282469363814e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CMC1,COX assembly mitochondrial protein homolog,19462,1849,1.02 [0.98-1.08],0.3350180331077396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CMIP,C-Maf-inducing protein,19371,1841,1.03 [0.98-1.09],0.2942722568375191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNDP1,Beta-Ala-His dipeptidase,22460,2144,1.03 [0.95-1.11],0.5370428264671079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNGB3,Cyclic nucleotide-gated cation channel beta-3,18824,1792,0.96 [0.88-1.04],0.3196333684938796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",18932,1802,1.09 [1.03-1.15],0.0050358765245785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNPY2,Protein canopy homolog 2,21913,2105,1.02 [0.96-1.09],0.4681136768078948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNPY4,Protein canopy homolog 4,22222,2129,1.05 [1.00-1.11],0.0673470286666969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNST,Consortin,22331,2138,1.05 [1.02-1.09],0.0035638331628063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTF,Ciliary neurotrophic factor,18824,1792,1.09 [0.96-1.24],0.1962531917400501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTN1,Contactin-1,22606,2166,1.09 [0.95-1.26],0.2066880494476885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTN2,Contactin-2,22508,2152,1.26 [1.16-1.37],9.416463375334485e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTN3,Contactin-3,22355,2147,2.64 [2.32-3.00],3.401864251755396e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTN4,Contactin-4,22355,2147,1.74 [1.48-2.03],8.180015493476621e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTN5,Contactin-5,22374,2145,0.77 [0.69-0.85],4.759505846855573e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTNAP2,Contactin-associated protein-like 2,22279,2137,1.24 [1.13-1.35],1.938863424146964e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTNAP4,Contactin-associated protein-like 4,18933,1813,0.97 [0.92-1.01],0.1535721185294039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COCH,Cochlin,19462,1849,1.08 [0.98-1.19],0.1033388775402178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL15A1,Collagen alpha-1(XV) chain,19475,1856,0.59 [0.50-0.70],4.728070731056734e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL18A1,Collagen alpha-1(XVIII) chain,22449,2145,1.97 [1.68-2.30],3.2034518792208304e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL1A1,Collagen alpha-1(I) chain,22606,2166,0.62 [0.53-0.73],5.833212305151923e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL24A1,Collagen alpha-1(XXIV) chain,19369,1846,1.00 [0.93-1.08],0.975484808901227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL28A1,Collagen alpha-1(XXVIII) chain,18933,1813,1.00 [0.94-1.06],0.9827210669515128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL2A1,Collagen alpha-1(II) chain,18968,1809,1.05 [1.00-1.11],0.0726874996956426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL3A1,Collagen alpha-1(III) chain,19475,1856,2.12 [1.78-2.54],1.3636453088221762e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL4A1,Collagen alpha-1(IV) chain,22331,2138,1.33 [1.21-1.46],3.250307711317265e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL4A4,Collagen alpha-4(IV) chain,19078,1824,1.03 [0.94-1.12],0.5471014990048491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL5A1,Collagen alpha-1(V) chain,19045,1813,1.56 [1.41-1.73],2.4707281239197762e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL6A3,Collagen alpha-3(VI) chain,22606,2166,1.59 [1.44-1.75],6.283440181496005e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL9A1,Collagen alpha-1(IX) chain,22279,2137,0.83 [0.77-0.90],8.126755180591175e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL9A2,Collagen alpha-2(IX) chain,19109,1826,0.95 [0.86-1.06],0.3676230073725658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COLEC12,Collectin-12,22325,2139,1.63 [1.42-1.86],2.668326295690044e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COMMD1,COMM domain-containing protein 1,18968,1809,1.06 [0.98-1.14],0.1566802367405252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COMMD9,COMM domain-containing protein 9,19371,1841,0.91 [0.81-1.02],0.1140856620706208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COMP,Cartilage oligomeric matrix protein,22120,2107,0.75 [0.67-0.84],8.884335837873722e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COMT,Catechol O-methyltransferase,21684,2088,1.04 [1.00-1.10],0.0745566263200987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COPB2,Coatomer subunit beta',18799,1796,1.03 [0.93-1.14],0.5833140407676731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COPE,Coatomer subunit epsilon,21826,2083,0.98 [0.90-1.07],0.6858843627642831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",18968,1809,0.95 [0.85-1.06],0.3321277241107403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CORO1A,Coronin-1A,21879,2101,1.04 [1.00-1.09],0.0615060570128596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CORO6,Coronin-6,18824,1792,1.03 [0.92-1.16],0.593603249007621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",22222,2129,1.09 [1.04-1.15],0.0012987281026415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COX6B1,Cytochrome c oxidase subunit 6B1,19462,1849,1.19 [1.04-1.36],0.0091874311158173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPA1,Carboxypeptidase A1,22606,2166,0.97 [0.91-1.03],0.3605543069067216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPA2,Carboxypeptidase A2,22444,2152,1.33 [1.25-1.40],2.3198302089703788e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPA4,Carboxypeptidase A4,18667,1766,0.82 [0.73-0.91],0.0001581191868049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPB1,Carboxypeptidase B,22606,2166,0.95 [0.89-1.02],0.1495547268383954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPB2,Carboxypeptidase B2,19460,1848,1.08 [0.88-1.31],0.4736419426350642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPE,Carboxypeptidase E,22315,2127,0.77 [0.70-0.84],1.8386095274284932e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPLX2,Complexin-2,18754,1788,0.92 [0.80-1.06],0.2593843865443365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPM,Carboxypeptidase M,22386,2142,3.14 [2.85-3.45],1.056917036157723e-120
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",18885,1799,0.90 [0.76-1.06],0.1989086328268861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPPED1,Serine/threonine-protein phosphatase CPPED1,22509,2156,1.06 [1.00-1.13],0.0416750985993597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPQ,Carboxypeptidase Q,19434,1854,1.54 [1.36-1.74],7.011530115704449e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPTP,Ceramide-1-phosphate transfer protein,18799,1796,1.02 [0.91-1.15],0.7190486885890008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPVL,Probable serine carboxypeptidase CPVL,22477,2150,1.24 [1.12-1.36],1.6089649393948617e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPXM1,Probable carboxypeptidase X1,22422,2149,1.05 [0.99-1.10],0.1050108722219583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPXM2,Inactive carboxypeptidase-like protein X2,19462,1849,1.42 [1.21-1.66],1.6665973331930855e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CR1,Complement receptor type 1,19396,1849,1.35 [1.19-1.53],1.80763787385624e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CR2,Complement receptor type 2,22460,2144,1.36 [1.26-1.48],1.6509469353223677e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,21834,2088,1.04 [1.00-1.09],0.0620028034444209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRADD,Death domain-containing protein CRADD,22104,2129,1.01 [0.96-1.07],0.6376088151177225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CREB3,Cyclic AMP-responsive element-binding protein 3,18754,1788,0.91 [0.83-0.99],0.0288586742178182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CREBZF,CREB/ATF bZIP transcription factor,18754,1788,0.98 [0.82-1.17],0.8018585735579844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CREG1,Protein CREG1,22069,2122,1.01 [0.92-1.11],0.8325684303963984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRELD1,Protein disulfide isomerase CRELD1,19045,1813,2.05 [1.82-2.31],1.281663949720945e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRELD2,Protein disulfide isomerase CRELD2,22391,2150,1.16 [1.08-1.25],4.09532652753225e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRH,Corticoliberin,21797,2086,0.79 [0.76-0.83],5.991111705499486e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRHBP,Corticotropin-releasing factor-binding protein,22325,2139,2.49 [2.17-2.86],6.377636694034826e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRHR1,Corticotropin-releasing factor receptor 1,21913,2105,0.99 [0.92-1.05],0.6715827229852844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRIM1,Cysteine-rich motor neuron 1 protein,22429,2152,1.26 [1.05-1.52],0.012528578725616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRIP2,Cysteine-rich protein 2,22137,2130,1.38 [1.26-1.51],2.1666005428593165e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRISP2,Cysteine-rich secretory protein 2,22508,2152,0.87 [0.82-0.93],1.642994040761802e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRISP3,Cysteine-rich secretory protein 3,19298,1838,0.62 [0.53-0.73],3.588054532714309e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRKL,Crk-like protein,22362,2147,1.03 [1.00-1.07],0.0895699329078804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRLF1,Cytokine receptor-like factor 1,22429,2152,1.57 [1.35-1.83],6.946889041848909e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRNN,Cornulin,21713,2076,0.85 [0.80-0.90],8.543676233734281e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRTAC1,Cartilage acidic protein 1,22606,2166,0.59 [0.52-0.66],8.039529636172109e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRTAM,Cytotoxic and regulatory T-cell molecule,22137,2130,0.95 [0.88-1.02],0.182900119006196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRTAP,Cartilage-associated protein,18933,1813,0.92 [0.83-1.02],0.1145508838607462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRX,Cone-rod homeobox protein,21913,2105,0.97 [0.93-1.00],0.0855867639831277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRYBB1,Beta-crystallin B1,19462,1849,1.01 [0.94-1.09],0.7027146355149516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRYBB2,Beta-crystallin B2,19425,1849,1.01 [0.96-1.07],0.6269303515140967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRYGD,Gamma-crystallin D,19425,1849,1.01 [0.96-1.05],0.7848993618300834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRYM,Ketimine reductase mu-crystallin,18824,1792,1.02 [0.96-1.09],0.4477863354134008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRYZL1,Quinone oxidoreductase-like protein 1,18968,1809,1.01 [0.96-1.06],0.7069125579866322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSDE1,Cold shock domain-containing protein E1,18799,1796,1.00 [0.96-1.04],0.9072397650779644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF1,Macrophage colony-stimulating factor 1,22429,2152,1.90 [1.67-2.18],3.954634579106128e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF1R,Macrophage colony-stimulating factor 1 receptor,19470,1855,1.57 [1.41-1.74],2.24836531497428e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF2,Granulocyte-macrophage colony-stimulating factor,18799,1796,1.29 [1.15-1.44],8.036326243113234e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,22137,2130,1.17 [1.10-1.24],1.944322595930193e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF2RB,Cytokine receptor common subunit beta,18885,1799,1.07 [0.96-1.19],0.2180286327688769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF3,Granulocyte colony-stimulating factor,21900,2081,1.08 [0.99-1.17],0.0681342153678187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF3R,Granulocyte colony-stimulating factor receptor,18885,1799,1.19 [1.03-1.38],0.0190723311596112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSH1,Chorionic somatomammotropin hormone 1,19470,1855,1.16 [0.99-1.35],0.064943021675529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSNK1D,Casein kinase I isoform delta,18885,1799,0.95 [0.88-1.03],0.188743214194638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSNK2A1,Casein kinase II subunit alpha,19419,1844,0.87 [0.79-0.97],0.0083291275954524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSPG4,Chondroitin sulfate proteoglycan 4,19475,1856,0.82 [0.71-0.93],0.0034698546319289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSPG5,Chondroitin sulfate proteoglycan 5,18824,1792,0.88 [0.80-0.97],0.0094756891123375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSRP3,Cysteine and glycine-rich protein 3,18799,1796,1.04 [0.99-1.09],0.1063648758869414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CST1,Cystatin-SN,16922,1604,1.00 [0.95-1.05],0.9387026172293343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CST3,Cystatin-C,22426,2139,1.58 [1.40-1.79],3.240370577680839e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CST5,Cystatin-D,21898,2111,1.01 [0.94-1.08],0.8785528806288241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CST6,Cystatin-M,21728,2077,0.84 [0.77-0.90],7.730335722994071e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CST7,Cystatin-F,22364,2145,1.11 [1.07-1.15],2.246618525527265e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSTB,Cystatin-B,22030,2109,1.24 [1.13-1.35],3.1881834812901337e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTAG1A_CTAG1B,Cancer/testis antigen 1,19079,1824,0.94 [0.86-1.03],0.1962017730318095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTBS,Di-N-acetylchitobiase,19168,1827,2.26 [1.90-2.68],6.439674201573661e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTF1,Cardiotrophin-1,21913,2105,1.03 [0.98-1.07],0.2605554736429506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTHRC1,Collagen triple helix repeat-containing protein 1,19475,1856,1.32 [1.14-1.53],0.0002289733322484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTLA4,Cytotoxic T-lymphocyte protein 4,19475,1856,1.09 [0.94-1.27],0.239421850508038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTNNA1,Catenin alpha-1,18824,1792,0.84 [0.73-0.97],0.0176523297530386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTRB1,Chymotrypsinogen B,22355,2147,0.96 [0.90-1.03],0.2999592338203019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTRC,Chymotrypsin-C,22327,2146,0.82 [0.77-0.86],4.92660336540971e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTRL,Chymotrypsin-like protease CTRL-1,19425,1849,0.83 [0.78-0.88],7.545279105955952e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSB,Cathepsin B,22381,2135,0.71 [0.66-0.77],7.29150033337996e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSC,Dipeptidyl peptidase 1,22283,2139,1.26 [1.15-1.37],1.0589628462366709e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSD,Cathepsin D,20932,2006,1.95 [1.82-2.08],3.8718687179271003e-82
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSE,Cathepsin E,19045,1813,1.39 [1.28-1.52],4.2495944835149496e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSF,Cathepsin F,22422,2149,1.04 [0.95-1.15],0.3948018101002973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSH,Pro-cathepsin H,21831,2102,1.10 [1.04-1.15],0.0004636803966077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSL,Cathepsin L1,22331,2138,1.75 [1.51-2.04],2.474798521657704e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSO,Cathepsin O,22551,2158,2.79 [2.52-3.09],4.539849888711096e-85
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSS,Cathepsin S,17465,1694,2.44 [2.02-2.95],1.3322810331456831e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSV,Cathepsin L2,22434,2144,1.04 [0.95-1.13],0.4313310985711009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSZ,Cathepsin Z,22399,2135,1.85 [1.65-2.07],3.090422028133418e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CUZD1,CUB and zona pellucida-like domain-containing protein 1,18933,1813,1.17 [1.05-1.30],0.0059379018291006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CWC15,Spliceosome-associated protein CWC15 homolog,19245,1834,1.07 [1.00-1.15],0.0503077805009841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CX3CL1,Fractalkine,22137,2130,0.79 [0.70-0.88],5.191324250524081e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXADR,Coxsackievirus and adenovirus receptor,22279,2137,1.21 [1.13-1.30],2.549265057075396e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL1,Growth-regulated alpha protein,22293,2140,0.99 [0.95-1.03],0.5896481969766167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL10,C-X-C motif chemokine 10,22429,2152,1.04 [0.99-1.10],0.1413813877121074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL11,C-X-C motif chemokine 11,22509,2156,1.05 [1.01-1.10],0.0224033014200934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL12,Stromal cell-derived factor 1,21900,2081,0.81 [0.73-0.89],3.524020948610732e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL13,C-X-C motif chemokine 13,22509,2156,1.14 [1.09-1.20],1.4325173574681768e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL14,C-X-C motif chemokine 14,21900,2081,1.06 [1.00-1.13],0.047065234478524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL16,C-X-C motif chemokine 16,22577,2164,1.66 [1.42-1.95],2.1529208599837623e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL17,C-X-C motif chemokine 17,22551,2158,1.36 [1.25-1.48],1.2608787456456549e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL3,C-X-C motif chemokine 3,22326,2143,0.99 [0.95-1.03],0.7383060252095452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL5,C-X-C motif chemokine 5,22264,2132,1.06 [1.02-1.09],0.0009201301822524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL6,C-X-C motif chemokine 6,22551,2158,1.14 [1.08-1.19],3.894169031212572e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL8,Interleukin-8,22167,2116,1.14 [1.09-1.20],1.1752863808407341e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL9,C-X-C motif chemokine 9,22429,2152,1.08 [1.02-1.15],0.0065905977735719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CYB5A,Cytochrome b5,18754,1788,1.08 [1.02-1.15],0.0066555005396514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CYB5R2,NADH-cytochrome b5 reductase 2,19172,1835,0.98 [0.90-1.06],0.5728568933118097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",18799,1796,1.01 [0.96-1.07],0.630893495656057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CYTH3,Cytohesin-3,18754,1788,0.99 [0.93-1.06],0.7540613739529617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CYTL1,Cytokine-like protein 1,19475,1856,0.53 [0.45-0.64],6.742278165134118e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DAAM1,Disheveled-associated activator of morphogenesis 1,19045,1813,1.07 [1.02-1.13],0.0098284511761986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DAB2,Disabled homolog 2,22508,2152,1.04 [1.00-1.07],0.0334432110875773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DAG1,Dystroglycan,22429,2152,1.42 [1.31-1.54],5.665531491047203e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DAND5,DAN domain family member 5,18885,1799,1.04 [0.96-1.12],0.3270887302198538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DAPK2,Death-associated protein kinase 2,18885,1799,1.05 [0.97-1.14],0.2075324939092558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,22279,2137,1.01 [0.98-1.04],0.5887734265567497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DARS1,"Aspartate--tRNA ligase, cytoplasmic",22104,2129,0.98 [0.93-1.04],0.5116108650960576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DBH,Dopamine beta-hydroxylase,19425,1851,1.03 [0.99-1.08],0.1193511419706633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DBI,Acyl-CoA-binding protein,22260,2137,1.07 [1.02-1.13],0.01004507046862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DBN1,Drebrin,18885,1799,0.98 [0.89-1.08],0.7137708768226746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DBNL,Drebrin-like protein,22429,2152,1.03 [0.99-1.07],0.1554690737635531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",22422,2149,1.82 [1.64-2.02],6.050919381520778e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCC,Netrin receptor DCC,18933,1813,0.75 [0.60-0.94],0.0122195766047379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCDC2C,Doublecortin domain-containing protein 2C,18754,1788,0.96 [0.89-1.03],0.2711062570916143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCLRE1C,Protein artemis,18754,1788,0.91 [0.79-1.06],0.2309404244541648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCN,Decorin,21913,2105,1.14 [0.97-1.34],0.1015695988265097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCTD,Deoxycytidylate deaminase,19045,1813,1.01 [0.96-1.06],0.7232464097832978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCTN1,Dynactin subunit 1,22508,2152,1.07 [1.01-1.14],0.0182097203256714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCTN2,Dynactin subunit 2,22222,2129,1.01 [0.97-1.05],0.6309382307733807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCTN6,Dynactin subunit 6,21826,2083,1.04 [0.99-1.10],0.1088969971853856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCTPP1,dCTP pyrophosphatase 1,22331,2138,0.90 [0.80-1.02],0.0959072382271084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCUN1D1,DCN1-like protein 1,18824,1792,0.98 [0.91-1.04],0.442730746650504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCUN1D2,DCN1-like protein 2,18754,1788,0.95 [0.90-1.01],0.0962711911019735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCXR,L-xylulose reductase,22422,2149,1.49 [1.39-1.59],1.661102612064062e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDA1,DET1- and DDB1-associated protein 1,18799,1796,0.96 [0.86-1.08],0.5400586602511033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",22222,2129,1.40 [1.29-1.52],3.432964762033977e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDC,Aromatic-L-amino-acid decarboxylase,22288,2136,1.07 [0.99-1.16],0.078801779369258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDHD2,Phospholipase DDHD2,19419,1844,1.09 [1.02-1.16],0.0165472965299714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDI2,Protein DDI1 homolog 2,19045,1813,0.96 [0.91-1.02],0.1793855226174502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDR1,Epithelial discoidin domain-containing receptor 1,22509,2156,1.82 [1.56-2.12],3.266732763014384e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDT,D-dopachrome decarboxylase,19475,1856,1.28 [1.16-1.42],8.925857210682382e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDX1,ATP-dependent RNA helicase DDX1,19369,1846,1.01 [0.93-1.11],0.793683943933263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDX25,ATP-dependent RNA helicase DDX25,18933,1813,0.83 [0.73-0.95],0.005997932035534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDX39A,ATP-dependent RNA helicase DDX39A,18885,1799,1.01 [0.83-1.23],0.934550096648378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDX4,Probable ATP-dependent RNA helicase DDX4,18885,1799,0.97 [0.89-1.06],0.5172732064022427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDX53,Probable ATP-dependent RNA helicase DDX53,18933,1813,0.94 [0.82-1.07],0.3404951174623963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDX58,Antiviral innate immune response receptor RIG-I,21834,2088,1.04 [0.97-1.11],0.2725637446377837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",22279,2137,1.07 [1.03-1.11],0.0015517190911502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DEFA1_DEFA1B,Neutrophil defensin 1,21916,2098,1.06 [0.99-1.14],0.0837622854260938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DEFB103A_DEFB103B,Beta-defensin 103,18727,1785,1.27 [1.17-1.39],4.9971052999811706e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DEFB104A_DEFB104B,Beta-defensin 104,18824,1792,0.93 [0.85-1.02],0.1229170138197569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DEFB116,Beta-defensin 116,18824,1792,0.94 [0.88-1.00],0.0561369985906698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DEFB118,Beta-defensin 118,18824,1792,1.06 [0.98-1.15],0.1364197212761862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DEFB4A_DEFB4B,Beta-defensin 4A,22033,2119,1.06 [1.03-1.08],3.800200726102884e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DENND2B,DENN domain-containing protein 2B,18799,1796,1.00 [0.91-1.10],0.998840196402619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DENR,Density-regulated protein,18885,1799,1.04 [0.96-1.13],0.3217849889176319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DFFA,DNA fragmentation factor subunit alpha,22551,2158,1.06 [1.00-1.12],0.0506954615483724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DGCR6,Protein DGCR6,18824,1792,1.04 [0.94-1.16],0.4275804040364792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DGKA,Diacylglycerol kinase alpha,18885,1799,1.09 [1.01-1.19],0.0369686158258371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DGKZ,Diacylglycerol kinase zeta,21900,2081,1.01 [0.90-1.13],0.8671650408278261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DHODH,Dihydroorotate dehydrogenase,18799,1796,1.03 [0.94-1.14],0.5010236880709571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DHPS,Deoxyhypusine synthase,19371,1841,1.26 [1.16-1.38],3.6486641587878427e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,19425,1849,1.02 [0.93-1.12],0.6784302100193489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DIABLO,"Diablo homolog, mitochondrial",22268,2132,1.01 [0.98-1.05],0.4215588347988822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DIPK1C,Divergent protein kinase domain 1C,18933,1813,0.94 [0.84-1.05],0.2983634818850508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DIPK2B,Divergent protein kinase domain 2B,19045,1813,0.59 [0.50-0.69],2.376921543910382e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DKK1,Dickkopf-related protein 1,22509,2156,1.10 [1.03-1.18],0.0029100339492806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DKK3,Dickkopf-related protein 3,22606,2166,0.92 [0.81-1.04],0.173730984355422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DKK4,Dickkopf-related protein 4,22104,2126,1.45 [1.34-1.56],1.2110529006143072e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DKKL1,Dickkopf-like protein 1,22222,2129,1.00 [0.95-1.04],0.8437010014575802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DLG4,Disks large homolog 4,19425,1849,1.01 [0.95-1.07],0.8066554553880513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DLGAP5,Disks large-associated protein 5,19419,1844,0.96 [0.88-1.05],0.3784791852417173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DLK1,Protein delta homolog 1,22606,2166,1.14 [1.07-1.22],0.000116399608271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DLL1,Delta-like protein 1,22422,2149,1.48 [1.32-1.67],1.0445643490356364e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DLL4,Delta-like protein 4,18968,1809,0.97 [0.91-1.02],0.2161005560910564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DMD,Dystrophin,18968,1809,1.13 [1.04-1.23],0.0040652526745622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DMP1,Dentin matrix acidic phosphoprotein 1,18968,1809,0.60 [0.57-0.64],3.7274021199109513e-63
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNAJA1,DnaJ homolog subfamily A member 1,18754,1788,0.91 [0.82-1.01],0.0680027220413261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNAJA2,DnaJ homolog subfamily A member 2,22487,2152,1.09 [1.04-1.14],0.0004255274790812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNAJA4,DnaJ homolog subfamily A member 4,19425,1849,1.01 [0.95-1.08],0.7032038804481628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNAJB1,DnaJ homolog subfamily B member 1,22222,2129,1.06 [1.01-1.10],0.0172930858792203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNAJB14,DnaJ homolog subfamily B member 14,19369,1846,1.06 [0.99-1.13],0.1219261526700746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNAJB2,DnaJ homolog subfamily B member 2,19045,1813,1.02 [0.93-1.11],0.7013377448869336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNAJB6,DnaJ homolog subfamily B member 6,18867,1799,1.04 [0.99-1.10],0.1440613507988687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNAJB8,DnaJ homolog subfamily B member 8,21913,2105,0.96 [0.89-1.03],0.2594641286070276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNAJC21,DnaJ homolog subfamily C member 21,19425,1849,0.98 [0.87-1.10],0.7020871695536556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNAJC6,Putative tyrosine-protein phosphatase auxilin,18968,1809,1.07 [1.02-1.13],0.0119421526797772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNAJC9,DnaJ homolog subfamily C member 9,19369,1846,1.00 [0.94-1.06],0.914984193941665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNER,Delta and Notch-like epidermal growth factor-related receptor,22285,2144,0.84 [0.73-0.98],0.023373590164037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNLZ,DNL-type zinc finger protein,18824,1792,0.96 [0.91-1.01],0.0988057759296783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNM1,Dynamin-1,19369,1846,0.98 [0.94-1.02],0.3225035445719866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNM3,Dynamin-3,19419,1844,1.08 [1.00-1.17],0.0488552548561288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNMBP,Dynamin-binding protein,22137,2130,1.09 [1.03-1.17],0.0057194940202035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNPEP,Aspartyl aminopeptidase,19425,1849,1.28 [1.18-1.38],1.951448618862218e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,22400,2149,1.07 [0.99-1.15],0.0857688329485771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DOC2B,Double C2-like domain-containing protein beta,18933,1813,1.03 [0.91-1.16],0.6885336777838144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DOCK9,Dedicator of cytokinesis protein 9,18824,1792,1.01 [0.97-1.05],0.641148042456213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DOK1,Docking protein 1,19425,1849,1.02 [0.98-1.05],0.3417822337124232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DOK2,Docking protein 2,22331,2138,1.04 [1.01-1.07],0.0160012977155072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPEP1,Dipeptidase 1,22104,2129,0.95 [0.87-1.02],0.1533164674856208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPEP2,Dipeptidase 2,22222,2129,0.88 [0.77-1.00],0.0471834442578281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPP10,Inactive dipeptidyl peptidase 10,22279,2137,1.50 [1.37-1.65],1.2926229386554679e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPP4,Dipeptidyl peptidase 4,21961,2100,1.09 [0.95-1.25],0.2091967006972331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,22222,2129,1.95 [1.75-2.18],5.200524639704926e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPP7,Dipeptidyl peptidase 2,22161,2123,1.20 [1.12-1.27],1.6917860772052937e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPT,Dermatopontin,22606,2166,1.21 [1.03-1.41],0.0188264371474444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPY30,Protein dpy-30 homolog,22428,2147,1.28 [1.21-1.35],9.223156348063372e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DRAXIN,Draxin,22137,2130,1.04 [0.96-1.14],0.3480092118280914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DRG2,Developmentally-regulated GTP-binding protein 2,22222,2129,1.02 [0.96-1.10],0.4882677032739079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSC2,Desmocollin-2,22126,2125,1.57 [1.42-1.75],1.1531766222618378e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSCAM,Down syndrome cell adhesion molecule,19419,1844,1.75 [1.55-1.98],2.0307401633321009e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSG2,Desmoglein-2,22355,2147,0.64 [0.56-0.74],3.73282937780848e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSG3,Desmoglein-3,22427,2147,0.85 [0.76-0.95],0.0048325165012828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSG4,Desmoglein-4,22156,2123,0.78 [0.72-0.84],1.6130219213355544e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DTD1,D-aminoacyl-tRNA deacylase 1,19045,1813,1.02 [0.97-1.08],0.4399445164489635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DTNB,Dystrobrevin beta,19327,1835,1.54 [1.40-1.70],2.911413625244805e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DTX2,Probable E3 ubiquitin-protein ligase DTX2,18933,1813,0.93 [0.86-1.01],0.0717947049957282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DTX3,Probable E3 ubiquitin-protein ligase DTX3,22222,2129,0.85 [0.72-1.00],0.0466914068487816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DTYMK,Thymidylate kinase,19462,1849,1.08 [1.01-1.16],0.0184153671089428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DUOX2,Dual oxidase 2,21913,2105,0.97 [0.91-1.02],0.2228774592988352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DUSP13,Dual specificity protein phosphatase 13 isoform A,19371,1841,0.94 [0.84-1.05],0.2616643916343133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DUSP29,Dual specificity phosphatase 29,18933,1813,1.06 [0.99-1.13],0.0757049521910377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DUSP3,Dual specificity protein phosphatase 3,21826,2083,0.97 [0.92-1.02],0.1825486840786965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",19369,1846,1.09 [1.04-1.13],0.0001610693194494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DXO,Decapping and exoribonuclease protein,19425,1849,1.08 [0.97-1.19],0.14548283306832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,19371,1841,0.93 [0.84-1.02],0.137246168300518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DYNLT1,Dynein light chain Tctex-type 1,18933,1813,1.06 [1.00-1.12],0.0435793668086681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DYNLT3,Dynein light chain Tctex-type 3,19371,1841,1.05 [0.95-1.16],0.3471074473181573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,22137,2130,1.06 [1.02-1.11],0.0041056453574563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EBI3_IL27,Interleukin-27,22470,2148,1.16 [1.03-1.32],0.0170070725585885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ECE1,Endothelin-converting enzyme 1,21826,2083,0.95 [0.85-1.06],0.3336254252788211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",19462,1849,1.29 [1.22-1.36],8.822076736716054e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ECHS1,"Enoyl-CoA hydratase, mitochondrial",18968,1809,1.18 [1.13-1.24],1.574422865971658e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ECI2,Enoyl-CoA delta isomerase 2,18799,1796,1.16 [1.08-1.24],1.7560942596858803e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ECM1,Extracellular matrix protein 1,18979,1794,1.19 [1.05-1.35],0.0080053290553927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ECSCR,Endothelial cell-specific chemotaxis regulator,18824,1792,0.93 [0.85-1.03],0.152609426731046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,22508,2152,1.38 [1.25-1.51],2.097985102014127e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDAR,Tumor necrosis factor receptor superfamily member EDAR,22279,2137,0.98 [0.93-1.02],0.2542138482565353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDDM3B,Epididymal secretory protein E3-beta,19371,1841,0.79 [0.72-0.86],9.448574522820537e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,18799,1796,1.03 [0.91-1.17],0.6039213707743111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDF1,Endothelial differentiation-related factor 1,19419,1844,1.06 [1.00-1.13],0.0559585332865019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,21913,2105,1.36 [1.22-1.52],2.6680442620282515e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDN1,Endothelin-1,18968,1809,1.33 [1.15-1.55],0.0001990450912051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDNRB,Endothelin receptor type B,18885,1799,1.01 [0.91-1.12],0.8847545989303505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EEF1D,Elongation factor 1-delta,19462,1849,1.10 [1.04-1.15],0.0002356555906027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,19369,1846,1.09 [0.94-1.26],0.2499672987602711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFCAB2,Dynein regulatory complex protein 8,19109,1826,1.09 [0.96-1.24],0.1773555808887708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,22431,2142,1.18 [1.05-1.33],0.0055191257720025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFHD1,EF-hand domain-containing protein D1,19419,1844,0.81 [0.71-0.93],0.0022634024885058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFNA1,Ephrin-A1,22323,2146,1.43 [1.26-1.62],1.9533822134509564e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFNA4,Ephrin-A4,22101,2129,1.94 [1.76-2.15],2.069180650376745e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFNB2,Ephrin-B2,18933,1813,1.00 [0.92-1.08],0.9271022909616328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EGF,Pro-epidermal growth factor,22295,2145,1.02 [0.98-1.06],0.260673764519267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EGFL7,Epidermal growth factor-like protein 7,21834,2088,1.19 [1.09-1.31],0.0001614545991571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EGFLAM,Pikachurin,19369,1846,1.21 [1.05-1.39],0.0071724725026775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EGFR,Epidermal growth factor receptor,22606,2166,0.65 [0.52-0.83],0.0004201181314816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EGLN1,Egl nine homolog 1,22279,2137,1.20 [1.13-1.27],2.5310991822157153e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EHBP1,EH domain-binding protein 1,19462,1849,1.06 [1.00-1.12],0.0722201723124923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EHD3,EH domain-containing protein 3,18968,1809,1.00 [0.96-1.04],0.9146240014719902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",19425,1849,0.97 [0.89-1.05],0.4136062681073188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",19285,1834,1.04 [1.00-1.08],0.0721692661636184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,18799,1796,1.01 [0.94-1.08],0.7337701912290071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,18968,1809,0.99 [0.88-1.11],0.8412522456450084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EIF4B,Eukaryotic translation initiation factor 4B,22137,2130,1.06 [0.99-1.14],0.0768900295565443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EIF4E,Eukaryotic translation initiation factor 4E,18885,1799,1.03 [0.98-1.08],0.2757795238546536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,22331,2138,1.11 [1.05-1.18],0.0003223816359983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,22551,2158,1.09 [1.05-1.13],3.2287278787837004e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,19419,1844,1.06 [0.99-1.13],0.1049018650978365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EIF5,Eukaryotic translation initiation factor 5,18799,1796,1.03 [0.93-1.14],0.5244202559450655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EIF5A,Eukaryotic translation initiation factor 5A-1,21900,2081,0.98 [0.86-1.11],0.7150361240152817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ELAC1,Zinc phosphodiesterase ELAC protein 1,19419,1844,1.03 [0.98-1.09],0.281925559399728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ELAVL4,ELAV-like protein 4,18824,1792,1.06 [1.01-1.12],0.0231478080589773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ELN,Elastin,19462,1849,0.79 [0.69-0.89],0.0002248559906218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ELOA,Elongin-A,22222,2129,1.14 [1.07-1.21],4.600167991568529e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ELOB,Elongin-B,18799,1796,1.06 [0.95-1.19],0.2912750362985056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENAH,Protein enabled homolog,21900,2081,1.10 [1.01-1.19],0.0221998521441181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENDOU,Poly(U)-specific endoribonuclease,17963,1732,0.91 [0.84-0.99],0.0359992661832626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENG,Endoglin,22606,2166,1.35 [1.09-1.68],0.0061463907609813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENO1,Alpha-enolase,22305,2139,1.06 [1.01-1.11],0.0237893032734437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENO2,Gamma-enolase,22509,2156,1.02 [0.96-1.08],0.5468733679788123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENO3,Beta-enolase,18968,1809,1.25 [1.16-1.34],1.559667610572874e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENOPH1,Enolase-phosphatase E1,19371,1841,0.93 [0.85-1.03],0.1492415437764305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,18799,1796,1.09 [0.93-1.28],0.2700138275994139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENPEP,Glutamyl aminopeptidase,18799,1796,1.03 [0.94-1.14],0.4998857967171923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,22606,2166,1.44 [1.26-1.65],8.770810080813154e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,22429,2152,0.97 [0.89-1.07],0.5741643240239895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,18968,1809,1.13 [0.99-1.28],0.062186139135672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,21596,2064,1.28 [1.22-1.34],1.4784305525892474e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENSA,Alpha-endosulfine,19371,1841,1.00 [0.92-1.09],0.9910836294065016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,21834,2088,1.41 [1.30-1.53],2.2272843487217058e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,21913,2105,0.57 [0.48-0.67],9.149728898849827e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,21913,2105,1.55 [1.33-1.81],2.5000362976878183e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENTR1,Endosome-associated-trafficking regulator 1,18968,1809,1.18 [1.10-1.27],6.840619841330921e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EP300,Histone acetyltransferase p300,18885,1799,1.04 [0.90-1.20],0.6038626879954746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPB41L5,Band 4.1-like protein 5,18933,1813,0.97 [0.90-1.05],0.4658173744044107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPCAM,Epithelial cell adhesion molecule,22316,2140,0.96 [0.92-1.00],0.027986946383432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPGN,Epigen,19371,1841,0.87 [0.78-0.98],0.0184948362623744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHA1,Ephrin type-A receptor 1,22400,2149,1.36 [1.21-1.54],2.768127068543488e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHA10,Ephrin type-A receptor 10,21826,2083,0.97 [0.92-1.03],0.3331381601803217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHA2,Ephrin type-A receptor 2,21514,2051,1.47 [1.32-1.64],7.345770025549317e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHA4,Ephrin type-A receptor 4,19045,1813,1.18 [1.01-1.37],0.0379406681869852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHB4,Ephrin type-B receptor 4,22606,2166,1.23 [1.06-1.42],0.0050867051329707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHB6,Ephrin type-B receptor 6,22104,2129,0.93 [0.83-1.05],0.2465913781051791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHX2,Bifunctional epoxide hydrolase 2,21913,2105,1.07 [1.01-1.13],0.0269050760019218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPN1,Epsin-1,19109,1826,1.04 [0.94-1.15],0.4553545859725115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPO,Erythropoietin,22279,2137,1.17 [1.12-1.23],1.0841793699078359e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPPK1,Epiplakin,18968,1809,1.04 [0.98-1.11],0.1884943348154844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,22466,2151,1.81 [1.62-2.02],1.578296463829586e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERBB2,Receptor tyrosine-protein kinase erbB-2,22422,2149,2.39 [2.05-2.79],5.29853577991483e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERBB3,Receptor tyrosine-protein kinase erbB-3,22265,2136,1.41 [1.16-1.71],0.0005866046607026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERBB4,Receptor tyrosine-protein kinase erbB-4,22422,2149,1.67 [1.43-1.95],8.8081286493233e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERBIN,Erbin,22222,2129,1.05 [1.01-1.09],0.0218465501949951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERC2,ERC protein 2,18933,1813,1.02 [0.96-1.08],0.5553601929049419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERCC1,DNA excision repair protein ERCC-1,18754,1788,0.94 [0.82-1.09],0.4293934802933611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EREG,Proepiregulin,22104,2129,1.05 [1.00-1.10],0.0374813618523936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERI1,3'-5' exoribonuclease 1,19109,1826,1.07 [0.94-1.22],0.2820615615396074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERMAP,Erythroid membrane-associated protein,18885,1799,1.26 [1.14-1.40],7.293977423014374e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,19371,1841,1.34 [1.20-1.49],1.961667222084377e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERP29,Endoplasmic reticulum resident protein 29,19045,1813,1.03 [1.00-1.08],0.0794776800800494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERP44,Endoplasmic reticulum resident protein 44,22178,2127,1.22 [1.05-1.42],0.0084616120182732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,18799,1796,0.99 [0.89-1.11],0.918086729502504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ESAM,Endothelial cell-selective adhesion molecule,22606,2166,1.16 [1.03-1.30],0.0115313976530323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ESM1,Endothelial cell-specific molecule 1,22325,2139,0.63 [0.56-0.70],4.205751208700778e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ESPL1,Separin,18754,1788,1.03 [0.96-1.12],0.4029323485216162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ESR1,Estrogen receptor,18885,1799,0.92 [0.84-1.01],0.0672708370408653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ESYT2,Extended synaptotagmin-2,19425,1849,1.08 [1.03-1.15],0.0035749373907416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EVI2B,Protein EVI2B,18754,1788,0.94 [0.83-1.06],0.3045655925084429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EVI5,Ecotropic viral integration site 5 protein homolog,18885,1799,1.03 [0.98-1.09],0.237417649980004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EVPL,Envoplakin,19109,1826,0.96 [0.84-1.10],0.5711048218808699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EXOSC10,Exosome component 10,18799,1796,0.98 [0.90-1.06],0.6155737516045003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EXTL1,Exostosin-like 1,18799,1796,0.80 [0.72-0.89],4.7103329966172894e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EZR,Ezrin,22509,2156,1.63 [1.41-1.88],3.6691469993614114e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F10,Coagulation factor X,19470,1855,1.21 [1.04-1.40],0.0127964642651138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F11,Coagulation factor XI,19216,1827,1.29 [1.12-1.48],0.0003900678990193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F11R,Junctional adhesion molecule A,22355,2147,1.25 [1.17-1.33],8.040945683934969e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F12,Coagulation factor XII,19494,1852,1.09 [0.98-1.21],0.1188039641354312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F13B,Coagulation factor XIII B chain,19380,1838,0.65 [0.55-0.78],1.4690388228338282e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F2,Prothrombin,19494,1852,0.72 [0.54-0.97],0.0301419688503533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F2R,Proteinase-activated receptor 1,22391,2150,1.12 [1.05-1.20],0.0008030305561637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F3,Tissue factor,22372,2140,0.75 [0.65-0.87],0.0001008244686903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F7,Coagulation factor VII,22424,2139,1.42 [1.26-1.61],2.8478164776970225e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F9,Coagulation factor IX,22412,2141,3.22 [2.62-3.95],6.199345873399897e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP1,"Fatty acid-binding protein, liver",22325,2139,1.40 [1.35-1.45],2.3985201567669785e-70
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP2,"Fatty acid-binding protein, intestinal",22331,2138,1.10 [1.05-1.15],3.711883460013903e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP3,"Fatty acid-binding protein, heart",19462,1849,1.39 [1.28-1.50],4.80867007584732e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP4,"Fatty acid-binding protein, adipocyte",22606,2166,1.53 [1.43-1.64],4.55545051954878e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP5,Fatty acid-binding protein 5,22426,2151,1.18 [1.12-1.25],6.329530237599835e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP6,Gastrotropin,21871,2101,1.09 [1.02-1.16],0.0132030171516863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP9,Fatty acid-binding protein 9,22279,2137,0.88 [0.82-0.95],0.0003533572458763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FADD,FAS-associated death domain protein,22331,2138,1.01 [0.96-1.07],0.6233443614237104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM13A,Protein FAM13A,19369,1846,1.06 [0.99-1.14],0.0747380174643718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM171A2,Protein FAM171A2,19419,1844,1.00 [0.97-1.03],0.8575683938293713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM171B,Protein FAM171B,19371,1841,0.92 [0.78-1.09],0.317759922883184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM172A,Cotranscriptional regulator FAM172A,18968,1809,0.99 [0.91-1.06],0.7293594301304622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM20A,Pseudokinase FAM20A,19462,1849,2.08 [1.84-2.36],6.200304756023349e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM3B,Protein FAM3B,22222,2129,1.62 [1.45-1.80],1.6231120357657078e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM3C,Protein FAM3C,22288,2136,2.04 [1.81-2.30],1.493824798472441e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM3D,Protein FAM3D,19369,1846,1.30 [1.24-1.37],3.051813185893688e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAP,Prolyl endopeptidase FAP,22606,2166,1.12 [0.98-1.29],0.0970217884162489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FARSA,Phenylalanine--tRNA ligase alpha subunit,18933,1813,1.04 [0.97-1.10],0.2538355563405406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAS,Tumor necrosis factor receptor superfamily member 6,22541,2159,1.38 [1.26-1.50],1.9137279156944426e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FASLG,Tumor necrosis factor ligand superfamily member 6,22551,2158,0.66 [0.59-0.73],5.927362612287055e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FBLN2,Fibulin-2,19475,1856,0.95 [0.83-1.09],0.4457458537415173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FBN2,Fibrillin-2,18933,1813,1.09 [1.01-1.18],0.0253163926759621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FBP1,"Fructose-1,6-bisphosphatase 1",22331,2138,1.24 [1.18-1.30],1.081030098389385e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,19462,1849,1.53 [1.44-1.62],1.038565321027595e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCAR,Immunoglobulin alpha Fc receptor,22279,2137,1.32 [1.22-1.42],4.3962787320596186e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,19419,1844,1.25 [1.05-1.50],0.0147035959476493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCER2,Low affinity immunoglobulin epsilon Fc receptor,22355,2147,1.12 [1.05-1.20],0.0010446162045506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,22270,2131,1.09 [1.02-1.17],0.0139312628308586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,21834,2088,1.06 [0.99-1.13],0.0776466787982902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,22386,2138,0.97 [0.90-1.05],0.4752605068236739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCN1,Ficolin-1,19425,1851,1.25 [1.14-1.36],4.673805307524135e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCN2,Ficolin-2,22269,2125,1.03 [0.93-1.13],0.5710734839949978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCRL1,Fc receptor-like protein 1,22331,2138,1.12 [1.03-1.21],0.0065530097701824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCRL2,Fc receptor-like protein 2,22433,2150,1.06 [0.98-1.14],0.1227462265236143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCRL3,Fc receptor-like protein 3,21900,2081,0.99 [0.92-1.06],0.8064106358839878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCRL5,Fc receptor-like protein 5,22355,2147,1.20 [1.12-1.27],4.244299298619675e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCRL6,Fc receptor-like protein 6,22279,2137,1.09 [1.04-1.16],0.0013307284198597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCRLB,Fc receptor-like B,21834,2088,1.14 [1.09-1.20],2.676104637957232e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FDX1,"Adrenodoxin, mitochondrial",18799,1796,1.13 [1.05-1.20],0.0006272644576281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FDX2,"Ferredoxin-2, mitochondrial",18799,1796,1.01 [0.93-1.09],0.834654752172827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FEN1,Flap endonuclease 1,21834,2088,1.06 [1.01-1.12],0.0256954242278152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FES,Tyrosine-protein kinase Fes/Fps,21834,2088,1.06 [0.98-1.15],0.1700067656322754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FETUB,Fetuin-B,22412,2141,1.52 [1.34-1.73],1.8061896132372047e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGA,Fibrinogen alpha chain,19035,1797,1.21 [1.04-1.40],0.0131912427662903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",19419,1844,1.05 [0.99-1.11],0.091621151881539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF12,Fibroblast growth factor 12,18885,1799,0.91 [0.81-1.01],0.0813190348021265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF16,Fibroblast growth factor 16,18885,1799,1.00 [0.91-1.11],0.9379105727095984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF19,Fibroblast growth factor 19,22429,2152,0.89 [0.85-0.94],3.589046250620759e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF2,Fibroblast growth factor 2,22279,2137,1.06 [1.01-1.12],0.0306677460350501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF20,Fibroblast growth factor 20,18885,1799,1.00 [0.90-1.10],0.93605290624074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF21,Fibroblast growth factor 21,22470,2148,1.25 [1.21-1.29],8.105912181430748e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF23,Fibroblast growth factor 23,22477,2147,1.33 [1.25-1.41],4.0278697218455123e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF3,Fibroblast growth factor 3,18885,1799,0.92 [0.78-1.07],0.2813292167289329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF5,Fibroblast growth factor 5,21900,2081,1.26 [1.13-1.42],7.12998913016046e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF6,Fibroblast growth factor 6,18885,1799,0.99 [0.89-1.11],0.8987252093476386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF7,Fibroblast growth factor 7,18754,1788,0.97 [0.91-1.03],0.2639819301191831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF9,Fibroblast growth factor 9,18726,1786,0.94 [0.84-1.05],0.2911614918508527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFBP1,Fibroblast growth factor-binding protein 1,22422,2149,0.33 [0.30-0.37],9.496488412780512e-85
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFBP2,Fibroblast growth factor-binding protein 2,19475,1856,0.79 [0.72-0.86],3.140535133188549e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFBP3,Fibroblast growth factor-binding protein 3,19425,1849,0.62 [0.54-0.70],1.75935128558198e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFR2,Fibroblast growth factor receptor 2,22422,2149,3.66 [3.17-4.22],4.5195576823179845e-70
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFR4,Fibroblast growth factor receptor 4,19045,1813,0.87 [0.79-0.94],0.0009475400210429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGL1,Fibrinogen-like protein 1,19470,1855,1.20 [1.12-1.29],9.882474793516853e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGR,Tyrosine-protein kinase Fgr,21826,2083,1.12 [1.06-1.19],0.0001380159030125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FH,"Fumarate hydratase, mitochondrial",18824,1792,0.99 [0.93-1.04],0.6603676279223727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FHIP2A,FHF complex subunit HOOK interacting protein 2A,18799,1796,0.98 [0.89-1.08],0.6668753699957021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FHIT,Bis(5'-adenosyl)-triphosphatase,21826,2083,1.01 [0.96-1.07],0.7129808833018914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FIS1,Mitochondrial fission 1 protein,22335,2142,1.02 [0.97-1.07],0.5591460232729881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,19419,1844,1.05 [1.00-1.09],0.0485170779710227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,22371,2139,1.01 [0.97-1.04],0.70923173420816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,22137,2130,1.22 [1.12-1.34],1.4133637767842676e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,22137,2130,1.05 [1.01-1.10],0.0187936196740228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,21793,2082,1.04 [0.96-1.13],0.3018681041231883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FKBPL,FK506-binding protein-like,19369,1846,1.03 [0.95-1.11],0.5250270194623385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FLI1,Friend leukemia integration 1 transcription factor,21834,2088,1.04 [1.01-1.08],0.0195335875717253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,22137,2130,1.36 [1.19-1.55],5.549735241544219e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FLT1,Vascular endothelial growth factor receptor 1,22186,2128,0.99 [0.83-1.18],0.9096942087503186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FLT3,Receptor-type tyrosine-protein kinase FLT3,21834,2088,0.89 [0.79-1.01],0.0822324719533065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FLT3LG,Fms-related tyrosine kinase 3 ligand,22551,2158,1.34 [1.20-1.49],2.5516337943473176e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FLT4,Vascular endothelial growth factor receptor 3,22422,2149,1.14 [1.01-1.28],0.0292983209530766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FMNL1,Formin-like protein 1,21826,2083,1.11 [1.06-1.18],5.368768512255628e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FMR1,Synaptic functional regulator FMR1,21834,2088,1.01 [0.90-1.13],0.8709766573112292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FN1,Fibronectin,19494,1852,1.15 [0.97-1.36],0.1039055301615927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FNDC1,Fibronectin type III domain-containing protein 1,19425,1849,0.93 [0.84-1.02],0.1230987872429179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,19371,1841,1.11 [0.98-1.26],0.1138528319053172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FOLH1,Glutamate carboxypeptidase 2,18885,1799,0.99 [0.95-1.04],0.7827512796858094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FOLR1,Folate receptor alpha,22325,2137,1.16 [1.02-1.32],0.0200631620436915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FOLR2,Folate receptor beta,22509,2156,1.12 [0.99-1.28],0.0755449591672809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FOLR3,Folate receptor gamma,22353,2140,1.02 [1.00-1.04],0.1138223888795748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FOS,Proto-oncogene c-Fos,18726,1786,1.11 [0.98-1.26],0.0989293668766657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FOSB,Protein fosB,21826,2083,0.92 [0.83-1.03],0.1500094065608187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FOXJ3,Forkhead box protein J3,18885,1799,1.08 [0.97-1.19],0.1605076770050123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FOXO1,Forkhead box protein O1,22279,2137,1.04 [0.99-1.09],0.0836008391144288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FOXO3,Forkhead box protein O3,21834,2088,1.01 [0.97-1.05],0.653754921625879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FRMD4B,FERM domain-containing protein 4B,18799,1796,0.99 [0.93-1.06],0.7834433821184328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FRMD7,FERM domain-containing protein 7,18933,1813,0.91 [0.79-1.04],0.1713893937690569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FRZB,Secreted frizzled-related protein 3,22066,2128,0.91 [0.78-1.05],0.2001932440455685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FSHB,Follitropin subunit beta,18968,1809,1.06 [0.97-1.16],0.1777306405609518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FST,Follistatin,22391,2150,0.77 [0.71-0.84],3.7557798695758814e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FSTL1,Follistatin-related protein 1,18968,1809,1.39 [1.13-1.70],0.0014582330681944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FSTL3,Follistatin-related protein 3,22287,2141,1.50 [1.34-1.68],4.679041674626471e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FTCD,Formimidoyltransferase-cyclodeaminase,19381,1843,1.49 [1.42-1.56],1.1877674162147654e-65
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FUCA1,Tissue alpha-L-fucosidase,22480,2155,1.08 [1.03-1.13],0.0019003916055734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FUOM,Fucose mutarotase,19045,1813,1.59 [1.49-1.70],4.3471335306677965e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FURIN,Furin,22422,2149,2.02 [1.80-2.27],2.006775604873509e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FUS,RNA-binding protein FUS,21804,2083,1.08 [0.98-1.19],0.1251341940227863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",19070,1823,1.11 [1.04-1.19],0.0018868466557245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,22509,2156,1.19 [1.10-1.29],1.1310918187154757e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FUT8,"Alpha-(1,6)-fucosyltransferase",22137,2130,1.01 [0.95-1.08],0.6653742130991777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FXN,"Frataxin, mitochondrial",22508,2152,1.03 [0.98-1.09],0.2024785314038459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FXYD5,FXYD domain-containing ion transport regulator 5,21900,2081,1.05 [0.99-1.12],0.0808600333528412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FYB1,FYN-binding protein 1,22312,2144,1.08 [1.03-1.12],0.0005247561240531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FZD10,Frizzled-10,18933,1813,1.00 [0.92-1.08],0.953820319950974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FZD8,Frizzled-8,18824,1792,0.95 [0.85-1.06],0.3251594550596436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GABARAP,Gamma-aminobutyric acid receptor-associated protein,19371,1841,1.07 [0.98-1.17],0.1350429126866892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,19109,1826,0.95 [0.88-1.02],0.1493479599997005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,18824,1792,0.95 [0.88-1.03],0.2028385495613687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAD1,Glutamate decarboxylase 1,18754,1788,1.05 [0.88-1.25],0.5799293640736314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAD2,Glutamate decarboxylase 2,18885,1799,0.94 [0.85-1.03],0.1837580441636882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,19109,1826,1.03 [0.94-1.13],0.4896595897935961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,18968,1809,1.08 [0.99-1.18],0.0736099961222854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAGE2A,G antigen 2A,18754,1788,1.06 [1.00-1.13],0.0638801265271124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAL,Galanin peptides,22429,2152,0.82 [0.78-0.87],7.970487821483179e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,22222,2129,2.23 [1.95-2.54],1.0812451030973784e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,22508,2152,0.85 [0.73-0.97],0.0200679714824771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,21900,2081,1.46 [1.34-1.59],9.433800751332836e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,19462,1849,1.16 [1.00-1.35],0.0551485277119332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GALNT7,N-acetylgalactosaminyltransferase 7,22222,2129,1.64 [1.36-1.97],1.2236518045954572e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAMT,Guanidinoacetate N-methyltransferase,18799,1796,0.94 [0.82-1.07],0.3214136255555243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,18613,1761,1.58 [1.35-1.85],1.9242754614809402e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GART,Trifunctional purine biosynthetic protein adenosine-3,19419,1844,1.04 [0.88-1.22],0.6706390198216241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAS2,Growth arrest-specific protein 2,19109,1826,1.21 [1.13-1.30],1.3849351639297976e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAS6,Growth arrest-specific protein 6,22481,2153,1.31 [1.12-1.52],0.0005694027701374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GASK1A,Golgi-associated kinase 1A,18799,1796,1.10 [0.99-1.22],0.0879560593776824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAST,Gastrin,19425,1849,1.10 [1.07-1.13],4.933811702913599e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,18754,1788,0.90 [0.75-1.06],0.2068588923307736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",18968,1809,1.04 [0.98-1.10],0.1833098530285297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GBA,Lysosomal acid glucosylceramidase,18933,1813,1.05 [0.97-1.14],0.2475322087757488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GBP1,Guanylate-binding protein 1,19391,1848,1.12 [1.05-1.20],0.0012833625965937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GBP2,Guanylate-binding protein 2,21900,2081,1.00 [0.94-1.07],0.9162875320188444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GBP4,Guanylate-binding protein 4,21826,2083,1.03 [0.95-1.12],0.4095161329291823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GBP6,Guanylate-binding protein 6,18799,1796,0.93 [0.83-1.03],0.1658812054105047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GC,Vitamin D-binding protein,19494,1852,0.96 [0.81-1.14],0.6528332874224945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GCC1,GRIP and coiled-coil domain-containing protein 1,19425,1849,1.06 [1.02-1.11],0.0052382452324267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GCG,Pro-glucagon,21834,2088,1.26 [1.22-1.30],5.5598353019533785e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,18582,1764,1.16 [1.06-1.27],0.0010086036510211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GCLM,Glutamate--cysteine ligase regulatory subunit,18799,1796,0.99 [0.90-1.10],0.912800353335286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",22222,2129,1.47 [1.32-1.64],2.8073218207653983e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GDF15,Growth/differentiation factor 15,22606,2166,2.61 [2.45-2.77],1.5278748521188357e-210
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GDF2,Growth/differentiation factor 2,22331,2138,1.26 [1.13-1.40],2.607454408461636e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GDNF,Glial cell line-derived neurotrophic factor,21826,2083,1.45 [1.32-1.59],3.537459055338049e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GET3,ATPase GET3,19462,1849,1.01 [0.93-1.09],0.834375518399676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GFAP,Glial fibrillary acidic protein,21795,2084,0.93 [0.86-1.01],0.092542961536868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GFER,FAD-linked sulfhydryl oxidase ALR,21834,2088,1.16 [1.09-1.24],1.3300498950108664e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,21834,2088,1.00 [0.97-1.03],0.9160588036963568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GFRA1,GDNF family receptor alpha-1,22470,2148,2.12 [1.87-2.40],2.6542050921389465e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GFRA2,GDNF family receptor alpha-2,22222,2129,0.92 [0.77-1.11],0.3907238189035343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GFRA3,GDNF family receptor alpha-3,22073,2121,1.11 [0.97-1.27],0.1309016304301414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GFRAL,GDNF family receptor alpha-like,18834,1792,0.85 [0.79-0.92],4.599141100421652e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GGA1,ADP-ribosylation factor-binding protein GGA1,21826,2083,0.98 [0.92-1.04],0.494979779407678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GGACT,Gamma-glutamylaminecyclotransferase,19462,1849,1.00 [0.94-1.07],0.9395782868807098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GGCT,Gamma-glutamylcyclotransferase,19421,1847,1.00 [0.91-1.10],0.9492724433061064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GGH,Gamma-glutamyl hydrolase,22001,2096,1.59 [1.43-1.76],5.911745218899675e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GGT1,Glutathione hydrolase 1 proenzyme,22323,2146,1.71 [1.61-1.82],2.212574139069837e-61
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GGT5,Glutathione hydrolase 5 proenzyme,22137,2130,2.30 [1.98-2.67],3.642191816268881e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GH1,Somatotropin,22288,2136,0.99 [0.96-1.01],0.2057387840278564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GH2,Growth hormone variant,21834,2088,0.97 [0.95-1.00],0.0243328147059167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GHR,Growth hormone receptor,19045,1813,1.84 [1.56-2.17],4.165668820726265e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GHRHR,Growth hormone-releasing hormone receptor,21826,2083,0.96 [0.89-1.03],0.2740038234380525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GHRL,Appetite-regulating hormone,22331,2138,0.87 [0.83-0.91],5.19093901386912e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GID8,Glucose-induced degradation protein 8 homolog,19419,1844,0.86 [0.74-0.99],0.0421512609897902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIGYF2,GRB10-interacting GYF protein 2,19419,1844,1.09 [1.03-1.16],0.0043171846648332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIMAP7,GTPase IMAP family member 7,19045,1813,0.66 [0.57-0.78],2.89648964285557e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIMAP8,GTPase IMAP family member 8,18754,1788,1.06 [0.98-1.16],0.1648001246938228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIP,Gastric inhibitory polypeptide,18968,1809,1.17 [1.09-1.26],2.8728650539318195e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIPC2,PDZ domain-containing protein GIPC2,19425,1849,1.58 [1.38-1.80],1.83444537787604e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIPC3,PDZ domain-containing protein GIPC3,19369,1846,1.00 [0.96-1.05],0.843578232715592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIPR,Gastric inhibitory polypeptide receptor,18885,1799,0.99 [0.90-1.09],0.8608068388253874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIT1,ARF GTPase-activating protein GIT1,18885,1799,1.03 [0.98-1.08],0.2949258357364634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GJA8,Gap junction alpha-8 protein,18754,1788,0.96 [0.89-1.04],0.3218515816385373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GKN1,Gastrokine-1,21409,2047,1.08 [0.94-1.24],0.2779658430762631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLA,Alpha-galactosidase A,19017,1812,2.06 [1.85-2.30],2.740516569839429e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLB1,Beta-galactosidase,22137,2130,1.49 [1.36-1.63],2.1002274290319616e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLI2,Zinc finger protein GLI2,18885,1799,0.94 [0.81-1.09],0.4212972751690671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLO1,Lactoylglutathione lyase,21913,2105,1.14 [1.07-1.22],5.612160798399875e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLOD4,Glyoxalase domain-containing protein 4,22297,2140,1.06 [0.95-1.19],0.2914615018848623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLP1R,Glucagon-like peptide 1 receptor,18824,1792,0.88 [0.78-1.00],0.0521604477917649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLRX,Glutaredoxin-1,22181,2129,1.07 [1.00-1.14],0.0549928256077669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",19045,1813,1.03 [0.98-1.09],0.2384665147800914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,21826,2083,1.02 [0.94-1.11],0.6536442616615333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLYR1,Putative oxidoreductase GLYR1,19371,1841,1.01 [0.93-1.09],0.8634065848489456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GM2A,Ganglioside GM2 activator,18977,1811,1.05 [0.94-1.17],0.3965388557258948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GMFG,Glia maturation factor gamma,19462,1849,1.02 [0.95-1.08],0.6413356494954063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GMPR,GMP reductase 1,22551,2158,0.97 [0.90-1.04],0.4091542126703177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GMPR2,GMP reductase 2,19045,1813,1.06 [0.99-1.14],0.0861952302674248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GNAS,Neuroendocrine secretory protein 55,19419,1844,0.97 [0.92-1.02],0.2250002618881195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,21834,2088,1.03 [0.97-1.09],0.3431612552336434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,18933,1813,0.92 [0.84-1.02],0.0997417414208704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GNLY,Granulysin,22355,2147,1.00 [0.93-1.07],0.990872445476236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GNPDA1,Glucosamine-6-phosphate isomerase 1,18968,1809,0.98 [0.86-1.12],0.7750233665365629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GNPDA2,Glucosamine-6-phosphate isomerase 2,19045,1813,0.88 [0.77-0.99],0.0389783148817645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GOLGA3,Golgin subfamily A member 3,19419,1844,1.05 [0.99-1.11],0.1075010222609998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GOLM2,Protein GOLM2,22509,2156,2.28 [2.02-2.57],1.0673565833756448e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,22279,2137,1.05 [1.01-1.09],0.018742674163523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GORASP2,Golgi reassembly-stacking protein 2,19369,1846,1.05 [0.95-1.15],0.3588001775826102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GOT1,"Aspartate aminotransferase, cytoplasmic",19475,1856,1.23 [1.12-1.35],2.896827426371331e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GP1BA,Platelet glycoprotein Ib alpha chain,22266,2131,0.83 [0.74-0.94],0.0022942750660187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GP1BB,Platelet glycoprotein Ib beta chain,18799,1796,1.02 [0.96-1.10],0.4876535699179248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,21633,2081,1.05 [1.00-1.10],0.0308123828457714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GP5,Platelet glycoprotein V,19045,1813,1.03 [0.91-1.17],0.6036265373813603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GP6,Platelet glycoprotein VI,22312,2144,1.02 [0.97-1.06],0.4480568547131901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPA33,Cell surface A33 antigen,22222,2129,0.93 [0.91-0.96],6.977327848677572e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPC1,Glypican-1,22508,2152,1.23 [1.08-1.39],0.0016872237471747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPC5,Glypican-5,22137,2130,0.87 [0.81-0.93],6.65253947449414e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPD1,Glycerol-3-phosphate dehydrogenase,19371,1841,1.73 [1.61-1.85],1.143933891953241e-52
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPHA2,Glycoprotein hormone alpha-2,19369,1846,0.84 [0.76-0.94],0.0024089973438366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPI,Glucose-6-phosphate isomerase,19470,1855,1.22 [1.11-1.34],2.9229901685792103e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,19369,1846,0.90 [0.85-0.95],0.0003372179967757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPKOW,G-patch domain and KOW motifs-containing protein,21826,2083,1.26 [1.13-1.40],2.4192836770023644e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPNMB,Transmembrane glycoprotein NMB,21720,2086,1.80 [1.58-2.06],6.114289633933672e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPR101,Probable G-protein coupled receptor 101,18824,1792,0.90 [0.83-0.98],0.0188985293536129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPR158,Probable G-protein coupled receptor 158,19419,1844,0.76 [0.66-0.87],0.0001071838693784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPR15L,Protein GPR15L,19369,1846,1.07 [0.99-1.15],0.070998824934955
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPR37,Prosaposin receptor GPR37,21913,2105,1.37 [1.30-1.45],2.3999523815522783e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPRC5C,G-protein coupled receptor family C group 5 member C,19371,1841,1.47 [1.38-1.57],1.081421097750548e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRAP2,GRB2-related adapter protein 2,22331,2138,1.03 [1.00-1.06],0.0596639147502649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,19462,1849,1.22 [1.13-1.31],5.7849393234426824e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRIK2,"Glutamate receptor ionotropic, kainate 2",19419,1844,0.95 [0.85-1.05],0.2936352312542977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",18824,1792,0.94 [0.86-1.02],0.1536779482101783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRK5,G protein-coupled receptor kinase 5,21913,2105,0.99 [0.92-1.07],0.8682312512444632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRN,Progranulin,22250,2139,1.64 [1.40-1.91],3.0618397702627605e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRP,Gastrin-releasing peptide,18968,1809,0.92 [0.85-1.00],0.0598316597093295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRPEL1,"GrpE protein homolog 1, mitochondrial",22222,2129,1.36 [1.28-1.44],6.4992322402095876e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRSF1,G-rich sequence factor 1,18660,1778,0.99 [0.94-1.05],0.8340465707220912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSAP,Gamma-secretase-activating protein,21834,2088,0.99 [0.95-1.04],0.7170062187191573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSN,Gelsolin,19405,1851,0.42 [0.38-0.47],4.5101823170142245e-60
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSR,"Glutathione reductase, mitochondrial",19352,1845,1.03 [0.84-1.27],0.7614293166206972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSTA1,Glutathione S-transferase A1,22292,2135,1.40 [1.35-1.46],1.1767486803529809e-57
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSTA3,Glutathione S-transferase A3,21834,2088,1.36 [1.31-1.43],3.975440199836785e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSTM4,Glutathione S-transferase Mu 4,18799,1796,1.00 [0.94-1.07],0.9151206286143284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSTP1,Glutathione S-transferase P,21693,2073,0.94 [0.88-0.99],0.0286496804345177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSTT2B,Glutathione S-transferase theta-2B,19425,1849,1.01 [0.99-1.03],0.2570019088592211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,19109,1826,0.93 [0.86-0.99],0.0338649072495959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GTPBP2,GTP-binding protein 2,18933,1813,1.02 [0.96-1.08],0.4776001984238729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GUCA2A,Guanylin,22240,2142,1.03 [0.92-1.15],0.6146973655589808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GUCY2C,Heat-stable enterotoxin receptor,19109,1826,1.02 [0.97-1.08],0.4415218561530271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GUK1,Guanylate kinase,18799,1796,1.02 [0.90-1.15],0.7413156155101336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GUSB,Beta-glucuronidase,22448,2148,1.61 [1.52-1.70],6.002743516075048e-63
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GYS1,"Glycogen [starch] synthase, muscle",21913,2105,0.97 [0.93-1.01],0.1413197462383957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GZMA,Granzyme A,22551,2158,1.35 [1.21-1.50],2.7863993361512605e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GZMB,Granzyme B,22279,2137,0.92 [0.87-0.98],0.0118736994589258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GZMH,Granzyme H,21913,2105,1.02 [0.97-1.07],0.3952644704218341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,H2AP,Huntingtin-interacting protein M,18754,1788,0.99 [0.91-1.09],0.8913998501001288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",18799,1796,1.02 [0.95-1.08],0.6081796190190554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",22433,2147,0.98 [0.93-1.04],0.5403604657459826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HAO1,Hydroxyacid oxidase 1,22508,2152,1.27 [1.24-1.31],1.0871901314711252e-61
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HARS1,"Histidine--tRNA ligase, cytoplasmic",22355,2147,1.06 [1.01-1.11],0.0280097116329976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HAVCR1,Hepatitis A virus cellular receptor 1,22471,2151,1.64 [1.56-1.73],4.7398543563021155e-77
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HAVCR2,Hepatitis A virus cellular receptor 2,22355,2147,1.55 [1.40-1.71],1.1963039005418069e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HBEGF,Proheparin-binding EGF-like growth factor,22433,2147,1.08 [1.02-1.14],0.004677315595848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HBQ1,Hemoglobin subunit theta-1,22508,2152,0.92 [0.86-0.98],0.0094317091051893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HBZ,Hemoglobin subunit zeta,19462,1849,0.98 [0.94-1.02],0.2472907610006146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HCG22,Protein PBMUCL2,18799,1796,1.01 [0.94-1.10],0.72560918850232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HCLS1,Hematopoietic lineage cell-specific protein,22551,2158,1.08 [1.01-1.16],0.0349737650034783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HDAC8,Histone deacetylase 8,18885,1799,0.92 [0.84-1.00],0.0444878595917394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HDAC9,Histone deacetylase 9,18824,1792,0.94 [0.87-1.01],0.0865807924593703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HDDC2,5'-deoxynucleotidase HDDC2,19369,1846,0.95 [0.86-1.05],0.3220449568168732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HDGF,Hepatoma-derived growth factor,22466,2149,1.03 [0.98-1.07],0.2203603835003681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HDGFL2,Hepatoma-derived growth factor-related protein 2,19425,1849,1.11 [1.04-1.19],0.0028817231944359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HEBP1,Heme-binding protein 1,21913,2105,0.93 [0.87-1.01],0.0739046091055842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HEG1,Protein HEG homolog 1,19045,1813,3.03 [2.59-3.55],1.3592530181318376e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HEPACAM2,HEPACAM family member 2,19425,1849,0.86 [0.78-0.96],0.0066090679983053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HEPH,Hephaestin,19462,1849,3.16 [2.65-3.78],6.210139908043511e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HEXIM1,Protein HEXIM1,22279,2137,1.09 [1.04-1.15],0.000303910064949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HGF,Hepatocyte growth factor,22551,2158,2.54 [2.31-2.79],3.643116487823316e-84
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HGFAC,Hepatocyte growth factor activator,19283,1836,0.93 [0.79-1.09],0.343165955476453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,21834,2088,1.04 [0.99-1.10],0.1168330142615754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HHEX,Hematopoietically-expressed homeobox protein HHEX,19425,1849,1.16 [1.10-1.23],6.195511316614734e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HIF1A,Hypoxia-inducible factor 1-alpha,18885,1799,1.03 [0.96-1.11],0.4141681800216734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HIP1,Huntingtin-interacting protein 1,18799,1796,0.96 [0.83-1.10],0.55368119200859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HIP1R,Huntingtin-interacting protein 1-related protein,19379,1843,1.41 [1.31-1.51],2.5215255749064934e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HJV,Hemojuvelin,19419,1844,1.33 [1.23-1.44],2.5058609900929205e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HK2,Hexokinase-2,21913,2105,1.00 [0.87-1.15],0.9803699355794758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",19419,1844,1.09 [0.95-1.24],0.2301042972204347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",22217,2131,1.33 [1.20-1.47],3.3218736558274674e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",22279,2137,1.20 [1.06-1.36],0.0047219007922825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HMBS,Porphobilinogen deaminase,22508,2152,1.03 [0.94-1.12],0.5484716512270178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HMCN2,Hemicentin-2,19016,1812,1.30 [1.20-1.41],1.9893994443304607e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",18968,1809,1.05 [0.96-1.15],0.2867208202274967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",18799,1796,0.95 [0.86-1.06],0.3793227339878053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HMMR,Hyaluronan mediated motility receptor,18711,1782,0.97 [0.88-1.06],0.4806149894987599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HMOX1,Heme oxygenase 1,22079,2121,0.83 [0.77-0.90],1.3555217213063149e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HMOX2,Heme oxygenase 2,21826,2083,1.11 [1.02-1.20],0.0143992257249291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HNF1A,Hepatocyte nuclear factor 1-alpha,18933,1813,1.01 [0.95-1.07],0.8062033531873048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HNMT,Histamine N-methyltransferase,22033,2127,1.31 [1.21-1.41],1.3907043229500209e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,21851,2100,1.05 [1.00-1.11],0.0468977461354993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,19419,1844,1.12 [1.02-1.22],0.0128483282958095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HPCAL1,Hippocalcin-like protein 1,22551,2158,1.05 [0.99-1.10],0.0939745746869604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HPGDS,Hematopoietic prostaglandin D synthase,21834,2088,0.76 [0.69-0.85],6.380159051393502e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HPSE,Heparanase,19209,1831,1.07 [1.02-1.12],0.0062190557572928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HRAS,GTPase Hras,19064,1820,0.99 [0.94-1.04],0.6271622664149081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,18968,1809,0.75 [0.65-0.87],0.0001247920809211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HRG,Histidine-rich glycoprotein,19380,1838,1.40 [1.22-1.62],2.494195750546756e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HS1BP3,HCLS1-binding protein 3,18968,1809,1.02 [0.96-1.07],0.5605660322990382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,22222,2129,1.21 [1.10-1.34],0.0001852921032326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,22508,2152,1.14 [1.02-1.26],0.0207485745019445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,18885,1799,1.31 [1.16-1.48],2.041046313602497e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSBP1,Heat shock factor-binding protein 1,18968,1809,1.04 [0.99-1.10],0.0807170735438141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,22279,2137,0.48 [0.44-0.53],1.0117702692646106e-54
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,19425,1849,1.32 [1.23-1.42],3.4305666498609773e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSD17B3,Testosterone 17-beta-dehydrogenase 3,18799,1796,1.00 [0.91-1.10],0.9716196520948251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,18968,1809,1.06 [0.97-1.17],0.2074837576604286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSP90B1,Endoplasmin,21713,2072,0.95 [0.89-1.01],0.1206414634842883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSPA1A,Heat shock 70 kDa protein 1A,22400,2149,1.08 [1.02-1.14],0.0060064258645067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSPA2,Heat shock-related 70 kDa protein 2,19371,1841,1.15 [1.02-1.30],0.0264370867908889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSPB1,Heat shock protein beta-1,21998,2106,1.07 [1.01-1.13],0.0251554324220187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSPB6,Heat shock protein beta-6,22508,2152,1.30 [1.19-1.43],3.622056016122702e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,22196,2118,1.14 [0.99-1.31],0.0603863972906687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HTR1A,5-hydroxytryptamine receptor 1A,18824,1792,0.99 [0.93-1.05],0.724953192928448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HTR1B,5-hydroxytryptamine receptor 1B,18824,1792,0.89 [0.79-0.99],0.0374253235097979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HTRA2,"Serine protease HTRA2, mitochondrial",22422,2149,1.05 [0.99-1.12],0.116436219505982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HYAL1,Hyaluronidase-1,22246,2122,2.34 [2.02-2.71],5.007810133871753e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HYOU1,Hypoxia up-regulated protein 1,22606,2166,0.83 [0.70-0.97],0.0214451877132755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICA1,Islet cell autoantigen 1,21900,2081,1.03 [0.98-1.08],0.3022274243462957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICAM1,Intercellular adhesion molecule 1,22263,2126,2.01 [1.78-2.26],7.096586408046512e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICAM2,Intercellular adhesion molecule 2,22606,2166,1.12 [0.99-1.26],0.0636267731564745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICAM3,Intercellular adhesion molecule 3,22606,2166,1.08 [0.94-1.24],0.2902070713634199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICAM4,Intercellular adhesion molecule 4,22279,2137,0.74 [0.69-0.80],8.195371156367469e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICAM5,Intercellular adhesion molecule 5,22331,2138,1.21 [1.11-1.31],6.406548014404559e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICOSLG,ICOS ligand,22222,2129,0.85 [0.70-1.04],0.122652819409555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ID4,DNA-binding protein inhibitor ID-4,19109,1826,1.03 [0.93-1.14],0.6165728729764435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IDI2,Isopentenyl-diphosphate delta-isomerase 2,21826,2083,1.10 [1.02-1.19],0.0166516804433814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IDO1,"Indoleamine 2,3-dioxygenase 1",18968,1809,1.10 [1.03-1.18],0.0079064372570272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IDS,Iduronate 2-sulfatase,22551,2158,0.45 [0.30-0.67],0.0001027465611884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IDUA,Alpha-L-iduronidase,22508,2152,1.68 [1.54-1.83],7.295342391736544e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,18888,1807,1.62 [1.46-1.80],3.1952711716492724e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,19109,1826,0.94 [0.86-1.03],0.1751559639917648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,19109,1826,1.06 [0.94-1.19],0.3674159088042344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNAR1,Interferon alpha/beta receptor 1,19369,1846,1.03 [0.86-1.23],0.7457104305617657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNG,Interferon gamma,21900,2081,1.03 [1.00-1.07],0.0580780717825976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNGR1,Interferon gamma receptor 1,22429,2152,1.01 [0.84-1.21],0.9208770327909224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNGR2,Interferon gamma receptor 2,22137,2130,1.44 [1.34-1.54],5.5221008292688e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNL1,Interferon lambda-1,21826,2083,1.15 [1.06-1.25],0.001050275162896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNL2,Interferon lambda-2,18824,1792,1.04 [0.97-1.11],0.277337006988038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNLR1,Interferon lambda receptor 1,22279,2137,1.27 [1.15-1.40],1.9073058406427664e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNW1,Interferon omega-1,18799,1796,0.90 [0.79-1.03],0.1284633366105082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFT20,Intraflagellar transport protein 20 homolog,18933,1813,1.01 [0.91-1.13],0.8335103488381441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGBP1,Immunoglobulin-binding protein 1,19419,1844,1.03 [0.95-1.10],0.4987718326655584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,18824,1792,0.95 [0.86-1.04],0.2762174519740809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,19475,1856,0.71 [0.60-0.84],4.344972213906915e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGF1R,Insulin-like growth factor 1 receptor,22222,2129,1.26 [1.06-1.50],0.0092401516165771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,18799,1796,0.98 [0.88-1.09],0.7081667119733721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGF2R,Cation-independent mannose-6-phosphate receptor,22355,2147,2.52 [2.14-2.96],7.531491655931617e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP1,Insulin-like growth factor-binding protein 1,22571,2164,0.78 [0.75-0.80],4.8962653167978466e-55
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP2,Insulin-like growth factor-binding protein 2,22580,2163,0.65 [0.61-0.69],8.162827339877657e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP3,Insulin-like growth factor-binding protein 3,22460,2144,0.83 [0.74-0.93],0.0012063028261511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP4,Insulin-like growth factor-binding protein 4,22065,2124,1.41 [1.31-1.52],1.7495640098116314e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP6,Insulin-like growth factor-binding protein 6,22258,2129,1.08 [0.96-1.22],0.2157552287223459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP7,Insulin-like growth factor-binding protein 7,22606,2166,1.68 [1.52-1.85],7.605966000228501e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,22331,2138,1.74 [1.57-1.92],8.617607782395714e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFL4,Insulin growth factor-like family member 4,18885,1799,1.03 [0.97-1.09],0.3396474203214764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGHMBP2,DNA-binding protein SMUBP-2,18799,1796,1.00 [0.92-1.09],0.996698438987772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGLC2,Immunoglobulin lambda constant 2,19458,1849,1.34 [1.16-1.54],5.529030742417698e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGLON5,IgLON family member 5,18754,1788,0.98 [0.93-1.03],0.3832243280224362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGSF21,Immunoglobulin superfamily member 21,18968,1809,0.99 [0.88-1.11],0.8183747519470632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGSF3,Immunoglobulin superfamily member 3,22222,2129,2.15 [2.02-2.30],2.9867389978477673e-122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGSF8,Immunoglobulin superfamily member 8,22331,2138,1.92 [1.71-2.15],5.38507798470089e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGSF9,Protein turtle homolog A,19462,1849,1.73 [1.65-1.81],4.245703091359604e-108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IKBKG,NF-kappa-B essential modulator,22279,2137,1.07 [1.02-1.11],0.00357146929282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IKZF2,Zinc finger protein Helios,21834,2088,1.03 [0.98-1.07],0.267862251226559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL10,Interleukin-10,21900,2081,1.07 [1.03-1.12],0.002035484555275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL10RA,Interleukin-10 receptor subunit alpha,21900,2081,0.98 [0.91-1.05],0.5137200685522718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL10RB,Interleukin-10 receptor subunit beta,22429,2152,1.81 [1.63-2.02],2.8004794644704797e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL11,Interleukin-11,21900,2081,0.98 [0.92-1.04],0.5576574312995644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL12A_IL12B,Interleukin-12,22222,2129,1.17 [1.12-1.23],3.1390114031288516e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL12B,Interleukin-12 subunit beta,22551,2158,1.26 [1.18-1.35],1.5502458681164722e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL12RB1,Interleukin-12 receptor subunit beta-1,21900,2081,1.43 [1.30-1.57],1.1131502942867628e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL12RB2,Interleukin-12 receptor subunit beta-2,18885,1799,0.95 [0.85-1.07],0.3837629170717908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL13,Interleukin-13,21900,2081,1.01 [0.93-1.09],0.8993304684159205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL13RA1,Interleukin-13 receptor subunit alpha-1,22080,2117,1.52 [1.28-1.80],1.680729982412749e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL13RA2,Interleukin-13 receptor subunit alpha-2,18824,1792,0.99 [0.85-1.16],0.8929862075849655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL15,Interleukin-15,22279,2137,1.19 [1.06-1.34],0.0027816689104419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL15RA,Interleukin-15 receptor subunit alpha,21900,2081,1.16 [1.04-1.30],0.0060358524545406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL16,Pro-interleukin-16,22551,2158,1.17 [1.07-1.27],0.000521205139135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL17A,Interleukin-17A,21867,2076,1.15 [1.06-1.26],0.0010203819762888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL17C,Interleukin-17C,21900,2081,1.18 [1.13-1.24],3.0211746623125564e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL17D,Interleukin-17D,21900,2081,0.90 [0.79-1.02],0.0989144154373088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL17F,Interleukin-17F,21900,2081,1.00 [0.95-1.05],0.97191221778049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL17RA,Interleukin-17 receptor A,22355,2147,1.16 [1.06-1.26],0.0007224908773184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL17RB,Interleukin-17 receptor B,22011,2118,0.70 [0.65-0.75],2.850622227717819e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL18,Interleukin-18,22257,2134,1.40 [1.30-1.52],1.3474946478912184e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL18BP,Interleukin-18-binding protein,22460,2144,1.60 [1.43-1.79],1.3775122710656062e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL18R1,Interleukin-18 receptor 1,22551,2158,3.25 [2.93-3.61],3.486545625362885e-107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL18RAP,Interleukin-18 receptor accessory protein,21997,2119,0.98 [0.96-1.01],0.1658505992674854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL19,Interleukin-19,21762,2095,1.17 [1.11-1.23],9.484189189954374e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1A,Interleukin-1 alpha,21900,2081,0.98 [0.92-1.05],0.6407297678719568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1B,Interleukin-1 beta,21807,2071,1.02 [0.95-1.09],0.6267772473959232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1R1,Interleukin-1 receptor type 1,22323,2146,2.56 [2.18-2.99],9.554712253575267e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1R2,Interleukin-1 receptor type 2,22289,2134,3.60 [2.97-4.37],1.926586628601767e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1RAP,Interleukin-1 receptor accessory protein,22355,2147,0.88 [0.81-0.96],0.00464834150339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1RL1,Interleukin-1 receptor-like 1,22541,2159,1.38 [1.26-1.50],1.8770948274812665e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1RL2,Interleukin-1 receptor-like 2,21900,2081,1.18 [1.06-1.31],0.0018872803819443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1RN,Interleukin-1 receptor antagonist protein,22293,2140,1.64 [1.55-1.73],2.2976998691352666e-72
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL2,Interleukin-2,21900,2081,0.93 [0.83-1.06],0.2765281703688021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL20,Interleukin-20,21900,2081,1.00 [0.92-1.08],0.9366614287963172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL20RA,Interleukin-20 receptor subunit alpha,21900,2081,1.02 [0.94-1.11],0.5881148917157218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL20RB,Interleukin-20 receptor subunit beta,18885,1799,0.94 [0.84-1.04],0.232560765963696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL21R,Interleukin-21 receptor,18885,1799,0.91 [0.84-0.99],0.0304056972745395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL22,Interleukin-22,19371,1841,1.12 [1.06-1.20],0.0001441644267825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL22RA1,Interleukin-22 receptor subunit alpha-1,21900,2081,1.03 [0.95-1.13],0.4520477963173549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL24,Interleukin-24,21900,2081,1.00 [0.93-1.09],0.9324912605431588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL25,Interleukin-25,18690,1783,1.00 [0.88-1.14],0.9816404930052348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL2RA,Interleukin-2 receptor subunit alpha,22157,2121,1.21 [1.11-1.33],2.0536538104011783e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL2RB,Interleukin-2 receptor subunit beta,21900,2081,1.01 [0.91-1.12],0.9136894270699002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL2RG,Cytokine receptor common subunit gamma,19371,1841,0.96 [0.85-1.09],0.504061944261507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL3,Interleukin-3,18754,1788,0.98 [0.91-1.05],0.5309282772570225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL31,Interleukin-31,18885,1799,1.04 [0.96-1.12],0.3781323065859266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL31RA,Interleukin-31 receptor subunit alpha,18807,1791,1.14 [1.01-1.28],0.036824328721379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL32,Interleukin-32,22279,2137,0.92 [0.84-1.01],0.0706211617602578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL33,Interleukin-33,21900,2081,1.00 [0.91-1.11],0.9603933273470716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL34,Interleukin-34,21793,2079,1.08 [0.97-1.20],0.1740730472955409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL36A,Interleukin-36 alpha,18885,1799,0.97 [0.89-1.05],0.4781356291242906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL36G,Interleukin-36 gamma,18796,1792,1.03 [0.96-1.10],0.410476920022832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL3RA,Interleukin-3 receptor subunit alpha,21900,2081,1.15 [1.02-1.30],0.01959907300116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL4,Interleukin-4,21900,2081,0.99 [0.95-1.03],0.5421128025833095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL4R,Interleukin-4 receptor subunit alpha,22279,2137,1.32 [1.20-1.46],2.7248442925500063e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL5,Interleukin-5,21900,2081,0.97 [0.94-0.99],0.017358374039478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL5RA,Interleukin-5 receptor subunit alpha,22279,2137,1.14 [1.07-1.22],4.948279248174381e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL6,Interleukin-6,22222,2129,1.21 [1.16-1.26],3.2335860123218934e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL6R,Interleukin-6 receptor subunit alpha,22237,2125,1.09 [0.97-1.22],0.1322706941667517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL6ST,Interleukin-6 receptor subunit beta,22331,2138,2.42 [1.97-2.98],7.968136457206268e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL7,Interleukin-7,22279,2137,0.96 [0.91-1.02],0.2406966936794472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL7R,Interleukin-7 receptor subunit alpha,22355,2147,0.81 [0.76-0.87],1.6512966900776347e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL9,Interleukin-9,19109,1826,1.00 [0.92-1.08],0.9427771505064996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,21788,2078,1.07 [1.01-1.15],0.0344728422904685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IMMT,MICOS complex subunit MIC60,19371,1841,1.52 [1.40-1.65],7.59116734618077e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IMPA1,Inositol monophosphatase 1,22137,2130,0.98 [0.92-1.05],0.599918039063354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IMPACT,Protein IMPACT,19425,1849,1.02 [0.94-1.10],0.6789880349404714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IMPG1,Interphotoreceptor matrix proteoglycan 1,18824,1792,0.90 [0.77-1.05],0.1915596262535065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ING1,Inhibitor of growth protein 1,21793,2082,1.03 [0.95-1.12],0.4517492858095321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INHBB,Inhibin beta B chain,19045,1813,1.10 [1.01-1.20],0.0211852902285986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INHBC,Inhibin beta C chain,22355,2147,2.01 [1.82-2.23],1.2106348053736052e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INPP1,Inositol polyphosphate 1-phosphatase,22222,2129,0.99 [0.92-1.06],0.7102162178151844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",18968,1809,1.17 [1.08-1.26],0.0001474239504212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",19419,1844,1.02 [0.92-1.13],0.7293240125773899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",22222,2129,1.05 [1.01-1.10],0.011576425432286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INSL3,Insulin-like 3,19425,1849,0.85 [0.81-0.90],2.329039108673447e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INSL4,Early placenta insulin-like peptide,19371,1841,1.00 [0.91-1.09],0.9910046386526522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INSL5,Insulin-like peptide INSL5,19369,1846,1.16 [1.11-1.21],1.2696681965337392e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INSR,Insulin receptor,18885,1799,1.39 [1.08-1.80],0.0109281308299192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IPCEF1,Interactor protein for cytohesin exchange factors 1,22101,2129,1.08 [1.03-1.12],0.0010665424171019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IQGAP2,Ras GTPase-activating-like protein IQGAP2,22222,2129,1.20 [1.12-1.28],3.7999281322183093e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",21913,2105,1.04 [0.99-1.09],0.089559489518164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IRAK1,Interleukin-1 receptor-associated kinase 1,21900,2081,1.06 [1.00-1.12],0.0596200753993158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IRAK4,Interleukin-1 receptor-associated kinase 4,22279,2137,1.05 [1.01-1.09],0.0193848416049966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,21536,2056,1.04 [0.93-1.15],0.5002073387620266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ISM1,Isthmin-1,22279,2137,1.06 [0.96-1.17],0.2235742125487708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ISM2,Isthmin-2,19475,1856,1.03 [0.93-1.14],0.5672920619920241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IST1,IST1 homolog,19228,1832,1.03 [0.98-1.08],0.1985177503580275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGA11,Integrin alpha-11,22279,2137,0.64 [0.58-0.72],1.4514914853133194e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGA2,Integrin alpha-2,19045,1813,0.80 [0.70-0.91],0.0006688649116464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGA5,Integrin alpha-5,22355,2147,2.69 [2.33-3.11],2.582881030258715e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGA6,Integrin alpha-6,22279,2137,0.96 [0.88-1.03],0.2418586810078886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGAL,Integrin alpha-L,18885,1799,1.27 [1.14-1.42],1.2671638969700833e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGAM,Integrin alpha-M,22355,2147,1.41 [1.25-1.59],1.8024157212299243e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGAV,Integrin alpha-V,22508,2152,0.33 [0.26-0.41],8.304528064055987e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGAX,Integrin alpha-X,19109,1826,0.99 [0.91-1.07],0.7584786126130043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGB1,Integrin beta-1,22350,2133,1.00 [0.83-1.19],0.9631992333665568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGB1BP1,Integrin beta-1-binding protein 1,21834,2088,1.04 [0.95-1.14],0.4410686968946042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGB1BP2,Integrin beta-1-binding protein 2,21913,2105,1.02 [0.99-1.06],0.1829217615916772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGB2,Integrin beta-2,22213,2137,1.78 [1.56-2.04],8.953855068881393e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGB5,Integrin beta-5,22422,2149,0.95 [0.86-1.05],0.2950918783007507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGB6,Integrin beta-6,21900,2081,1.41 [1.24-1.60],1.659394003479873e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGB7,Integrin beta-7,22508,2152,1.17 [1.08-1.27],0.0001760932270813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGBL1,Integrin beta-like protein 1,19475,1856,1.88 [1.71-2.07],5.330853204126108e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,19494,1852,1.03 [0.81-1.32],0.7897297281373618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,22460,2144,1.04 [0.94-1.15],0.43777592614645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,19494,1852,0.99 [0.83-1.19],0.9520915927144318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,19371,1841,1.05 [0.95-1.16],0.3176028086738969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITM2A,Integral membrane protein 2A,22279,2137,0.95 [0.89-1.01],0.1029244576170458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITPA,Inosine triphosphate pyrophosphatase,18799,1796,1.00 [0.94-1.07],0.904483803273337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",18968,1809,1.08 [1.01-1.15],0.0227680325153005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",18824,1792,0.92 [0.82-1.03],0.1471676753408091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",21826,2083,0.97 [0.90-1.05],0.4882918651354849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IZUMO1,Izumo sperm-egg fusion protein 1,18754,1788,0.95 [0.86-1.05],0.3113381266740561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,JAM2,Junctional adhesion molecule B,22509,2156,1.20 [1.05-1.38],0.0081924503890694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,JAM3,Junctional adhesion molecule C,19045,1813,1.11 [1.02-1.22],0.0175532029678943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,JCHAIN,Immunoglobulin J chain,21900,2081,1.01 [0.95-1.08],0.6564999330893564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,18754,1788,0.92 [0.85-1.00],0.0540652830045083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,JPT2,Jupiter microtubule associated homolog 2,19369,1846,1.02 [0.97-1.07],0.4623233862425536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,JUN,Transcription factor AP-1,21900,2081,1.12 [1.03-1.20],0.0054069421786234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,22222,2129,1.07 [0.98-1.17],0.1061302881162757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KAZN,Kazrin,19369,1846,1.04 [1.00-1.08],0.0811845255243128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KCNC4,Potassium voltage-gated channel subfamily C member 4,18824,1792,0.93 [0.85-1.01],0.0952151606715275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KCNH2,Potassium voltage-gated channel subfamily H member 2,18933,1813,0.98 [0.92-1.04],0.4525434069465144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KCNIP4,Kv channel-interacting protein 4,21826,2083,1.03 [0.95-1.11],0.4967003219164669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KCTD5,BTB/POZ domain-containing protein KCTD5,19069,1809,1.28 [1.17-1.40],9.728542089649753e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KDM3A,Lysine-specific demethylase 3A,18885,1799,0.95 [0.90-1.01],0.1005417609708551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KDR,Vascular endothelial growth factor receptor 2,22422,2149,1.20 [1.03-1.40],0.0222263864180633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KEL,Kell blood group glycoprotein,21826,2083,1.15 [1.03-1.28],0.0094585569163912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KHDC3L,KH domain-containing protein 3,18754,1788,0.96 [0.89-1.02],0.197133654076346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KHK,Ketohexokinase,18968,1809,1.58 [1.47-1.69],1.4936162617791676e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIAA0319,Dyslexia-associated protein KIAA0319,19425,1849,0.62 [0.53-0.72],1.0242030945322615e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIAA1549,UPF0606 protein KIAA1549,19109,1826,1.02 [0.95-1.08],0.6393859450535766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIAA1549L,UPF0606 protein KIAA1549L,19109,1826,0.96 [0.82-1.12],0.5828273500177237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIAA2013,Uncharacterized protein KIAA2013,19371,1841,0.97 [0.89-1.06],0.5551088712262411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIF1C,Kinesin-like protein KIF1C,18799,1796,1.17 [1.04-1.33],0.0105363888752896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIF20B,Kinesin-like protein KIF20B,18824,1792,0.98 [0.93-1.04],0.5880225557279853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIF22,Kinesin-like protein KIF22,18799,1796,1.09 [1.05-1.13],5.14145028932963e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIFBP,KIF-binding protein,22222,2129,1.06 [1.01-1.11],0.0231966721954235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,19371,1841,1.03 [0.98-1.08],0.2688322044358305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,21834,2088,1.04 [0.99-1.09],0.0980471044513307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,19369,1846,0.97 [0.94-0.99],0.0076199263884331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,21834,2088,0.99 [0.96-1.02],0.3718091264446036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,18754,1788,0.97 [0.91-1.03],0.2822320080455213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIRREL1,Kin of IRRE-like protein 1,18824,1792,0.95 [0.87-1.03],0.2166058872997698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIRREL2,Kin of IRRE-like protein 2,21826,2083,0.83 [0.75-0.92],0.0001965863711031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIT,Mast/stem cell growth factor receptor Kit,22412,2141,0.66 [0.58-0.75],7.838045903100903e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KITLG,Kit ligand,22331,2138,0.70 [0.63-0.77],5.630362849602269e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLB,Beta-klotho,21826,2083,0.92 [0.87-0.97],0.0027930764982409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLF4,Krueppel-like factor 4,18824,1792,1.11 [1.00-1.24],0.0519749322903241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLHL41,Kelch-like protein 41,19419,1844,0.92 [0.84-1.02],0.1167590577832694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK1,Kallikrein-1,22128,2121,0.98 [0.95-1.01],0.1116173085206648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK10,Kallikrein-10,22355,2143,0.86 [0.78-0.94],0.0016543466524096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK11,Kallikrein-11,22214,2127,1.07 [0.95-1.20],0.262164136311928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK12,Kallikrein-12,21834,2088,1.00 [0.97-1.03],0.8685473780356612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK13,Kallikrein-13,21847,2091,0.92 [0.85-1.00],0.0454050669233846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK14,Kallikrein-14,22508,2152,0.77 [0.71-0.84],6.97562665811113e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK15,Kallikrein-15,19331,1837,1.01 [0.92-1.10],0.8991234374759998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK3,Prostate-specific antigen,19475,1856,0.95 [0.91-0.99],0.024355298683168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK4,Kallikrein-4,22508,2152,1.20 [1.13-1.27],4.96449362128392e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK6,Kallikrein-6,22379,2146,0.93 [0.82-1.05],0.2405098645706549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK7,Kallikrein-7,18563,1766,0.77 [0.68-0.87],2.4748251187364106e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK8,Kallikrein-8,21602,2078,0.93 [0.83-1.03],0.1723749789069986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLKB1,Plasma kallikrein,19075,1814,1.01 [0.84-1.22],0.8830892783071633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,22551,2158,1.76 [1.61-1.93],3.6168110183317694e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,18824,1792,0.99 [0.91-1.07],0.767496201423382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLRD1,Natural killer cells antigen CD94,22551,2158,1.23 [1.14-1.33],3.463660474341016e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLRF1,Killer cell lectin-like receptor subfamily F member 1,18885,1799,1.23 [1.14-1.33],2.783577285148324e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLRK1,NKG2-D type II integral membrane protein,19425,1849,1.16 [1.06-1.27],0.0018185368537601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT14,"Keratin, type I cytoskeletal 14",21145,2023,0.98 [0.85-1.12],0.7446821355539622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT17,"Keratin, type I cytoskeletal 17",18799,1796,0.97 [0.86-1.09],0.6037505403270906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT18,"Keratin, type I cytoskeletal 18",22222,2129,1.45 [1.39-1.50],6.255451813935092e-77
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT19,"Keratin, type I cytoskeletal 19",22234,2132,1.33 [1.26-1.40],1.0756745683474683e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT5,"Keratin, type II cytoskeletal 5",21826,2083,0.87 [0.80-0.94],0.0004723671559955
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT6C,"Keratin, type II cytoskeletal 6C",18799,1796,1.07 [0.94-1.20],0.3007624929724264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT8,"Keratin, type II cytoskeletal 8",18824,1792,1.30 [1.26-1.35],2.818231667872809e-52
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KYAT1,Kynurenine--oxoglutarate transaminase 1,22302,2136,1.04 [0.97-1.11],0.2564079399662967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KYNU,Kynureninase,22551,2158,1.61 [1.49-1.74],1.1374037825005768e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,L1CAM,Neural cell adhesion molecule L1,22422,2149,1.08 [0.95-1.23],0.2562695112670987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,19462,1849,1.07 [1.02-1.13],0.0058764073635191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LACRT,Extracellular glycoprotein lacritin,19335,1836,0.93 [0.84-1.02],0.1301753784682824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LACTB2,Endoribonuclease LACTB2,22331,2138,1.04 [0.98-1.11],0.1541564094021339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAG3,Lymphocyte activation gene 3 protein,22222,2129,1.31 [1.19-1.43],7.757586460002836e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,22325,2139,1.34 [1.23-1.45],4.5000321958971396e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,22137,2130,1.04 [1.00-1.07],0.0623475195420647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMA1,Laminin subunit alpha-1,18799,1796,0.94 [0.86-1.03],0.2179762919710507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMA4,Laminin subunit alpha-4,22429,2152,1.01 [0.90-1.14],0.8214726140983356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMB1,Laminin subunit beta-1,18968,1809,2.25 [1.94-2.62],5.448791922247054e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMP1,Lysosome-associated membrane glycoprotein 1,18913,1805,1.37 [1.26-1.50],2.351345343531749e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMP2,Lysosome-associated membrane glycoprotein 2,21651,2089,2.49 [2.05-3.03],7.554035564583371e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMP3,Lysosome-associated membrane glycoprotein 3,22519,2155,1.09 [1.02-1.17],0.014396759836436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMTOR5,Ragulator complex protein LAMTOR5,19371,1841,0.88 [0.78-0.98],0.0267919795426821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAP3,Cytosol aminopeptidase,21900,2081,1.17 [1.09-1.27],3.157823005986243e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LARP1,La-related protein 1,19371,1841,1.05 [0.98-1.12],0.2030246092256013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAT,Linker for activation of T-cells family member 1,22551,2158,1.10 [1.05-1.16],0.0001990472114008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAT2,Linker for activation of T-cells family member 2,22222,2129,1.05 [1.02-1.09],0.0008974505393397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LATS1,Serine/threonine-protein kinase LATS1,18885,1799,1.08 [1.03-1.14],0.0042104649728042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAYN,Layilin,22104,2129,1.35 [1.22-1.50],4.88701024742878e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LBP,Lipopolysaccharide-binding protein,22460,2144,1.26 [1.18-1.35],2.2137945645904888e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LBR,Delta(14)-sterol reductase LBR,22509,2156,1.16 [1.11-1.22],3.7865532382059986e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LCAT,Phosphatidylcholine-sterol acyltransferase,19470,1855,1.96 [1.58-2.42],6.33909033472079e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LCN15,Lipocalin-15,19419,1844,1.15 [1.08-1.23],7.231939185987381e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LCN2,Neutrophil gelatinase-associated lipocalin,21710,2067,1.14 [1.04-1.26],0.0054718536992458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LCP1,Plastin-2,19475,1856,0.90 [0.82-0.99],0.029223002621299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LDLR,Low-density lipoprotein receptor,22388,2146,1.28 [1.19-1.38],1.5360543945723823e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LDLRAP1,Low density lipoprotein receptor adapter protein 1,19419,1844,1.04 [0.99-1.09],0.1120551164375392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LECT2,Leukocyte cell-derived chemotaxin-2,19462,1849,1.15 [1.08-1.23],2.77888847846366e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LEFTY2,Left-right determination factor 2,22470,2148,1.00 [0.93-1.08],0.9702836146186932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LEG1,Protein LEG1 homolog,18426,1754,1.04 [0.97-1.11],0.2826156776389567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LELP1,Late cornified envelope-like proline-rich protein 1,18824,1792,0.98 [0.92-1.04],0.5190280750398799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LEO1,RNA polymerase-associated protein LEO1,19419,1844,1.18 [1.05-1.33],0.0057702685895948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LEP,Leptin,22331,2138,1.29 [1.22-1.37],1.0451271760194295e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LEPR,Leptin receptor,22331,2138,0.82 [0.72-0.93],0.0016477207031811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LETM1,Mitochondrial proton/calcium exchanger protein,19419,1844,1.20 [1.11-1.30],6.646594816513811e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS1,Galectin-1,22331,2138,1.15 [1.03-1.28],0.0134786501063521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS3,Galectin-3,22395,2142,1.09 [0.96-1.24],0.1919606625767856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS3BP,Galectin-3-binding protein,19494,1852,1.76 [1.59-1.95],3.357197304722875e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS4,Galectin-4,22325,2139,2.15 [2.02-2.28],1.3201958035782013e-140
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS7_LGALS7B,Galectin-7,22238,2125,0.86 [0.78-0.94],0.0009057084110403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS8,Galectin-8,22509,2156,1.06 [1.00-1.13],0.0505515527413111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS9,Galectin-9,22326,2143,1.66 [1.48-1.87],3.9436370032191495e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGMN,Legumain,22429,2152,1.41 [1.27-1.57],1.1779050000325828e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LHB,Lutropin subunit beta,21834,2088,0.97 [0.93-1.02],0.220733704724799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,22358,2147,1.00 [0.94-1.07],0.9842416506066244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LIF,Leukemia inhibitory factor,21826,2083,1.13 [1.06-1.22],0.0005225841989868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LIFR,Leukemia inhibitory factor receptor,22279,2137,2.49 [2.17-2.87],1.0418908182452585e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,22355,2147,1.26 [1.13-1.40],2.416077540821776e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,19475,1856,1.00 [0.97-1.03],0.8835644201870999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,18799,1796,0.95 [0.87-1.05],0.3236295643733801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,22288,2136,1.49 [1.32-1.67],3.3407143343771386e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,19462,1849,1.06 [1.00-1.13],0.0558494069665969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,22606,2166,1.51 [1.31-1.73],5.8005156300285815e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,22515,2156,1.32 [1.18-1.48],9.391261052520434e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,21900,2081,1.27 [1.17-1.39],1.8880158771774032e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,22606,2166,1.00 [0.95-1.06],0.9533213568105916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LIPF,Gastric triacylglycerol lipase,18968,1809,1.19 [1.11-1.28],1.6177283608474234e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LMNB1,Lamin-B1,19338,1844,1.01 [0.94-1.09],0.7848645338684405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LMNB2,Lamin-B2,19425,1849,1.21 [1.04-1.41],0.0164347515845207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LMOD1,Leiomodin-1,19419,1844,0.86 [0.75-0.99],0.0344721141500711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LMOD2,Leiomodin-2,18824,1792,0.95 [0.87-1.03],0.1780439300798604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LONP1,"Lon protease homolog, mitochondrial",18968,1809,1.12 [1.06-1.18],3.5771989316079207e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LPA,Apolipoprotein(a),19045,1802,1.01 [0.98-1.03],0.6660962159694801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LPCAT2,Lysophosphatidylcholine acyltransferase 2,22222,2129,1.12 [1.03-1.21],0.005015763863853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LPL,Lipoprotein lipase,22331,2138,0.53 [0.50-0.56],8.706292513546481e-92
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LPO,Lactoperoxidase,21567,2077,1.41 [1.33-1.50],7.779484967157695e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LPP,Lipoma-preferred partner,18799,1796,1.00 [0.93-1.07],0.9984780659739584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,18799,1796,1.16 [1.09-1.24],5.148699314974521e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,18933,1813,0.93 [0.84-1.04],0.1982418243865181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRG1,Leucine-rich alpha-2-glycoprotein,19494,1852,0.93 [0.79-1.10],0.3886739596013469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,22433,2147,1.17 [1.05-1.30],0.0042537915171894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,18820,1794,1.49 [1.30-1.71],2.09544405252806e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRP1,Prolow-density lipoprotein receptor-related protein 1,22222,2129,0.84 [0.72-0.97],0.0178028368088528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRP11,Low-density lipoprotein receptor-related protein 11,22331,2138,1.36 [1.23-1.50],3.191950659480584e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRP2,Low-density lipoprotein receptor-related protein 2,18933,1813,0.93 [0.82-1.05],0.2565500920026031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRP2BP,LRP2-binding protein,18933,1813,0.97 [0.92-1.03],0.3156375834975663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,22509,2156,1.03 [0.96-1.10],0.4066586070160268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRRC25,Leucine-rich repeat-containing protein 25,22222,2129,1.14 [1.04-1.26],0.0072387644342171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRRC37A2,Leucine-rich repeat-containing protein 37A2,19369,1846,1.10 [0.99-1.22],0.0686583890738562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRRC38,Leucine-rich repeat-containing protein 38,18933,1813,1.09 [1.00-1.20],0.0615687172498165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRRC59,Leucine-rich repeat-containing protein 59,19462,1849,1.11 [1.02-1.22],0.0215570741500642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,19371,1841,1.13 [1.03-1.24],0.0103338755161815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRRN1,Leucine-rich repeat neuronal protein 1,21900,2081,0.86 [0.78-0.95],0.0034830464514421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,18933,1813,0.95 [0.84-1.06],0.3446790481199773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,19419,1844,0.66 [0.55-0.79],7.903608830897942e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LSM1,U6 snRNA-associated Sm-like protein LSm1,21834,2088,0.98 [0.92-1.06],0.6600675634188575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LSM8,U6 snRNA-associated Sm-like protein LSm8,19109,1826,1.05 [1.00-1.10],0.051683857494695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LSP1,Lymphocyte-specific protein 1,22279,2137,1.31 [1.19-1.43],1.6203062594437382e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LTA,Lymphotoxin-alpha,22279,2137,1.11 [1.01-1.22],0.0272901315420191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LTA4H,Leukotriene A-4 hydrolase,22508,2152,0.94 [0.88-1.00],0.0621095818422311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LTB,Lymphotoxin-beta,19371,1841,0.97 [0.86-1.10],0.6468069483811717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,22606,2166,1.00 [0.89-1.12],0.9679054226078396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LTBP3,Latent-transforming growth factor beta-binding protein 3,21834,2088,1.24 [1.16-1.32],2.2007180984359568e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LTBR,Tumor necrosis factor receptor superfamily member 3,22231,2129,1.19 [1.05-1.35],0.0069021186099601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LTO1,Protein LTO1 homolog,21900,2081,0.99 [0.90-1.08],0.7923834573426641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LUZP2,Leucine zipper protein 2,19371,1841,0.91 [0.82-1.01],0.0652389953826412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LXN,Latexin,22044,2116,0.96 [0.91-1.02],0.1582502946043762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LY6D,Lymphocyte antigen 6D,22228,2136,0.88 [0.80-0.97],0.0117927417807573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LY75,Lymphocyte antigen 75,22279,2137,1.07 [0.97-1.18],0.2013898715826162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LY9,T-lymphocyte surface antigen Ly-9,22036,2108,1.31 [1.16-1.49],2.4404225258363817e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LY96,Lymphocyte antigen 96,22137,2130,1.33 [1.20-1.48],3.917502656789783e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYAR,Cell growth-regulating nucleolar protein,21834,2088,1.00 [0.93-1.08],0.9522279715497188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYN,Tyrosine-protein kinase Lyn,22222,2129,1.07 [1.02-1.12],0.0055941186377174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYPD1,Ly6/PLAUR domain-containing protein 1,21826,2083,0.94 [0.87-1.00],0.0535983502225239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYPD3,Ly6/PLAUR domain-containing protein 3,22237,2131,1.40 [1.25-1.56],3.1980706509926843e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYPD8,Ly6/PLAUR domain-containing protein 8,21834,2088,1.13 [1.05-1.21],0.0006206207892275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYPLA2,Acyl-protein thioesterase 2,18824,1792,0.99 [0.95-1.03],0.6569841369437297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,18933,1813,0.97 [0.93-1.01],0.1882180777997985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,19494,1852,1.33 [1.07-1.67],0.0118697632460498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYZL2,Lysozyme-like protein 2,18754,1788,1.05 [0.93-1.20],0.4340144782674991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LZTFL1,Leucine zipper transcription factor-like protein 1,19045,1813,1.04 [0.98-1.11],0.2172468718607836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,M6PR,Cation-dependent mannose-6-phosphate receptor,18968,1809,1.15 [1.03-1.28],0.0115459374809206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,22062,2125,1.25 [1.18-1.34],1.0361363874862017e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAEA,E3 ubiquitin-protein transferase MAEA,21834,2088,1.01 [0.91-1.12],0.864366695777598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAG,Myelin-associated glycoprotein,18933,1813,0.98 [0.89-1.07],0.6060728722953597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAGEA3,Melanoma-associated antigen 3,19109,1826,1.02 [0.97-1.07],0.4877010187597086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAGED1,Melanoma-associated antigen D1,21834,2088,1.06 [0.97-1.14],0.1862063060678888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAMDC2,MAM domain-containing protein 2,19462,1849,1.20 [1.06-1.35],0.0036668878130909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAMDC4,Apical endosomal glycoprotein,19371,1841,1.49 [1.38-1.61],1.9493000285895288e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",18968,1809,1.02 [0.85-1.22],0.8207399020186898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAN2B2,Epididymis-specific alpha-mannosidase,19462,1849,1.34 [1.24-1.44],2.507900792778184e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",18754,1788,0.95 [0.87-1.04],0.2491923316989538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MANF,Mesencephalic astrocyte-derived neurotrophic factor,22429,2152,1.03 [1.00-1.07],0.053187506973736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MANSC1,MANSC domain-containing protein 1,22422,2149,0.92 [0.80-1.06],0.2461988229769902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MANSC4,MANSC domain-containing protein 4,18799,1796,1.03 [0.96-1.10],0.3917581856131871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,18824,1792,0.98 [0.85-1.14],0.8162345229989176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,18799,1796,1.00 [0.93-1.07],0.9773991857695812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAP2,Microtubule-associated protein 2,19425,1849,1.18 [1.08-1.29],0.000318323841538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,19369,1846,1.03 [0.96-1.11],0.4145081390806563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,22279,2137,1.00 [0.97-1.04],0.8071735053203908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,21834,2088,1.04 [1.00-1.08],0.0783340472859309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,22104,2129,1.03 [0.99-1.07],0.0955687987918912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAPK13,Mitogen-activated protein kinase 13,18754,1788,1.12 [1.01-1.24],0.0369282537502405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAPK9,Mitogen-activated protein kinase 9,22279,2137,1.00 [0.91-1.09],0.969217024674374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAPKAPK2,MAP kinase-activated protein kinase 2,19109,1826,1.04 [0.98-1.10],0.2298114758641293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAPRE3,Microtubule-associated protein RP/EB family member 3,18754,1788,0.97 [0.94-1.01],0.1105556555359884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAPT,Microtubule-associated protein tau,21826,2083,1.04 [0.96-1.12],0.3081783821056638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MARCO,Macrophage receptor MARCO,22331,2138,1.62 [1.40-1.87],8.09838083659045e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MARS1,"Methionine--tRNA ligase, cytoplasmic",19017,1812,1.05 [0.99-1.10],0.1008053672642505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MASP1,Mannan-binding lectin serine protease 1,22104,2129,1.88 [1.60-2.22],5.5943770962031565e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MATN2,Matrilin-2,22359,2146,1.16 [1.02-1.32],0.0260455775031904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MATN3,Matrilin-3,22101,2129,0.45 [0.40-0.51],3.799127232615431e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAVS,Mitochondrial antiviral-signaling protein,21834,2088,1.03 [0.98-1.07],0.2143703902585683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAX,Protein max,21826,2083,1.04 [1.00-1.08],0.0416222619873694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MB,Myoglobin,22606,2166,1.10 [1.03-1.18],0.0048586525793743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MBL2,Mannose-binding protein C,19216,1818,1.00 [0.96-1.04],0.8665911173916342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MCAM,Cell surface glycoprotein MUC18,22460,2144,0.67 [0.60-0.75],1.5637808680094288e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",19419,1844,0.94 [0.84-1.05],0.2452879434629432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MCEMP1,Mast cell-expressed membrane protein 1,18885,1799,1.04 [0.99-1.10],0.1101853804385307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MCFD2,Multiple coagulation factor deficiency protein 2,22217,2128,1.11 [1.01-1.21],0.0234830494226908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MCTS1,Malignant T-cell-amplified sequence 1,19369,1846,0.88 [0.75-1.05],0.1537053124198432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,22137,2130,1.16 [1.09-1.22],2.640216718970869e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MDH1,"Malate dehydrogenase, cytoplasmic",19363,1846,1.08 [0.97-1.21],0.1572979340918326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MDK,Midkine,22359,2143,1.20 [1.12-1.28],2.086007198671209e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MDM1,Nuclear protein MDM1,18933,1813,0.81 [0.70-0.94],0.0065877150250791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",18968,1809,1.08 [1.02-1.13],0.0037552823586578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MED18,Mediator of RNA polymerase II transcription subunit 18,21834,2088,1.01 [0.96-1.06],0.7341972542529864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MED21,Mediator of RNA polymerase II transcription subunit 21,18799,1796,1.01 [0.92-1.11],0.8149935427957513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MEGF10,Multiple epidermal growth factor-like domains protein 10,22325,2139,0.87 [0.78-0.96],0.0053929278347398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MEGF11,Multiple epidermal growth factor-like domains protein 11,18799,1796,1.10 [0.96-1.25],0.1763858102566673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MEGF9,Multiple epidermal growth factor-like domains protein 9,22541,2159,1.77 [1.46-2.16],8.333381650480166e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MELTF,Melanotransferrin,19462,1849,0.98 [0.85-1.13],0.7754067924747063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MENT,Protein MENT,19045,1813,0.32 [0.27-0.39],2.6029016896896767e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MEP1A,Meprin A subunit alpha,19369,1846,1.31 [1.24-1.39],2.8593967404640867e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MEP1B,Meprin A subunit beta,22331,2138,0.97 [0.94-1.01],0.1016593480450268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MEPE,Matrix extracellular phosphoglycoprotein,22325,2139,0.63 [0.55-0.72],7.017242783842259e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MERTK,Tyrosine-protein kinase Mer,22551,2158,1.30 [1.12-1.50],0.0006012878479066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MESD,LRP chaperone MESD,22355,2147,1.03 [0.99-1.06],0.1098982455064089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MET,Hepatocyte growth factor receptor,22385,2148,0.32 [0.27-0.39],7.981111607551358e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,METAP1,Methionine aminopeptidase 1,21826,2083,1.03 [0.90-1.18],0.6285989731876269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",22279,2137,1.06 [1.01-1.11],0.0151750944321309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,METAP2,Methionine aminopeptidase 2,22470,2148,1.09 [1.02-1.17],0.0129400655187224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MFAP3,Microfibril-associated glycoprotein 3,21913,2105,1.04 [0.96-1.12],0.3554436037282998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MFAP3L,Microfibrillar-associated protein 3-like,18933,1813,0.94 [0.88-1.01],0.110706323891945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MFAP4,Microfibril-associated glycoprotein 4,19045,1813,1.94 [1.69-2.22],7.369240467707674e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MFAP5,Microfibrillar-associated protein 5,22606,2166,1.11 [1.01-1.21],0.0354204473095044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MFGE8,Lactadherin,22355,2147,1.95 [1.80-2.12],2.609635835330313e-60
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MGLL,Monoglyceride lipase,22391,2150,1.03 [0.98-1.08],0.2063986588776282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MGMT,Methylated-DNA--protein-cysteine methyltransferase,22279,2137,1.02 [0.99-1.05],0.2373543459711783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MIA,Melanoma-derived growth regulatory protein,22422,2149,0.84 [0.75-0.93],0.0011095755031212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MICALL2,MICAL-like protein 2,18933,1813,1.01 [0.95-1.08],0.7525193026213097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,22279,2137,1.06 [1.03-1.09],2.7060330048054e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MIF,Macrophage migration inhibitory factor,22319,2142,1.06 [1.00-1.13],0.0373556127895772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MILR1,Allergin-1,21900,2081,1.22 [1.13-1.31],2.5307563004404854e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,19371,1841,1.02 [0.98-1.07],0.2793205781802012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MINK1,Misshapen-like kinase 1,19425,1849,1.06 [1.01-1.11],0.022746591040619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MITD1,MIT domain-containing protein 1,22137,2130,1.03 [0.99-1.07],0.1548140951779958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MKI67,Proliferation marker protein Ki-67,18885,1799,1.04 [0.92-1.17],0.535507698529557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MLLT1,Protein ENL,18754,1788,0.97 [0.90-1.04],0.3813576405342944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MLN,Promotilin,22279,2137,1.13 [1.08-1.18],8.610525186662839e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MME,Neprilysin,22222,2129,1.42 [1.36-1.49],5.654469136583372e-56
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP1,Interstitial collagenase,21511,2068,1.07 [1.02-1.12],0.0031144445106174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP10,Stromelysin-2,22269,2137,1.17 [1.10-1.25],8.157661931649337e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP12,Macrophage metalloelastase,22328,2141,1.50 [1.40-1.60],9.326399945173164e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP13,Collagenase 3,21826,2083,0.76 [0.68-0.86],9.836585419513088e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP15,Matrix metalloproteinase-15,19462,1849,1.03 [0.95-1.13],0.4593485759768572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP3,Stromelysin-1,22355,2147,0.92 [0.85-0.99],0.0241184263796025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP7,Matrilysin,21879,2102,1.54 [1.41-1.67],1.3801900361899268e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP8,Neutrophil collagenase,22468,2154,1.16 [1.10-1.22],2.3061636454319943e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP9,Matrix metalloproteinase-9,22310,2143,1.24 [1.16-1.32],7.385428438828844e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",18799,1796,0.99 [0.90-1.09],0.8545344540432027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MN1,Transcriptional activator MN1,18933,1813,1.02 [0.95-1.11],0.5534459034149791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MNAT1,CDK-activating kinase assembly factor MAT1,19109,1826,1.00 [0.90-1.11],0.9362803585352308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MNDA,Myeloid cell nuclear differentiation antigen,22292,2135,1.05 [1.01-1.09],0.0115670260221224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MOCS2,Molybdopterin synthase catalytic subunit,19045,1813,1.08 [1.01-1.16],0.023397542863166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MOG,Myelin-oligodendrocyte glycoprotein,22508,2152,0.85 [0.76-0.95],0.0049249722031692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MORC3,MORC family CW-type zinc finger protein 3,19425,1849,1.08 [0.92-1.27],0.3261153028780502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MORF4L1,Mortality factor 4-like protein 1,19109,1826,1.02 [0.92-1.14],0.6761949169614137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MORF4L2,Mortality factor 4-like protein 2,18754,1788,0.96 [0.84-1.09],0.4840198546615712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MORN4,MORN repeat-containing protein 4,18754,1788,1.04 [0.98-1.10],0.2287740227145581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MPHOSPH8,M-phase phosphoprotein 8,21913,2105,1.05 [1.00-1.11],0.0647419093478287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MPI,Mannose-6-phosphate isomerase,22222,2129,1.03 [0.99-1.08],0.1711011975314902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,22391,2150,1.03 [0.98-1.09],0.1908962588732539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MPO,Myeloperoxidase,22355,2147,1.21 [1.12-1.31],7.860640423290596e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MPRIP,Myosin phosphatase Rho-interacting protein,19332,1838,1.06 [0.96-1.17],0.2654477065234593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MRC1,Macrophage mannose receptor 1,19470,1855,1.83 [1.58-2.12],1.1999396096790926e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MRI1,Methylthioribose-1-phosphate isomerase,18933,1813,0.96 [0.90-1.03],0.2164924244522369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MRPL24,"39S ribosomal protein L24, mitochondrial",18799,1796,1.07 [0.95-1.20],0.249147547608124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MRPL28,"39S ribosomal protein L28, mitochondrial",19419,1844,0.94 [0.83-1.07],0.3842861599233106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MRPL46,"39S ribosomal protein L46, mitochondrial",21826,2083,1.21 [1.06-1.37],0.0045062644159758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MRPL52,"39S ribosomal protein L52, mitochondrial",18711,1782,0.81 [0.68-0.97],0.0242890799401711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",19419,1844,1.07 [1.01-1.13],0.0270098831666358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MRPS16,"28S ribosomal protein S16, mitochondrial",18885,1799,0.92 [0.77-1.09],0.3355142491990681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MSLN,Mesothelin,22180,2120,1.02 [0.96-1.09],0.4516466426378697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MSLNL,Mesothelin-like protein,18933,1813,0.89 [0.79-1.01],0.0631041819625088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MSMB,Beta-microseminoprotein,22291,2140,1.03 [0.98-1.08],0.2889564104539951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MSR1,Macrophage scavenger receptor types I and II,22509,2156,1.69 [1.56-1.84],2.9020470616340423e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MSRA,Mitochondrial peptide methionine sulfoxide reductase,22422,2149,1.04 [0.98-1.09],0.177302936645066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MST1,Hepatocyte growth factor-like protein,19164,1827,1.01 [0.95-1.09],0.691585953105393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MSTN,Growth/differentiation factor 8,21913,2105,1.08 [1.01-1.16],0.0347552012788284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTDH,Protein LYRIC,18885,1799,1.10 [1.05-1.16],0.0001003648268878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",19425,1849,1.13 [0.96-1.32],0.150065079287644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,19109,1826,1.05 [1.01-1.09],0.014280017153418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTIF3,"Translation initiation factor IF-3, mitochondrial",19369,1846,1.03 [0.98-1.09],0.1876982526050548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTPN,Myotrophin,21913,2105,0.89 [0.79-1.01],0.0702348581156706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTR,Methionine synthase,18799,1796,0.99 [0.92-1.06],0.6984363342941515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTSS1,Protein MTSS 1,19369,1846,1.07 [1.03-1.11],0.0008377534308937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTSS2,Protein MTSS 2,19371,1841,1.04 [0.99-1.08],0.1339153053290433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTUS1,Microtubule-associated tumor suppressor 1,19109,1826,1.39 [1.30-1.49],1.0710684358038036e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MUC13,Mucin-13,21826,2083,2.05 [1.92-2.19],3.9100988665297524e-103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MUC16,Mucin-16,22222,2129,1.02 [1.00-1.04],0.0560222217441035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MUC2,Mucin-2,19475,1856,1.10 [1.05-1.15],8.379549340442046e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MUCL3,Mucin-like protein 3,18754,1788,0.99 [0.90-1.10],0.8762010747521486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MVK,Mevalonate kinase,21900,2081,1.46 [1.39-1.52],2.360187931989472e-64
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MXRA8,Matrix remodeling-associated protein 8,19045,1813,0.28 [0.25-0.32],2.3656490486107577e-73
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYBPC1,"Myosin-binding protein C, slow-type",19462,1849,1.13 [1.07-1.20],2.722571402361096e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYBPC2,"Myosin-binding protein C, fast-type",18968,1809,1.06 [1.01-1.12],0.0189878205306302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,19419,1844,1.03 [0.96-1.10],0.400380817432189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYDGF,Myeloid-derived growth factor,19462,1849,1.08 [1.03-1.13],0.0007962518027044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYH4,Myosin-4,18799,1796,0.96 [0.87-1.06],0.4228061369569186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYH7B,Myosin-7B,18754,1788,0.94 [0.85-1.05],0.2938634382400901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYH9,Myosin-9,19475,1856,1.05 [1.01-1.09],0.0130248123552976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",18799,1796,1.10 [0.99-1.22],0.084827875721505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYL3,Myosin light chain 3,18968,1809,1.10 [1.04-1.17],0.0015405568646106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYL4,Myosin light chain 4,18968,1809,1.10 [1.02-1.19],0.015851158807145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYL6B,Myosin light chain 6B,18933,1813,0.95 [0.90-1.00],0.0568657896038689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",18933,1813,1.14 [1.05-1.23],0.0025562661893523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYO6,Unconventional myosin-VI,19419,1844,1.01 [0.90-1.14],0.8783816513003649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYO9B,Unconventional myosin-IXb,21900,2081,1.02 [0.96-1.08],0.5947931065112968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYOC,Myocilin,22355,2147,0.76 [0.70-0.83],1.8317876107761152e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYOM1,Myomesin-1,18824,1792,1.01 [0.91-1.11],0.8905170534398344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYOM2,Myomesin-2,18799,1796,1.01 [0.93-1.11],0.7460571355225626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYOM3,Myomesin-3,19045,1813,1.02 [0.97-1.07],0.3788092960197007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MZB1,Marginal zone B- and B1-cell-specific protein,22397,2148,1.22 [1.13-1.31],7.52549397658873e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MZT1,Mitotic-spindle organizing protein 1,21834,2088,1.01 [0.94-1.10],0.7083337307064563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAA10,N-alpha-acetyltransferase 10,18799,1796,1.01 [0.93-1.11],0.7629454629913413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAA80,N-alpha-acetyltransferase 80,18933,1813,1.04 [1.00-1.08],0.0723281824261538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAAA,N-acylethanolamine-hydrolyzing acid amidase,22042,2123,0.91 [0.85-0.97],0.0035078864303008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NACC1,Nucleus accumbens-associated protein 1,19371,1841,1.08 [1.00-1.17],0.0526408750592723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NADK,NAD kinase,22331,2138,1.16 [1.09-1.24],2.3212092530897413e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAGA,Alpha-N-acetylgalactosaminidase,18840,1793,1.09 [1.01-1.18],0.029217353897301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAGK,N-acetyl-D-glucosamine kinase,18932,1802,0.97 [0.90-1.06],0.5394462577750638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,19045,1813,2.64 [2.16-3.22],1.3070736510111756e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAMPT,Nicotinamide phosphoribosyltransferase,21834,2088,1.15 [1.07-1.22],2.8456194085388352e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAP1L4,Nucleosome assembly protein 1-like 4,19325,1840,0.98 [0.88-1.09],0.7283026084937747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAPRT,Nicotinate phosphoribosyltransferase,19425,1849,0.98 [0.86-1.12],0.7635012805663277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NARS1,"Asparagine--tRNA ligase, cytoplasmic",19419,1844,1.10 [1.00-1.21],0.0528661650539873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,22422,2149,1.47 [1.28-1.69],4.336720037912753e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NBN,Nibrin,21900,2081,1.07 [1.00-1.15],0.0413534829014077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCAM1,Neural cell adhesion molecule 1,22460,2144,0.81 [0.72-0.92],0.0011057527006223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCAM2,Neural cell adhesion molecule 2,22355,2147,0.71 [0.62-0.82],4.198059435618243e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCAN,Neurocan core protein,22509,2156,0.59 [0.53-0.65],2.0971644786579635e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCF2,Neutrophil cytosol factor 2,22247,2133,1.07 [1.02-1.11],0.003609788095316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCK2,Cytoplasmic protein NCK2,22429,2152,1.03 [0.99-1.06],0.1555341591300642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCLN,Nicalin,21900,2081,0.98 [0.90-1.06],0.5704430200924678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCR1,Natural cytotoxicity triggering receptor 1,22245,2135,1.25 [1.14-1.38],6.989415386853471e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,19369,1846,1.20 [1.06-1.37],0.004168864539041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCS1,Neuronal calcium sensor 1,22508,2152,1.57 [1.37-1.78],1.9154104121485367e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NDRG1,Protein NDRG1,21826,2083,1.01 [0.95-1.07],0.7400564426399288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,19371,1841,0.87 [0.81-0.94],0.0007231793196698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,18862,1795,1.11 [0.98-1.26],0.1126261894914468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,19369,1846,1.00 [0.95-1.05],0.9167918956853875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",21834,2088,1.08 [1.03-1.13],0.0011049660479138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NEB,Nebulin,18799,1796,1.07 [0.95-1.20],0.2632963302904528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NECAP2,Adaptin ear-binding coat-associated protein 2,18799,1796,0.94 [0.88-1.01],0.0853518389395349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NECTIN1,Nectin-1,18885,1799,1.04 [0.91-1.20],0.5751295826668507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NECTIN2,Nectin-2,22288,2136,1.83 [1.63-2.06],1.9292383457115475e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NECTIN4,Nectin-4,22422,2149,1.16 [1.04-1.29],0.0101530959759802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,18885,1799,1.04 [0.95-1.15],0.3732591488824731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NEDD9,Enhancer of filamentation 1,18885,1799,1.03 [0.91-1.18],0.6220618297132716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NEFL,Neurofilament light polypeptide,21759,2077,1.25 [1.15-1.36],1.065926038778978e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NEK7,Serine/threonine-protein kinase Nek7,19109,1826,1.01 [0.95-1.07],0.7474239895656785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NELL1,Protein kinase C-binding protein NELL1,22422,2149,0.74 [0.68-0.81],2.2438374399307424e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NELL2,Protein kinase C-binding protein NELL2,22429,2152,1.24 [1.09-1.41],0.0011668479121123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NENF,Neudesin,19371,1841,0.99 [0.95-1.03],0.5576961921012509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NEO1,Neogenin,19419,1844,0.93 [0.76-1.13],0.4687314614584885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NEXN,Nexilin,19470,1855,1.03 [0.97-1.10],0.3106686231004924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFASC,Neurofascin,22551,2158,5.32 [4.74-5.97],9.774608329959894e-177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFAT5,Nuclear factor of activated T-cells 5,18885,1799,1.01 [0.96-1.06],0.7475446427839962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",22279,2137,1.05 [1.01-1.09],0.0198009196118806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",21900,2081,1.30 [1.22-1.38],3.600000899455725e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFE2,Transcription factor NF-E2 45 kDa subunit,18968,1809,1.10 [1.03-1.17],0.0022956976102763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFIC,Nuclear factor 1 C-type,19419,1844,1.05 [0.96-1.15],0.2916627745075453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFKB1,Nuclear factor NF-kappa-B p105 subunit,18799,1796,1.07 [1.00-1.14],0.0381203391458559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFKB2,Nuclear factor NF-kappa-B p100 subunit,19109,1826,0.96 [0.88-1.05],0.3555963870305687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFKBIE,NF-kappa-B inhibitor epsilon,21834,2088,1.12 [1.03-1.21],0.0063558891647555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",19369,1846,1.04 [0.99-1.09],0.0941064798168265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFX1,Transcriptional repressor NF-X1,18799,1796,1.10 [1.03-1.18],0.0046899111323241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFYA,Nuclear transcription factor Y subunit alpha,18799,1796,1.04 [0.93-1.16],0.5408758287986402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NGF,Beta-nerve growth factor,22137,2130,0.90 [0.66-1.24],0.5382769401945309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NGFR,Tumor necrosis factor receptor superfamily member 16,19462,1849,1.14 [0.99-1.32],0.0664752446470453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NGRN,Neugrin,19425,1849,1.35 [1.13-1.61],0.0008629918046175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NHLRC3,NHL repeat-containing protein 3,18562,1765,2.87 [2.48-3.32],3.60621637193202e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NID1,Nidogen-1,22375,2141,1.14 [1.03-1.26],0.0109777462120799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NID2,Nidogen-2,22355,2147,1.06 [1.01-1.12],0.0198476194677862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NINJ1,Ninjurin-1,21834,2088,0.97 [0.90-1.05],0.4246568662634024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NIT1,Deaminated glutathione amidase,18968,1809,1.08 [0.98-1.20],0.1162356794627064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NIT2,Omega-amidase NIT2,19389,1838,1.20 [1.13-1.27],1.2796111258675304e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NLGN1,Neuroligin-1,18933,1813,0.99 [0.92-1.06],0.7098507103363856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NLGN2,Neuroligin-2,18824,1792,1.00 [0.91-1.10],0.9972882614549864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NME1,Nucleoside diphosphate kinase A,18885,1799,1.10 [0.89-1.36],0.3791860157259493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NME3,Nucleoside diphosphate kinase 3,22359,2146,0.51 [0.43-0.61],5.51619340106559e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NMI,N-myc-interactor,19309,1835,1.00 [0.94-1.07],0.9274929843172974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,22137,2130,1.11 [1.06-1.16],2.0680099259403e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NMRK2,Nicotinamide riboside kinase 2,18754,1788,0.91 [0.80-1.03],0.1279057445331413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,19419,1844,0.99 [0.93-1.06],0.8346346319112143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOMO1,Nodal modulator 1,22355,2147,2.15 [1.83-2.53],1.232761968135756e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOP56,Nucleolar protein 56,18799,1796,1.03 [0.99-1.07],0.1478456280833152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOS1,"Nitric oxide synthase, brain",21826,2083,1.14 [1.06-1.22],0.0002716860572105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOS2,"Nitric oxide synthase, inducible",18799,1796,1.02 [0.90-1.14],0.7843696310157648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOS3,"Nitric oxide synthase, endothelial",21826,2083,1.36 [1.28-1.43],3.750414966090548e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOTCH1,Neurogenic locus notch homolog protein 1,22606,2166,1.68 [1.32-2.12],1.7358735740186733e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOTCH2,Neurogenic locus notch homolog protein 2,19475,1856,0.71 [0.58-0.88],0.0014349323933703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOTCH3,Neurogenic locus notch homolog protein 3,22606,2166,0.60 [0.53-0.67],1.5678624523888404e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPC2,NPC intracellular cholesterol transporter 2,19133,1823,1.64 [1.46-1.83],2.7037711918682933e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPDC1,Neural proliferation differentiation and control protein 1,22331,2138,1.28 [1.15-1.43],7.204846950087495e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPHS1,Nephrin,18885,1799,1.04 [0.91-1.20],0.5335916245383185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPHS2,Podocin,18885,1799,1.00 [0.96-1.04],0.9839894905770116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPL,N-acetylneuraminate lyase,19462,1849,1.37 [1.25-1.50],2.942110163018074e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPPB,Natriuretic peptides B,21913,2105,1.03 [1.00-1.05],0.0733330989682801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPPC,C-type natriuretic peptide,22279,2137,1.20 [1.11-1.28],6.334306685835735e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPR1,Atrial natriuretic peptide receptor 1,18799,1796,0.91 [0.81-1.03],0.1217237180969928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPTN,Neuroplastin,21834,2088,0.99 [0.94-1.04],0.5740880826644184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPTX1,Neuronal pentraxin-1,22355,2147,1.22 [1.11-1.34],2.9051910126883865e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPTX2,Neuronal pentraxin-2,19475,1856,1.04 [0.91-1.19],0.6076374757135303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPTXR,Neuronal pentraxin receptor,22331,2138,0.87 [0.78-0.97],0.0131578517430025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPY,Pro-neuropeptide Y,22508,2152,1.54 [1.44-1.64],1.914160353908064e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NRCAM,Neuronal cell adhesion molecule,22331,2138,2.13 [1.91-2.38],1.3783985392712415e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NRGN,Neurogranin,19470,1855,1.02 [0.97-1.07],0.4501093805344469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NRN1,Neuritin,19419,1844,0.95 [0.83-1.08],0.4130051110518101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NRP1,Neuropilin-1,22487,2145,1.96 [1.72-2.24],1.4851944157363742e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NRP2,Neuropilin-2,22355,2147,1.03 [0.90-1.17],0.6951366211092398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NRTN,Neurturin,21900,2081,1.02 [0.94-1.10],0.6858536135654014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NRXN3,Neurexin-3,18933,1813,0.85 [0.74-0.98],0.022043871752749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NSFL1C,NSFL1 cofactor p47,22509,2156,1.05 [0.99-1.11],0.1109524177042603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",19462,1849,1.01 [0.95-1.07],0.7946663549022546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,19425,1849,1.31 [1.17-1.48],3.819177177188525e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NT5C3A,Cytosolic 5'-nucleotidase 3A,22249,2134,0.99 [0.95-1.04],0.6675040061215363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NT5E,5'-nucleotidase,22422,2149,1.27 [1.19-1.36],3.251019492671493e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NTF3,Neurotrophin-3,22279,2137,1.24 [1.12-1.37],3.8876372201906e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NTF4,Neurotrophin-4,21834,2088,1.00 [0.90-1.11],0.991523598501994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NTRK2,BDNF/NT-3 growth factors receptor,22331,2138,1.48 [1.27-1.71],3.368746683745671e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NTRK3,NT-3 growth factor receptor,22509,2156,0.39 [0.33-0.46],1.1327578014203371e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,22331,2138,1.03 [0.99-1.06],0.1113598466128972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUB1,NEDD8 ultimate buster 1,22279,2137,1.02 [0.98-1.07],0.3640446129102387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,19371,1841,0.97 [0.93-1.02],0.2972126318233321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUCB2,Nucleobindin-2,22464,2150,1.20 [1.08-1.33],0.0006494312033823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUDC,Nuclear migration protein nudC,22551,2158,1.08 [1.01-1.15],0.0150060061146659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,18968,1809,1.02 [0.85-1.22],0.8705862237185087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,18799,1796,0.96 [0.88-1.06],0.4451171059966166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUDT16,U8 snoRNA-decapping enzyme,19331,1844,1.05 [0.99-1.10],0.0869655142190502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],22222,2129,0.91 [0.84-0.97],0.0057977023533915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUDT5,ADP-sugar pyrophosphatase,22355,2147,1.17 [1.08-1.26],5.660738165279416e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUMB,Protein numb homolog,18885,1799,1.09 [1.03-1.16],0.0018750614299218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUP50,Nuclear pore complex protein Nup50,18799,1796,0.87 [0.75-1.01],0.0663064641264061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NXPE4,NXPE family member 4,18799,1796,0.98 [0.86-1.13],0.8175691252682916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NXPH1,Neurexophilin-1,21826,2083,0.99 [0.89-1.09],0.8153552295803488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NXPH3,Neurexophilin-3,18885,1799,0.74 [0.64-0.86],9.655903817120824e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OBP2B,Odorant-binding protein 2b,22070,2127,0.84 [0.79-0.89],3.4183200106305626e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OCLN,Occludin,19419,1844,1.67 [1.53-1.83],3.992444698392741e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ODAM,Odontogenic ameloblast-associated protein,21793,2079,0.88 [0.82-0.94],0.0004727124428488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OFD1,Oral-facial-digital syndrome 1 protein,19109,1826,0.97 [0.91-1.05],0.4819858862376609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OGA,Protein O-GlcNAcase,19369,1846,1.05 [0.98-1.12],0.1530217400242363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OGFR,Opioid growth factor receptor,22222,2129,0.90 [0.80-1.02],0.0983190303556397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OGN,Mimecan,22355,2147,1.14 [1.04-1.24],0.0041271250180161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,19109,1826,0.95 [0.88-1.02],0.1729692533422279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OLFM4,Olfactomedin-4,18329,1742,1.16 [1.12-1.21],9.805529546701749e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OLR1,Oxidized low-density lipoprotein receptor 1,22110,2116,1.13 [1.06-1.20],0.0002090190917648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OMD,Osteomodulin,22429,2152,0.58 [0.53-0.63],2.3062428080599715e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OMG,Oligodendrocyte-myelin glycoprotein,22222,2129,0.88 [0.83-0.93],1.2096553705140822e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OMP,Olfactory marker protein,18824,1792,1.02 [0.93-1.11],0.7376721051845136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OPHN1,Oligophrenin-1,19425,1849,1.02 [0.98-1.07],0.2528537568356494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OPLAH,5-oxoprolinase,18968,1809,1.10 [1.02-1.17],0.0083853461535529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OPTC,Opticin,22222,2129,0.73 [0.66-0.80],1.0533946949466926e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ORM1,Alpha-1-acid glycoprotein 1,19421,1846,0.93 [0.74-1.16],0.5100707635434498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OSBPL2,Oxysterol-binding protein-related protein 2,19425,1849,1.06 [0.95-1.18],0.3212527481371435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OSCAR,Osteoclast-associated immunoglobulin-like receptor,22359,2146,1.18 [1.06-1.32],0.0027633952859155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OSM,Oncostatin-M,22182,2127,1.28 [1.21-1.35],1.3129252255676377e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OSMR,Oncostatin-M-specific receptor subunit beta,22487,2145,1.62 [1.34-1.96],4.546800483143624e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OSTN,Osteocrin,18933,1813,0.95 [0.85-1.06],0.3434505228108695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OTOA,Otoancorin,18824,1792,1.01 [0.93-1.10],0.8206246791260983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OTUD6B,Deubiquitinase OTUD6B,19369,1846,1.01 [0.93-1.09],0.8687391418121868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OTUD7B,OTU domain-containing protein 7B,19419,1844,1.08 [1.00-1.16],0.048756554755422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",18968,1809,0.99 [0.92-1.05],0.686262784348934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OXT,Oxytocin-neurophysin 1,22509,2156,1.16 [1.13-1.19],2.9096977234787075e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,P4HB,Protein disulfide-isomerase,22241,2130,1.38 [1.25-1.53],1.0921731952642684e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PACS2,Phosphofurin acidic cluster sorting protein 2,18799,1796,1.07 [1.00-1.16],0.0594462872229217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PADI2,Protein-arginine deiminase type-2,21900,2081,1.10 [1.04-1.17],0.0022471250190048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PADI4,Protein-arginine deiminase type-4,21793,2079,1.06 [1.01-1.11],0.0168005967833802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAEP,Glycodelin,22137,2130,1.03 [0.99-1.07],0.2056304077922486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,19419,1844,0.98 [0.94-1.02],0.2676063542694354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",19109,1826,1.05 [0.96-1.15],0.3207344053266753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,21913,2105,1.34 [1.26-1.43],1.0416461355250013e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAGR1,PAXIP1-associated glutamate-rich protein 1,18968,1809,1.08 [0.98-1.20],0.1232297422703726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,18726,1786,0.93 [0.84-1.02],0.1017809113952775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAK4,Serine/threonine-protein kinase PAK 4,21826,2083,1.08 [1.01-1.15],0.0201498991127209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PALLD,Palladin,18885,1799,1.05 [0.94-1.17],0.4317711395621009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PALM,Paralemmin-1,19258,1835,0.89 [0.77-1.03],0.1128604218580052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PALM2,Paralemmin-2,19425,1849,1.87 [1.70-2.07],2.0555868563050984e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PALM3,Paralemmin-3,18799,1796,1.00 [0.94-1.07],0.989236910227932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAM,Peptidyl-glycine alpha-amidating monooxygenase,22504,2160,0.81 [0.71-0.93],0.0020783507651611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAMR1,Inactive serine protease PAMR1,22355,2147,2.37 [2.06-2.73],4.052643671145382e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAPPA,Pappalysin-1,21900,2081,0.90 [0.83-0.98],0.0185060143025217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PARD3,Partitioning defective 3 homolog,19109,1826,1.03 [0.97-1.09],0.3998047468085645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PARK7,Parkinson disease protein 7,22355,2147,1.05 [0.98-1.14],0.1643501359702526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PARP1,Poly [ADP-ribose] polymerase 1,22279,2137,1.11 [1.05-1.18],0.0003507297370433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAXX,Protein PAXX,19045,1813,1.12 [1.02-1.24],0.0204993780008726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PBK,Lymphokine-activated killer T-cell-originated protein kinase,18754,1788,1.02 [0.89-1.18],0.7486519595623623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PBLD,Phenazine biosynthesis-like domain-containing protein,21826,2083,1.33 [1.24-1.42],6.9798900296768665e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,19369,1846,1.11 [0.96-1.28],0.1546064458029299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCARE,Photoreceptor cilium actin regulator,18824,1792,1.01 [0.96-1.07],0.6528527736837233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,19016,1811,1.80 [1.67-1.95],1.062648327589969e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCBP2,Poly(rC)-binding protein 2,19419,1844,1.02 [0.96-1.08],0.5533733796380841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDH1,Protocadherin-1,22478,2148,1.31 [1.11-1.55],0.0013995796767121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDH12,Protocadherin-12,19419,1844,1.24 [1.04-1.47],0.0157225694416722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDH17,Protocadherin-17,22331,2138,1.77 [1.62-1.94],2.2790615735665188e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDH7,Protocadherin-7,19369,1846,1.07 [0.94-1.20],0.3041465820288616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDH9,Protocadherin-9,19369,1846,1.49 [1.31-1.69],1.7625377821586583e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDHB15,Protocadherin beta-15,19371,1841,1.05 [0.94-1.17],0.3869481493392184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCNA,Proliferating cell nuclear antigen,18754,1788,1.03 [0.96-1.10],0.4408414610757504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCSK7,Proprotein convertase subtilisin/kexin type 7,19371,1841,1.09 [0.99-1.19],0.0854555187273193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCSK9,Proprotein convertase subtilisin/kexin type 9,22606,2166,1.88 [1.71-2.07],6.623621319131032e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCYT2,Ethanolamine-phosphate cytidylyltransferase,19369,1846,1.15 [1.09-1.22],2.7277861674289166e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDAP1,28 kDa heat- and acid-stable phosphoprotein,19462,1849,1.04 [0.99-1.08],0.1352928085561318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDCD1,Programmed cell death protein 1,22468,2149,1.21 [1.12-1.32],4.278762046279406e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDCD1LG2,Programmed cell death 1 ligand 2,22222,2129,1.46 [1.31-1.64],4.254700130348681e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDCD5,Programmed cell death protein 5,22509,2156,1.06 [0.99-1.13],0.103938925707709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDCD6,Programmed cell death protein 6,22331,2138,1.05 [0.99-1.11],0.0896314832719681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDCL2,Phosducin-like protein 2,18754,1788,0.96 [0.88-1.05],0.3450045356199306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",18754,1788,0.98 [0.90-1.07],0.7175965033027384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",18799,1796,1.02 [0.94-1.10],0.6313450367460656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",19045,1813,1.04 [0.99-1.08],0.0996827956985124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDGFA,Platelet-derived growth factor subunit A,22606,2166,1.04 [0.99-1.10],0.1254882593862162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDGFB,Platelet-derived growth factor subunit B,22429,2152,1.04 [0.99-1.09],0.0900287027671462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDGFC,Platelet-derived growth factor C,21834,2088,1.30 [1.14-1.49],0.0001087274591905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDGFRA,Platelet-derived growth factor receptor alpha,22331,2138,1.42 [1.24-1.62],2.769204749004264e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDGFRB,Platelet-derived growth factor receptor beta,22606,2166,1.07 [0.95-1.19],0.2559774190704741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDIA2,Protein disulfide-isomerase A2,18754,1788,0.93 [0.83-1.04],0.218073310153209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDIA3,Protein disulfide-isomerase A3,19045,1813,1.32 [1.11-1.57],0.0015003920644666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDIA4,Protein disulfide-isomerase A4,19475,1856,1.05 [0.98-1.13],0.1954670172277614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDIA5,Protein disulfide-isomerase A5,18754,1788,1.02 [0.95-1.10],0.5648540085417229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDLIM5,PDZ and LIM domain protein 5,19419,1844,1.02 [0.98-1.06],0.3619815329911587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDLIM7,PDZ and LIM domain protein 7,22429,2152,1.03 [1.00-1.06],0.0487949866848361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",21834,2088,1.03 [0.95-1.12],0.4472616477249219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDRG1,p53 and DNA damage-regulated protein 1,18933,1813,0.93 [0.85-1.02],0.1363767563914838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,18754,1788,0.96 [0.89-1.05],0.3782123039841348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDZD2,PDZ domain-containing protein 2,18799,1796,1.04 [0.97-1.12],0.2915804151498911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,18885,1799,1.87 [1.73-2.02],2.0040486409968368e-56
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PEAR1,Platelet endothelial aggregation receptor 1,22606,2166,1.05 [0.89-1.24],0.5669681152706595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PEBP1,Phosphatidylethanolamine-binding protein 1,22355,2147,1.08 [1.01-1.16],0.0172114282168979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PECAM1,Platelet endothelial cell adhesion molecule,22355,2147,1.30 [1.15-1.47],3.265103825421755e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PECR,Peroxisomal trans-2-enoyl-CoA reductase,18968,1809,1.00 [0.85-1.17],0.9591895320990782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PENK,Proenkephalin-A,19045,1813,1.00 [0.87-1.14],0.9478897917919864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PEPD,Xaa-Pro dipeptidase,19470,1855,0.64 [0.54-0.76],3.811322764797125e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PER3,Period circadian protein homolog 3,18885,1799,1.00 [0.97-1.04],0.8055025390741464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PF4,Platelet factor 4,19346,1838,1.07 [1.02-1.12],0.0056909789874684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PFDN2,Prefoldin subunit 2,21826,2083,1.00 [0.93-1.07],0.9788572342680154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PFDN4,Prefoldin subunit 4,18754,1788,0.97 [0.88-1.06],0.4638177453565059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PFDN6,Prefoldin subunit 6,18933,1813,0.96 [0.89-1.03],0.2689973251063253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",22178,2127,1.04 [0.99-1.09],0.1236600416258781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PGA4,Pepsin A-4,19470,1855,1.12 [1.06-1.18],5.491693148941153e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",19462,1849,1.10 [1.01-1.20],0.0275609679394326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PGF,Placenta growth factor,22551,2158,1.78 [1.56-2.03],7.164298920737985e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PGLYRP1,Peptidoglycan recognition protein 1,22515,2156,1.09 [1.00-1.18],0.0603308214174007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,19252,1828,1.01 [0.86-1.17],0.945761273482006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PGLYRP4,Peptidoglycan recognition protein 4,18799,1796,1.00 [0.93-1.08],0.996815634527084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PGM2,Phosphoglucomutase-2,18933,1813,0.93 [0.86-1.01],0.0968015556035336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PGR,Progesterone receptor,18885,1799,0.97 [0.92-1.02],0.1793705163960932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PHACTR2,Phosphatase and actin regulator 2,19419,1844,1.02 [0.98-1.06],0.2976658867227628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PHLDB1,Pleckstrin homology-like domain family B member 1,19369,1846,1.06 [0.97-1.16],0.175786431356745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PHLDB2,Pleckstrin homology-like domain family B member 2,18754,1788,1.00 [0.95-1.05],0.99432160346458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,22137,2130,1.16 [1.02-1.32],0.0261684628824405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,19045,1813,1.30 [1.16-1.44],3.22546924582718e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PI16,Peptidase inhibitor 16,19470,1855,0.68 [0.57-0.81],1.183842975575364e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PI3,Elafin,22053,2110,1.13 [1.06-1.21],0.0001338680615531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",19419,1844,1.08 [1.01-1.14],0.0137661690446348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PIGR,Polymeric immunoglobulin receptor,22057,2118,2.66 [2.41-2.93],9.280062292044038e-86
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,22279,2137,1.03 [0.96-1.09],0.4087678600909656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,22355,2147,1.58 [1.40-1.78],2.2405476661191522e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,18885,1799,1.03 [0.95-1.12],0.4688153868141721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,22355,2147,1.52 [1.39-1.66],1.6521495660141026e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,22331,2138,1.33 [1.24-1.43],1.1028690626169584e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,19045,1813,0.98 [0.92-1.05],0.5874652523926547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PITHD1,PITH domain-containing protein 1,18726,1786,1.01 [0.95-1.07],0.7299656918035643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PKD1,Polycystin-1,19462,1849,1.95 [1.65-2.31],6.054294592726901e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PKD2,Polycystin-2,18799,1796,1.11 [1.03-1.20],0.0087496937178858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PKLR,Pyruvate kinase PKLR,22362,2147,1.03 [0.97-1.09],0.334177781658479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PKN3,Serine/threonine-protein kinase N3,19109,1826,1.04 [0.98-1.11],0.1952382694336318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G10,Group 10 secretory phospholipase A2,22137,2130,1.07 [1.01-1.15],0.033839207560711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G15,Phospholipase A2 group XV,22422,2149,2.39 [2.10-2.74],7.057874784064214e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G1B,Phospholipase A2,22575,2164,0.67 [0.62-0.73],3.123993026957495e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G2A,"Phospholipase A2, membrane associated",22292,2136,1.00 [0.93-1.07],0.9657539033669452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G4A,Cytosolic phospholipase A2,22429,2152,1.03 [0.99-1.08],0.1900280792031478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G7,Platelet-activating factor acetylhydrolase,22355,2147,0.42 [0.37-0.46],3.245029761728051e-59
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLAT,Tissue-type plasminogen activator,22541,2159,1.43 [1.33-1.54],6.644923262787542e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLAU,Urokinase-type plasminogen activator,22355,2147,0.96 [0.84-1.09],0.5254811613111134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLAUR,Urokinase plasminogen activator surface receptor,22184,2127,2.08 [1.83-2.37],2.603310037060452e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLB1,"Phospholipase B1, membrane-associated",19425,1849,0.90 [0.83-0.97],0.0056473981746062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",18885,1799,0.92 [0.82-1.03],0.1436328929032338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",19425,1849,1.04 [0.99-1.09],0.0960881862391217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLEKHO1,Pleckstrin homology domain-containing family O member 1,19425,1849,1.13 [1.06-1.20],0.0002068610055741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLG,Plasminogen,19008,1795,1.45 [1.17-1.79],0.0006387170174179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLIN1,Perilipin-1,21826,2083,1.28 [1.16-1.41],8.825425189616261e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLIN3,Perilipin-3,22331,2138,1.18 [1.08-1.29],0.0003167661053414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLPBP,Pyridoxal phosphate homeostasis protein,22331,2138,1.03 [0.97-1.09],0.3785508142051289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLSCR3,Phospholipid scramblase 3,19384,1842,1.18 [1.09-1.27],3.919027485330722e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLTP,Phospholipid transfer protein,22547,2162,0.61 [0.55-0.67],4.504636097603101e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLXDC1,Plexin domain-containing protein 1,21834,2088,0.97 [0.86-1.11],0.6887646865327308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLXDC2,Plexin domain-containing protein 2,19425,1849,1.42 [1.24-1.62],2.716516049878218e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLXNA4,Plexin-A4,22279,2137,1.08 [1.03-1.13],0.001076194053333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLXNB2,Plexin-B2,22491,2153,5.60 [4.92-6.38],5.032456672348869e-148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLXNB3,Plexin-B3,22271,2132,1.15 [1.06-1.24],0.0008681308213089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,22202,2129,1.02 [1.00-1.04],0.0799746895592316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PMCH,Pro-MCH,18799,1796,0.98 [0.92-1.03],0.4292573496208798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PMM2,Phosphomannomutase 2,18799,1796,1.01 [0.93-1.09],0.8293803638172902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PMS1,PMS1 protein homolog 1,18933,1813,1.05 [0.96-1.15],0.2575610844123499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PMVK,Phosphomevalonate kinase,21789,2082,1.03 [1.00-1.07],0.0888520628568112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PNLIP,Pancreatic triacylglycerol lipase,19470,1855,1.05 [0.98-1.12],0.1956403630272775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PNLIPRP1,Inactive pancreatic lipase-related protein 1,19425,1849,1.08 [1.02-1.14],0.0048309289837068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PNLIPRP2,Pancreatic lipase-related protein 2,22325,2139,1.01 [1.00-1.02],0.1650301194936893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PNMA1,Paraneoplastic antigen Ma1,18968,1809,1.03 [0.94-1.11],0.5517576980377121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PNMA2,Paraneoplastic antigen Ma2,18824,1792,0.98 [0.88-1.08],0.6707502001314332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",21900,2081,0.98 [0.94-1.01],0.2339976730025782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PODXL,Podocalyxin,22222,2129,0.62 [0.48-0.80],0.0002022366362436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PODXL2,Podocalyxin-like protein 2,22422,2149,0.70 [0.61-0.80],3.24995980404271e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,POF1B,Protein POF1B,18885,1799,1.34 [1.23-1.46],1.1262339483381135e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,POLR2A,DNA-directed RNA polymerase II subunit RPB1,18885,1799,0.97 [0.83-1.13],0.7150979192647511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",22222,2129,1.16 [1.04-1.28],0.0058474021573888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,POMC,Pro-opiomelanocortin,18968,1809,0.94 [0.88-1.00],0.0654489508330166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PON1,Serum paraoxonase/arylesterase 1,19470,1855,0.64 [0.56-0.73],1.7464711092921819e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PON2,Serum paraoxonase/arylesterase 2,21913,2105,1.20 [1.08-1.34],0.0008013754102409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PON3,Serum paraoxonase/lactonase 3,22429,2152,0.60 [0.56-0.63],4.9115313037470185e-74
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,POSTN,Periostin,19475,1856,0.71 [0.63-0.80],1.4158990169140684e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPBP,Platelet basic protein,19357,1838,1.06 [1.01-1.12],0.0247359290609519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPCDC,Phosphopantothenoylcysteine decarboxylase,22509,2156,1.08 [1.00-1.18],0.0512536787669628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPIB,Peptidyl-prolyl cis-trans isomerase B,22379,2141,1.03 [0.99-1.07],0.2117495967736828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPIE,Peptidyl-prolyl cis-trans isomerase E,19109,1826,0.98 [0.91-1.05],0.5344674257227817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",19475,1856,1.01 [0.94-1.09],0.7392690265847023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPL,Periplakin,18885,1799,1.07 [0.93-1.22],0.3601138466948773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPM1A,Protein phosphatase 1A,21834,2088,0.92 [0.81-1.05],0.2340379671653631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPM1B,Protein phosphatase 1B,18885,1799,0.96 [0.89-1.04],0.3581657691798607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPM1F,Protein phosphatase 1F,19462,1849,1.00 [0.92-1.09],0.946876832025738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPME1,Protein phosphatase methylesterase 1,22222,2129,1.01 [0.95-1.08],0.6771011780300876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,19371,1841,1.02 [0.96-1.08],0.5140178792075618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,22422,2149,1.05 [1.01-1.10],0.0108099491145141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,19109,1826,1.03 [0.97-1.09],0.410719361878437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,19419,1844,1.01 [0.96-1.07],0.6633046782620317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,19419,1844,1.16 [1.04-1.29],0.007421298646862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPP1R2,Protein phosphatase inhibitor 2,22331,2138,1.06 [1.01-1.11],0.0279691537394579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPP1R9B,Neurabin-2,22551,2158,1.07 [1.03-1.12],0.0007733542517739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,19369,1846,1.03 [1.00-1.07],0.0864387569232116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPP3R1,Calcineurin subunit B type 1,22137,2130,1.02 [0.93-1.12],0.6721548201796974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPT1,Palmitoyl-protein thioesterase 1,18933,1813,0.98 [0.92-1.05],0.5703345688215464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPY,Pancreatic prohormone,22332,2139,1.11 [1.07-1.15],9.112189261192704e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PQBP1,Polyglutamine-binding protein 1,21834,2088,1.01 [0.95-1.08],0.7233433853807856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRAME,Melanoma antigen preferentially expressed in tumors,18754,1788,1.00 [0.84-1.20],0.9670175451282031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRAP1,Proline-rich acidic protein 1,19475,1856,3.71 [3.29-4.19],7.187027792811635e-100
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRC1,Protein regulator of cytokinesis 1,19371,1841,1.06 [0.96-1.16],0.2528037068221805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRCP,Lysosomal Pro-X carboxypeptidase,22482,2153,2.73 [2.53-2.95],4.4844784199273147e-150
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRDX1,Peroxiredoxin-1,21685,2085,0.97 [0.93-1.01],0.1744765325856522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRDX2,Peroxiredoxin-2,19122,1826,1.00 [0.93-1.07],0.993895649145484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",21900,2081,1.12 [1.06-1.18],5.45582042048669e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRDX5,"Peroxiredoxin-5, mitochondrial",22551,2158,1.01 [0.96-1.07],0.6708343053873714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRDX6,Peroxiredoxin-6,22508,2152,0.92 [0.86-0.98],0.0080049279160298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PREB,Prolactin regulatory element-binding protein,21900,2081,1.35 [1.21-1.51],1.3813200795421605e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRELP,Prolargin,22325,2139,0.97 [0.83-1.14],0.7164789063740433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRG2,Bone marrow proteoglycan,19475,1856,1.00 [0.92-1.09],0.9533386124134194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRG3,Proteoglycan 3,19475,1856,0.87 [0.79-0.95],0.0015224875890426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,21900,2081,1.07 [0.99-1.15],0.0868550799025689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,18933,1813,0.95 [0.82-1.10],0.4893822294269296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,22331,2138,1.06 [1.01-1.11],0.0156620768361034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,19390,1845,1.10 [1.04-1.16],0.001542439836918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRKCQ,Protein kinase C theta type,21900,2081,0.97 [0.88-1.06],0.4650398100644077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRKD2,Serine/threonine-protein kinase D2,18799,1796,0.97 [0.87-1.07],0.5179080160061531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRKG1,cGMP-dependent protein kinase 1,19045,1813,1.01 [0.98-1.05],0.5403213131439559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,21834,2088,1.14 [1.08-1.20],7.733122230385165e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRL,Prolactin,22509,2156,1.01 [0.96-1.07],0.5819149505943579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRND,Prion-like protein doppel,19425,1849,1.02 [0.94-1.11],0.6806160768518879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PROC,Vitamin K-dependent protein C,22412,2141,1.30 [1.12-1.51],0.0007765964371918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PROCR,Endothelial protein C receptor,18799,1796,0.83 [0.72-0.97],0.0170506793558568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PROK1,Prokineticin-1,22279,2137,1.07 [1.00-1.15],0.0365795585410976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PROS1,Vitamin K-dependent protein S,19494,1852,1.27 [1.07-1.51],0.0069135614583252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRR4,Proline-rich protein 4,18886,1788,0.98 [0.92-1.05],0.6118003934872096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRR5,Proline-rich protein 5,18885,1799,1.07 [0.98-1.18],0.1474504256222862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRRT3,Proline-rich transmembrane protein 3,18968,1809,0.73 [0.65-0.82],1.572262176016854e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRSS2,Trypsin-2,22460,2144,1.01 [0.94-1.08],0.7391506633612628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRSS22,Brain-specific serine protease 4,18885,1799,1.15 [1.03-1.29],0.0132082127244753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRSS27,Serine protease 27,22268,2132,1.26 [1.14-1.38],1.784087473525983e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRSS53,Serine protease 53,19425,1849,0.88 [0.79-0.99],0.0381848321625024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRSS8,Prostasin,22248,2136,2.55 [2.34-2.77],1.6128788485599577e-103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,21826,2083,1.01 [0.98-1.05],0.4853677195765832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRTG,Protogenin,22508,2152,1.38 [1.18-1.61],4.851954368633512e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRTN3,Myeloblastin,21769,2090,1.05 [0.97-1.13],0.248765485401443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRUNE2,Protein prune homolog 2,19109,1826,1.44 [1.26-1.64],4.5599312992689696e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSAP,Prosaposin,19279,1835,1.51 [1.32-1.72],8.74777207421511e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSAPL1,Proactivator polypeptide-like 1,19369,1846,0.71 [0.65-0.78],5.90701137641777e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSCA,Prostate stem cell antigen,19369,1846,1.01 [0.99-1.02],0.4719084113982555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,22137,2130,1.01 [0.98-1.05],0.5330850872028188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSIP1,PC4 and SFRS1-interacting protein,22279,2137,1.09 [1.03-1.16],0.001612183191889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSMA1,Proteasome subunit alpha type-1,21834,2088,0.95 [0.87-1.04],0.2471063527877178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSMC3,26S proteasome regulatory subunit 6A,18754,1788,0.94 [0.81-1.09],0.4278012093716179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSMD1,26S proteasome non-ATPase regulatory subunit 1,19419,1844,1.00 [0.91-1.09],0.9627900745207416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSMD5,26S proteasome non-ATPase regulatory subunit 5,18933,1813,0.95 [0.87-1.04],0.2720163413206304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSMD9,26S proteasome non-ATPase regulatory subunit 9,22222,2129,0.98 [0.91-1.05],0.5299088793273555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSME1,Proteasome activator complex subunit 1,22087,2128,1.16 [1.05-1.29],0.0041696089347005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSME2,Proteasome activator complex subunit 2,22028,2121,1.18 [1.07-1.32],0.0016795623595554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSMG3,Proteasome assembly chaperone 3,22279,2137,1.09 [1.01-1.17],0.0189180533052338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSMG4,Proteasome assembly chaperone 4,18885,1799,1.02 [0.94-1.10],0.6986884986264134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSPN,Persephin,22279,2137,1.04 [1.00-1.09],0.0389636933491611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSRC1,Proline/serine-rich coiled-coil protein 1,21834,2088,1.13 [1.06-1.20],0.0001700030968226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,18391,1747,1.00 [0.95-1.04],0.882853407641552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",21826,2083,0.98 [0.86-1.11],0.7404751256158169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTGDS,Prostaglandin-H2 D-isomerase,22185,2115,1.55 [1.39-1.73],7.769530912135458e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTGES2,Prostaglandin E synthase 2,18746,1784,1.09 [1.00-1.19],0.0445778470588824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTGR1,Prostaglandin reductase 1,19462,1849,1.38 [1.31-1.45],4.128597513243506e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTH,Parathyroid hormone,18933,1813,1.04 [0.99-1.10],0.1234569835647647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,22279,2137,1.25 [1.15-1.36],8.886492051707831e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTK7,Inactive tyrosine-protein kinase 7,21826,2083,1.32 [1.19-1.46],6.872661323017906e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTN,Pleiotrophin,21913,2105,1.18 [1.09-1.28],2.0249309627249907e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTP4A3,Protein tyrosine phosphatase type IVA 3,18885,1799,1.26 [1.17-1.36],8.578186039647641e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,22137,2130,1.08 [1.02-1.13],0.0035321807513819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,22391,2150,1.02 [0.97-1.06],0.4398009684441242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,18855,1798,0.97 [0.86-1.10],0.654886101414109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRB,Receptor-type tyrosine-protein phosphatase beta,19462,1849,2.21 [1.90-2.56],1.348472894541299e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRC,Receptor-type tyrosine-protein phosphatase C,19475,1856,1.57 [1.31-1.87],9.050801789678256e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRF,Receptor-type tyrosine-protein phosphatase F,22606,2166,0.48 [0.42-0.54],7.749920126297264e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRH,Receptor-type tyrosine-protein phosphatase H,19369,1846,1.29 [1.18-1.41],4.68699688691322e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,19369,1846,1.70 [1.48-1.97],3.1438441735234734e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRM,Receptor-type tyrosine-protein phosphatase mu,22249,2132,1.53 [1.31-1.79],1.0279170027433922e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,22071,2125,1.00 [0.89-1.12],0.956373372507968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRR,Receptor-type tyrosine-protein phosphatase R,19425,1849,0.77 [0.68-0.87],3.793426858607437e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRS,Receptor-type tyrosine-protein phosphatase S,22606,2166,0.47 [0.40-0.55],4.575026331196804e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,19462,1849,1.01 [0.87-1.16],0.9188130765758438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,19045,1813,1.02 [0.94-1.10],0.6849375382647531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTS,6-pyruvoyl tetrahydrobiopterin synthase,21718,2071,1.59 [1.50-1.68],2.9036701707734284e-57
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTTG1,Securin,19109,1826,1.04 [0.94-1.16],0.4570958414914552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTX3,Pentraxin-related protein PTX3,22279,2137,1.13 [1.04-1.23],0.0026363977975671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PVALB,Parvalbumin alpha,22386,2142,0.97 [0.94-1.01],0.1244691768358145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PVR,Poliovirus receptor,22509,2156,1.77 [1.61-1.94],3.74932598523314e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PXDNL,Peroxidasin-like protein,19371,1841,0.94 [0.86-1.02],0.1591376798470308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PXN,Paxillin,21826,2083,1.13 [1.05-1.21],0.0010288227877574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PYDC1,Pyrin domain-containing protein 1,18968,1809,0.76 [0.68-0.86],6.124568055141128e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PYY,Peptide YY,18799,1796,1.33 [1.27-1.39],2.073636293942409e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PZP,Pregnancy zone protein,19494,1852,0.97 [0.88-1.06],0.4699353179063841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,QDPR,Dihydropteridine reductase,22224,2130,1.30 [1.19-1.42],1.2481154182886472e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,QPCT,Glutaminyl-peptide cyclotransferase,22380,2140,1.58 [1.38-1.81],2.8078824718122398e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,QSOX1,Sulfhydryl oxidase 1,19114,1811,1.32 [1.23-1.43],3.6662459923488266e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB10,Ras-related protein Rab-10,19462,1849,1.05 [0.97-1.14],0.2566884929866003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB11FIP3,Rab11 family-interacting protein 3,19462,1849,1.04 [1.00-1.09],0.0468811838275561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB27B,Ras-related protein Rab-27B,19462,1849,1.10 [1.04-1.16],0.0009592878058088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB2B,Ras-related protein Rab-2B,19371,1841,0.98 [0.91-1.05],0.5303066577880748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB33A,Ras-related protein Rab-33A,18799,1796,1.00 [0.93-1.07],0.9618580447938664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB37,Ras-related protein Rab-37,21900,2081,1.00 [0.95-1.05],0.9709566075760916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB39B,Ras-related protein Rab-39B,18799,1796,1.06 [1.01-1.11],0.0091490749791119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,18824,1792,0.97 [0.90-1.05],0.4569087921321417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB44,Ras-related protein Rab-44,19371,1841,1.14 [1.04-1.24],0.0048157169938484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB6A,Ras-related protein Rab-6A,22279,2137,0.73 [0.67-0.80],9.068267591692309e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB6B,Ras-related protein Rab-6B,21826,2083,0.98 [0.90-1.06],0.6117797231112599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RABEP1,Rab GTPase-binding effector protein 1,19045,1813,1.05 [0.99-1.11],0.1250930471254759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RABEPK,Rab9 effector protein with kelch motifs,21834,2088,1.03 [0.97-1.10],0.3444311009301068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RABGAP1L,Rab GTPase-activating protein 1-like,21900,2081,1.04 [0.98-1.11],0.2214284536346697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAC3,Ras-related C3 botulinum toxin substrate 3,18933,1813,1.00 [0.93-1.06],0.9095724406660634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAD23B,UV excision repair protein RAD23 homolog B,21834,2088,1.00 [0.92-1.09],0.9832659005707104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAD51,DNA repair protein RAD51 homolog 1,19109,1826,0.94 [0.86-1.03],0.2046013390356508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RALB,Ras-related protein Ral-B,18885,1799,1.06 [0.91-1.24],0.4486578339351293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RALY,RNA-binding protein Raly,19371,1841,1.09 [1.00-1.19],0.0450303425011555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RANBP1,Ran-specific GTPase-activating protein,18968,1809,1.04 [0.96-1.14],0.3252351803657102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RANBP2,E3 SUMO-protein ligase RanBP2,18824,1792,0.92 [0.80-1.06],0.2521262072995819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RANGAP1,Ran GTPase-activating protein 1,21834,2088,0.95 [0.87-1.04],0.2796581141538848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAP1A,Ras-related protein Rap-1A,18885,1799,0.94 [0.88-1.01],0.0808652905180008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAPGEF2,Rap guanine nucleotide exchange factor 2,19109,1826,0.97 [0.89-1.06],0.5399743535716566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RARRES1,Retinoic acid receptor responder protein 1,21834,2088,1.14 [1.02-1.27],0.0167907543520858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RARRES2,Retinoic acid receptor responder protein 2,22487,2145,1.41 [1.31-1.52],9.379607549187282e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RASA1,Ras GTPase-activating protein 1,21826,2083,1.03 [0.91-1.16],0.6572107439511571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,18754,1788,0.97 [0.88-1.08],0.6107732901929099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RASSF2,Ras association domain-containing protein 2,21834,2088,1.09 [1.03-1.16],0.0061257042462636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBFOX3,RNA binding protein fox-1 homolog 3,19419,1844,1.49 [1.36-1.63],3.917566275706528e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBKS,Ribokinase,21802,2109,1.19 [1.11-1.29],3.532078190952808e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBM17,Splicing factor 45,19419,1844,0.99 [0.93-1.05],0.625096865787673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBM19,Probable RNA-binding protein 19,18799,1796,0.96 [0.87-1.07],0.4707221441699728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBM25,RNA-binding protein 25,18754,1788,0.98 [0.89-1.09],0.7477172836349426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBP1,Retinol-binding protein 1,18933,1813,0.95 [0.88-1.02],0.1638868535648695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBP2,Retinol-binding protein 2,22222,2129,1.16 [1.11-1.22],1.670496358313993e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBP5,Retinol-binding protein 5,22222,2129,1.72 [1.62-1.82],4.0190526801211753e-69
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBP7,Retinoid-binding protein 7,19369,1846,1.13 [1.06-1.22],0.0004067430473063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBPMS,RNA-binding protein with multiple splicing,18885,1799,1.00 [0.93-1.08],0.9438502641872316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBPMS2,RNA-binding protein with multiple splicing 2,18968,1809,1.07 [1.03-1.12],0.0017684864101652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RCC1,Regulator of chromosome condensation,19371,1841,1.16 [1.07-1.26],0.0001689029303024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RCOR1,REST corepressor 1,21913,2105,1.08 [1.00-1.18],0.0591039418540873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,18968,1809,1.21 [0.97-1.51],0.0859432138731325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REEP4,Receptor expression-enhancing protein 4,19419,1844,1.04 [0.97-1.12],0.2545084156727835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG1A,Lithostathine-1-alpha,22214,2122,1.46 [1.36-1.56],5.641352926011256e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG1B,Lithostathine-1-beta,22606,2166,1.31 [1.23-1.39],6.464008246332779e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG3A,Regenerating islet-derived protein 3-alpha,22606,2166,1.14 [1.08-1.21],4.080998806447805e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG3G,Regenerating islet-derived protein 3-gamma,19371,1841,1.06 [0.95-1.18],0.3063087099210908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG4,Regenerating islet-derived protein 4,22359,2146,1.69 [1.57-1.81],5.417873996228945e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RELB,Transcription factor RelB,18885,1799,1.02 [0.93-1.12],0.6798661754787314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RELT,Tumor necrosis factor receptor superfamily member 19L,22355,2147,1.28 [1.13-1.45],0.0001217667561836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REN,Renin,22331,2138,1.47 [1.41-1.52],7.950412627820952e-88
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REPS1,RalBP1-associated Eps domain-containing protein 1,18885,1799,1.01 [0.89-1.13],0.918495072415054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REST,RE1-silencing transcription factor,18754,1788,0.98 [0.86-1.12],0.8044445679534569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,22222,2129,2.25 [2.04-2.48],9.273357011594265e-60
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RETN,Resistin,22290,2140,1.13 [1.04-1.23],0.0051150761384963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REXO2,"Oligoribonuclease, mitochondrial",18799,1796,0.91 [0.83-1.01],0.0684320157302627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RFC4,Replication factor C subunit 4,19371,1841,1.16 [0.94-1.43],0.1677203660331424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RGCC,Regulator of cell cycle RGCC,19419,1844,1.04 [0.98-1.10],0.1928687849396156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,19109,1826,1.08 [1.02-1.16],0.0155807738193814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RGMA,Repulsive guidance molecule A,22509,2156,1.03 [0.91-1.16],0.6783857325639739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RGMB,RGM domain family member B,22509,2156,0.90 [0.78-1.03],0.1213380322873522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RGS10,Regulator of G-protein signaling 10,19419,1844,0.97 [0.90-1.05],0.4512880535620039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RGS8,Regulator of G-protein signaling 8,21900,2081,1.01 [0.95-1.07],0.7338636436136241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RHOC,Rho-related GTP-binding protein RhoC,22004,2123,1.03 [1.00-1.07],0.0487815804238226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RICTOR,Rapamycin-insensitive companion of mTOR,18885,1799,1.07 [0.98-1.16],0.1503062363798299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,19045,1813,1.62 [1.50-1.76],5.890201165631657e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RILP,Rab-interacting lysosomal protein,22433,2147,1.03 [0.97-1.10],0.3460017860695533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RILPL2,RILP-like protein 2,19462,1849,1.00 [0.96-1.05],0.955643102502256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,18799,1796,1.03 [0.96-1.10],0.4289014656113913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RLN1,Prorelaxin H1,19419,1844,0.97 [0.88-1.07],0.5295137277587625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RLN2,Prorelaxin H2,19006,1807,1.06 [0.97-1.16],0.1920199010883251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASE1,Ribonuclease pancreatic,19470,1855,1.45 [1.25-1.68],1.2354165789668295e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASE10,Inactive ribonuclease-like protein 10,18968,1809,1.00 [0.91-1.10],0.9806509282932728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASE3,Eosinophil cationic protein,22229,2129,1.05 [1.01-1.08],0.0044724009290428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASE4,Ribonuclease 4,18799,1784,1.77 [1.54-2.03],1.0665342359320968e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASE6,Ribonuclease K6,19329,1843,1.46 [1.32-1.62],3.4271391473546373e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASEH2A,Ribonuclease H2 subunit A,19419,1844,0.99 [0.90-1.09],0.8349448823113201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASET2,Ribonuclease T2,22511,2158,1.83 [1.62-2.08],2.99993762014086e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNF149,E3 ubiquitin-protein ligase RNF149,18968,1809,1.48 [1.30-1.69],2.226417882009174e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNF168,E3 ubiquitin-protein ligase RNF168,18885,1799,0.93 [0.82-1.05],0.2245702545356231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNF31,E3 ubiquitin-protein ligase RNF31,18885,1799,1.02 [0.90-1.16],0.7093321884724861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNF4,E3 ubiquitin-protein ligase RNF4,19109,1826,1.00 [0.93-1.07],0.9540734663183532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNF41,E3 ubiquitin-protein ligase NRDP1,21834,2088,1.09 [1.03-1.15],0.0050625858456938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNF43,E3 ubiquitin-protein ligase RNF43,19109,1826,1.04 [0.97-1.12],0.2301735228685168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNF5,E3 ubiquitin-protein ligase RNF5,18968,1809,1.03 [0.96-1.09],0.4232739920272957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ROBO1,Roundabout homolog 1,22359,2146,2.11 [1.83-2.43],7.171221178082226e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ROBO2,Roundabout homolog 2,22509,2156,1.52 [1.30-1.78],2.325938732577849e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ROBO4,Roundabout homolog 4,18968,1809,0.91 [0.70-1.17],0.4563575528161595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,22331,2138,0.92 [0.82-1.03],0.1619901995050922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RP2,Protein XRP2,22222,2129,1.01 [0.92-1.11],0.8475309470715755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RPA2,Replication protein A 32 kDa subunit,18885,1799,1.03 [0.89-1.19],0.6770723723280927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RPE,Ribulose-phosphate 3-epimerase,19109,1826,1.01 [0.95-1.08],0.6720824845021115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RPGR,X-linked retinitis pigmentosa GTPase regulator,18933,1813,0.97 [0.87-1.08],0.5801522903957497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RPL14,60S ribosomal protein L14,18968,1809,1.12 [1.01-1.25],0.0328761409402308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RPS10,40S ribosomal protein S10,18799,1796,0.95 [0.85-1.06],0.3842931108610812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RRAS,Ras-related protein R-Ras,18933,1813,1.02 [0.99-1.06],0.259536523107048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RRM2,Ribonucleoside-diphosphate reductase subunit M2,21834,2088,1.15 [1.07-1.23],6.683708100277203e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,21834,2088,1.07 [1.00-1.13],0.0346553224396796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RRP15,RRP15-like protein,18824,1792,1.01 [0.96-1.06],0.7128539966127682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RSPO1,R-spondin-1,22137,2130,0.74 [0.66-0.83],2.1590147656369725e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RSPO3,R-spondin-3,22508,2152,0.81 [0.70-0.92],0.0017086835950384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RTBDN,Retbindin,22222,2129,1.00 [0.88-1.13],0.9626600118057864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RTKN2,Rhotekin-2,18799,1796,0.98 [0.90-1.07],0.646370111845516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",19419,1844,1.03 [0.98-1.08],0.242453349751704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RTN4R,Reticulon-4 receptor,22508,2152,2.67 [2.45-2.91],1.1728707298318153e-110
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RUVBL1,RuvB-like 1,21834,2088,0.97 [0.93-1.00],0.0777304695198899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RWDD1,RWD domain-containing protein 1,22509,2156,1.06 [0.99-1.12],0.0836221932872844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RYR1,Ryanodine receptor 1,18799,1796,1.00 [0.88-1.14],0.9992608816209532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100A11,Protein S100-A11,22162,2117,1.10 [1.02-1.19],0.0162329996882563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100A12,Protein S100-A12,22012,2107,1.03 [0.97-1.08],0.3343027067694814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100A13,Protein S100-A13,18885,1799,0.94 [0.83-1.07],0.3535029850797933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100A14,Protein S100-A14,19419,1844,0.84 [0.77-0.92],0.0001001689809281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100A16,Protein S100-A16,21793,2079,0.95 [0.89-1.02],0.1434433340948915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100A3,Protein S100-A3,19371,1841,0.96 [0.86-1.06],0.3814912484764012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100A4,Protein S100-A4,22422,2149,1.06 [0.99-1.14],0.0894101302251944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100G,Protein S100-G,19419,1844,0.96 [0.87-1.05],0.3358157359039994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100P,Protein S100-P,21913,2105,1.21 [1.14-1.29],1.102548172559854e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SAA4,Serum amyloid A-4 protein,19494,1852,1.01 [0.87-1.17],0.8817567713294563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SAFB2,Scaffold attachment factor B2,19419,1844,1.05 [0.89-1.23],0.5611003451045058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SAG,S-arrestin,18824,1792,1.01 [0.92-1.10],0.8328893744148829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SAMD9L,Sterile alpha motif domain-containing protein 9-like,22279,2137,1.07 [1.01-1.12],0.0195707874005945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SAP18,Histone deacetylase complex subunit SAP18,19109,1826,0.97 [0.91-1.03],0.3189592209618881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SARG,Specifically androgen-regulated gene protein,19375,1844,1.07 [1.02-1.11],0.0017053565962217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SART1,U4/U6.U5 tri-snRNP-associated protein 1,18799,1796,1.14 [1.02-1.27],0.0195418231526264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SAT1,Diamine acetyltransferase 1,18799,1796,0.98 [0.90-1.07],0.684381915966739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SAT2,Thialysine N-epsilon-acetyltransferase,19109,1826,1.12 [1.05-1.20],0.0004128761697867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SATB1,DNA-binding protein SATB1,19419,1844,1.07 [0.92-1.24],0.3692861647643247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SBSN,Suprabasin,19437,1849,0.65 [0.57-0.74],5.966430790226243e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCAMP3,Secretory carrier-associated membrane protein 3,22222,2129,1.11 [1.06-1.16],7.277613973343342e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCARA5,Scavenger receptor class A member 5,22509,2156,1.84 [1.63-2.07],2.8192658919637176e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCARB1,Scavenger receptor class B member 1,21826,2083,0.95 [0.88-1.02],0.1589936854082488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCARB2,Lysosome membrane protein 2,21723,2089,1.56 [1.40-1.73],2.2241387900938293e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCARF1,Scavenger receptor class F member 1,22606,2166,1.16 [1.06-1.26],0.0016223133738696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCARF2,Scavenger receptor class F member 2,22509,2156,1.17 [1.03-1.33],0.0180489699056948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCG2,Secretogranin-2,22389,2145,1.75 [1.57-1.96],1.005879744301761e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCG3,Secretogranin-3,22359,2146,0.84 [0.75-0.94],0.0027789616331493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCGB1A1,Uteroglobin,22339,2143,0.98 [0.91-1.04],0.4822621972909375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCGB2A2,Mammaglobin-A,18799,1796,1.01 [0.87-1.17],0.8644451411973563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCGB3A1,Secretoglobin family 3A member 1,19045,1813,1.13 [0.95-1.34],0.1669740272421241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCGB3A2,Secretoglobin family 3A member 2,22391,2150,0.97 [0.93-1.01],0.1391163318693812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCGN,Secretagogin,21900,2081,1.34 [1.23-1.46],1.03144673032976e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCIN,Adseverin,18824,1792,0.94 [0.88-1.00],0.0622436750851012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCLY,Selenocysteine lyase,22433,2147,1.70 [1.58-1.83],2.857928374370073e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCN2A,Sodium channel protein type 2 subunit alpha,18824,1792,0.96 [0.87-1.05],0.3404470426018726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCN2B,Sodium channel subunit beta-2,18933,1813,0.88 [0.75-1.03],0.120232214474097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCN3A,Sodium channel protein type 3 subunit alpha,18933,1813,0.93 [0.82-1.07],0.3056285201521236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCN3B,Sodium channel subunit beta-3,18824,1792,0.91 [0.82-1.00],0.0555329616461867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCN4B,Sodium channel subunit beta-4,18968,1809,1.00 [0.90-1.11],0.9369821951755248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCP2,Non-specific lipid-transfer protein,21834,2088,1.05 [1.00-1.10],0.0665720512625202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCPEP1,Retinoid-inducible serine carboxypeptidase,18890,1801,1.39 [1.27-1.51],9.584262287563684e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCRG1,Scrapie-responsive protein 1,19462,1849,0.89 [0.76-1.05],0.1652461770461207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCRIB,Protein scribble homolog,18968,1809,1.06 [1.01-1.11],0.0238389599342108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCRN1,Secernin-1,22279,2137,1.01 [0.94-1.08],0.7606753175301827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCT,Secretin,18933,1813,0.99 [0.90-1.09],0.8481341242344627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SDC1,Syndecan-1,22331,2138,1.41 [1.29-1.55],1.484440133500612e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SDC4,Syndecan-4,22331,2138,0.93 [0.86-1.01],0.0816026166360037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SDCCAG8,Serologically defined colon cancer antigen 8,19371,1841,1.05 [1.01-1.09],0.0213542206990766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SDHB,Succinate dehydrogenase,19369,1846,1.07 [1.00-1.15],0.0455388293596113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SDK2,Protein sidekick-2,19045,1813,1.13 [1.01-1.26],0.0281306965107823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEC31A,Protein transport protein Sec31A,18968,1809,1.09 [1.02-1.15],0.007118456188384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEL1L,Protein sel-1 homolog 1,18968,1809,1.35 [1.20-1.53],7.396454250867926e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SELE,E-selectin,22606,2166,1.78 [1.65-1.92],1.004947519244607e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SELENOP,Selenoprotein P,19494,1852,1.15 [0.95-1.40],0.1534540348811004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SELL,L-selectin,19494,1852,0.57 [0.47-0.69],3.0783245797384446e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SELP,P-selectin,22460,2144,1.16 [1.08-1.24],1.580852106995079e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SELPLG,P-selectin glycoprotein ligand 1,22279,2137,2.32 [2.00-2.68],1.2164913394139924e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEMA3F,Semaphorin-3F,22331,2138,1.63 [1.42-1.88],1.045832856643777e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEMA3G,Semaphorin-3G,19045,1813,1.02 [0.92-1.13],0.6725223963477712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEMA4C,Semaphorin-4C,22222,2129,0.94 [0.81-1.08],0.3532206246917243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEMA4D,Semaphorin-4D,22509,2156,1.03 [0.90-1.17],0.6874828450743855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEMA6C,Semaphorin-6C,18885,1799,1.27 [1.08-1.49],0.0037144168868214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEMA7A,Semaphorin-7A,22541,2159,1.80 [1.62-1.99],4.774208414705528e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEPTIN3,Neuronal-specific septin-3,19419,1844,1.06 [1.00-1.13],0.0353277369619324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEPTIN7,Septin-7,19109,1826,1.04 [0.96-1.13],0.2902098897580966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEPTIN8,Septin-8,19397,1848,1.10 [0.96-1.26],0.1714925970806469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEPTIN9,Septin-9,22222,2129,1.03 [0.90-1.18],0.6357245948662902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA1,Alpha-1-antitrypsin,19103,1820,2.35 [1.42-3.90],0.0008537300710299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA11,Serpin A11,22606,2166,1.00 [0.91-1.10],0.9816832613566252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA12,Serpin A12,21660,2083,1.10 [1.06-1.13],9.980823272951737e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA3,Alpha-1-antichymotrypsin,19413,1845,0.81 [0.60-1.09],0.1679961593744056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA4,Kallistatin,19130,1810,2.10 [1.73-2.55],4.2312152953170966e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA5,Plasma serine protease inhibitor,19205,1825,1.39 [1.22-1.58],6.309207330483214e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA6,Corticosteroid-binding globulin,19494,1852,1.13 [0.85-1.50],0.3922506189688365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA7,Thyroxine-binding globulin,19494,1852,1.66 [1.32-2.10],1.937254452687663e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA9,Serpin A9,22112,2122,1.18 [1.12-1.25],2.06836427419131e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINB1,Leukocyte elastase inhibitor,22274,2138,1.03 [0.99-1.07],0.1861736989086438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINB5,Serpin B5,21913,2105,1.00 [0.93-1.09],0.9054209613626504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINB6,Serpin B6,22437,2149,1.01 [0.94-1.08],0.806684362169219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINB8,Serpin B8,22551,2158,1.08 [1.01-1.14],0.0171182938121803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINB9,Serpin B9,22137,2130,1.03 [0.92-1.16],0.5841951451814079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINC1,Antithrombin-III,19460,1848,0.97 [0.72-1.32],0.868800472745401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPIND1,Heparin cofactor 2,19460,1848,2.19 [1.87-2.57],4.31384248537259e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINE1,Plasminogen activator inhibitor 1,22606,2166,1.21 [1.14-1.28],1.8618457967489623e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINE2,Glia-derived nexin,19462,1849,1.05 [0.98-1.13],0.139863176540805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINF1,Pigment epithelium-derived factor,19188,1825,2.61 [2.25-3.01],2.2749756268665583e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINF2,Alpha-2-antiplasmin,19117,1818,1.61 [1.15-2.25],0.0053589860066977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPING1,Plasma protease C1 inhibitor,19460,1848,1.01 [0.79-1.28],0.9562340897093932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINH1,Serpin H1,19109,1826,1.06 [1.02-1.10],0.0010419210990266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINI1,Neuroserpin,19017,1812,0.74 [0.63-0.86],0.0001460870458967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINI2,Serpin I2,19369,1846,1.05 [0.97-1.14],0.2068787337533205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,21826,2083,1.03 [0.97-1.09],0.3505795631162518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SETMAR,Histone-lysine N-methyltransferase SETMAR,22060,2123,0.94 [0.83-1.07],0.3712702382259547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEZ6,Seizure protein 6 homolog,18933,1813,0.89 [0.77-1.04],0.1335903436469643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEZ6L,Seizure 6-like protein,22422,2149,1.01 [0.88-1.16],0.8707397212572221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEZ6L2,Seizure 6-like protein 2,22222,2129,0.81 [0.69-0.96],0.0130700628791297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SF3B4,Splicing factor 3B subunit 4,22222,2129,0.95 [0.90-1.00],0.0446621535074838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SFRP1,Secreted frizzled-related protein 1,22068,2125,1.18 [1.08-1.28],0.0001887703033783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SFRP4,Secreted frizzled-related protein 4,19045,1813,1.38 [1.24-1.55],1.6579019619460184e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SFTPA1,Pulmonary surfactant-associated protein A1,21834,2088,0.97 [0.90-1.04],0.3601443782565067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SFTPA2,Pulmonary surfactant-associated protein A2,21834,2088,0.99 [0.92-1.06],0.7158225865219743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SFTPD,Pulmonary surfactant-associated protein D,22331,2138,1.13 [1.07-1.20],9.96770637649615e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SGSH,N-sulphoglucosamine sulphohydrolase,19104,1816,1.29 [1.20-1.39],2.457759563730884e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SH2B3,SH2B adapter protein 3,21834,2088,1.02 [0.98-1.06],0.3172141193721789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SH2D1A,SH2 domain-containing protein 1A,22279,2137,1.09 [1.02-1.16],0.0091873915343488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,18824,1792,1.02 [0.95-1.10],0.6238847954732805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SH3BP1,SH3 domain-binding protein 1,19369,1846,1.09 [1.00-1.19],0.0483633998179787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SH3GL3,Endophilin-A3,19019,1816,0.98 [0.93-1.03],0.4339516788209061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SH3GLB2,Endophilin-B2,19425,1849,1.04 [0.97-1.11],0.2927181968516639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SHBG,Sex hormone-binding globulin,19470,1855,0.53 [0.50-0.58],2.234709851652515e-60
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SHC1,SHC-transforming protein 1,18754,1788,0.96 [0.92-1.00],0.043396451322938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SHD,SH2 domain-containing adapter protein D,18754,1790,0.98 [0.93-1.03],0.4556884877804333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SHH,Sonic hedgehog protein,18885,1799,1.03 [0.93-1.14],0.5419137529367272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SHISA5,Protein shisa-5,19475,1856,1.45 [1.25-1.67],8.207904664950147e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SHMT1,"Serine hydroxymethyltransferase, cytosolic",22391,2150,1.13 [1.08-1.19],6.278815598891971e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SHPK,Sedoheptulokinase,19109,1826,0.97 [0.87-1.08],0.5962967114536517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIAE,Sialate O-acetylesterase,22386,2148,1.35 [1.24-1.46],9.076096759318312e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC1,Sialoadhesin,22429,2152,1.50 [1.38-1.64],8.431609540124321e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,22279,2137,1.57 [1.42-1.72],6.800673419442645e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC15,Sialic acid-binding Ig-like lectin 15,21826,2083,0.97 [0.93-1.02],0.3109975876461209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC5,Sialic acid-binding Ig-like lectin 5,22355,2147,1.08 [1.04-1.11],2.090727611325361e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,22508,2152,1.58 [1.42-1.76],8.251460033098939e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC7,Sialic acid-binding Ig-like lectin 7,22331,2138,2.64 [2.32-2.99],2.509471217137476e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC8,Sialic acid-binding Ig-like lectin 8,18968,1809,1.47 [1.34-1.62],5.2644875194472855e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC9,Sialic acid-binding Ig-like lectin 9,22471,2151,1.48 [1.30-1.68],1.697448963556616e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIL1,Nucleotide exchange factor SIL1,18968,1809,1.16 [1.03-1.32],0.0191016566317471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,22398,2141,1.13 [1.05-1.21],0.0005539572739804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIRPB1,Signal-regulatory protein beta-1,22296,2136,1.31 [1.21-1.42],1.2381843093550408e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIRT1,NAD-dependent protein deacetylase sirtuin-1,18885,1799,0.96 [0.91-1.02],0.225624412589518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIRT2,NAD-dependent protein deacetylase sirtuin-2,22222,2129,1.03 [0.98-1.07],0.2481277349995082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",21826,2083,1.00 [0.93-1.07],0.9026776074201912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIT1,Signaling threshold-regulating transmembrane adapter 1,21900,2081,1.58 [1.48-1.69],7.668508307453912e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SKAP1,Src kinase-associated phosphoprotein 1,22104,2129,1.19 [1.13-1.25],1.984967825545752e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SKAP2,Src kinase-associated phosphoprotein 2,22429,2152,1.04 [1.01-1.08],0.0193950388079348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SKIV2L,Helicase SKI2W,18799,1796,0.96 [0.85-1.08],0.4950872924061893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLA2,Src-like-adapter 2,19419,1844,1.04 [0.99-1.08],0.0999171578668829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLAMF1,Signaling lymphocytic activation molecule,21900,2081,1.25 [1.17-1.33],1.5892748232036252e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLAMF6,SLAM family member 6,21834,2088,1.37 [1.25-1.51],1.1215233668243923e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLAMF7,SLAM family member 7,22279,2137,1.14 [1.07-1.22],3.2847789047874096e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLAMF8,SLAM family member 8,21834,2088,1.33 [1.24-1.43],1.775152517896095e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC12A2,Solute carrier family 12 member 2,18799,1796,1.03 [0.88-1.21],0.7201304083937694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC13A1,Solute carrier family 13 member 1,19371,1841,0.97 [0.89-1.05],0.4132339136636863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC16A1,Monocarboxylate transporter 1,21826,2083,1.13 [1.06-1.21],0.0001185673862182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC1A4,Neutral amino acid transporter A,18933,1813,1.02 [0.93-1.12],0.6171398394717483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC27A4,Long-chain fatty acid transport protein 4,21826,2083,1.12 [1.06-1.18],5.459796354977074e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC28A1,Sodium/nucleoside cotransporter 1,18754,1788,1.11 [1.03-1.19],0.006363288870264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC34A3,Sodium-dependent phosphate transport protein 2C,18754,1788,0.96 [0.87-1.06],0.4141642817048621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC39A14,Zinc transporter ZIP14,21826,2083,0.86 [0.76-0.97],0.0125022484974061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC39A5,Zinc transporter ZIP5,22279,2137,1.10 [1.02-1.18],0.008263194556445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC44A4,Choline transporter-like protein 4,18933,1813,0.98 [0.92-1.05],0.6075342509620041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC4A1,Band 3 anion transport protein,19475,1856,0.95 [0.87-1.05],0.3143030145700287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC51B,Organic solute transporter subunit beta,18799,1796,0.97 [0.91-1.03],0.3823356976472791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,19045,1813,1.04 [0.98-1.09],0.1911132942084417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,19369,1846,1.21 [1.13-1.30],2.689111737633643e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",18754,1788,0.99 [0.92-1.08],0.882964768951521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLIT2,Slit homolog 2 protein,21826,2083,1.19 [1.12-1.27],1.856777301432537e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLITRK1,SLIT and NTRK-like protein 1,18885,1799,0.69 [0.60-0.80],3.2145145623171364e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLITRK2,SLIT and NTRK-like protein 2,22508,2152,1.34 [1.22-1.48],8.852375300620064e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLITRK6,SLIT and NTRK-like protein 6,21913,2105,1.03 [0.93-1.15],0.5433676529503646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLK,STE20-like serine/threonine-protein kinase,19109,1826,1.01 [0.95-1.07],0.788323920958115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLMAP,Sarcolemmal membrane-associated protein,19369,1846,1.10 [1.04-1.16],0.0005707894993815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLURP1,Secreted Ly-6/uPAR-related protein 1,19328,1837,0.93 [0.82-1.05],0.2526470687297547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMAD1,Mothers against decapentaplegic homolog 1,21834,2088,1.09 [1.04-1.14],0.0005412693810604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMAD2,Mothers against decapentaplegic homolog 2,19371,1841,1.05 [0.98-1.11],0.169940884842858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMAD3,Mothers against decapentaplegic homolog 3,19371,1841,0.99 [0.91-1.08],0.8604897321541397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMAD5,Mothers against decapentaplegic homolog 5,22222,2129,0.94 [0.77-1.14],0.5219556933736194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMARCA2,Probable global transcription activator SNF2L2,21826,2083,0.99 [0.94-1.05],0.7562056187933132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMC3,Structural maintenance of chromosomes protein 3,18754,1788,1.03 [0.95-1.11],0.534499470130197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMNDC1,Survival of motor neuron-related-splicing factor 30,19369,1846,1.10 [1.03-1.18],0.0040115798631974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMOC1,SPARC-related modular calcium-binding protein 1,22508,2152,1.58 [1.42-1.76],8.75513385784693e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMOC2,SPARC-related modular calcium-binding protein 2,22429,2152,1.25 [1.13-1.37],6.39917888561769e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMPD1,Sphingomyelin phosphodiesterase,22397,2149,1.37 [1.28-1.48],6.736735464135278e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMPD3,Sphingomyelin phosphodiesterase 3,18885,1799,0.88 [0.80-0.97],0.0128349955609885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,22400,2149,0.96 [0.90-1.01],0.1378002195460265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,19371,1841,0.98 [0.93-1.04],0.5339060924147125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMS,Spermine synthase,18824,1792,0.97 [0.90-1.05],0.4713707770656166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMTN,Smoothelin,19397,1846,1.06 [1.01-1.12],0.0120829934378939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNAP23,Synaptosomal-associated protein 23,22331,2138,1.08 [1.04-1.13],0.0004659404745507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNAP25,Synaptosomal-associated protein 25,18824,1792,1.03 [0.93-1.13],0.5608563243617952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNAP29,Synaptosomal-associated protein 29,22422,2149,1.07 [1.03-1.12],0.0008362841773899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNAPIN,SNARE-associated protein Snapin,19419,1844,0.96 [0.89-1.04],0.287462473962106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNCA,Alpha-synuclein,19045,1813,1.03 [0.99-1.07],0.1349460397985258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNCG,Gamma-synuclein,22137,2130,1.20 [1.13-1.27],2.9189456896242724e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",18968,1809,1.35 [1.20-1.53],1.28805891221601e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNRPB2,U2 small nuclear ribonucleoprotein B'',19425,1849,1.17 [1.08-1.28],0.0001417233969694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNU13,NHP2-like protein 1,18799,1796,0.92 [0.85-0.99],0.032621048161701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNX15,Sorting nexin-15,19045,1813,1.03 [0.95-1.12],0.4482673128999984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNX18,Sorting nexin-18,19369,1846,1.04 [0.94-1.15],0.4386969959615854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNX2,Sorting nexin-2,19371,1841,1.02 [0.97-1.08],0.4373614446060154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNX5,Sorting nexin-5,18968,1809,1.02 [0.87-1.19],0.8468238589550937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNX9,Sorting nexin-9,22331,2138,1.06 [1.00-1.12],0.0369995292338789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SOD1,Superoxide dismutase [Cu-Zn],21927,2093,1.08 [1.00-1.17],0.0608085388594404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SOD2,"Superoxide dismutase [Mn], mitochondrial",22355,2147,1.24 [1.13-1.36],5.963771885829453e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SOD3,Extracellular superoxide dismutase,19470,1855,0.88 [0.81-0.96],0.0039981704802065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SORBS1,Sorbin and SH3 domain-containing protein 1,19419,1844,1.14 [1.04-1.25],0.0075415395966886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SORCS2,VPS10 domain-containing receptor SorCS2,21834,2088,1.24 [1.12-1.38],4.684315262004794e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SORD,Sorbitol dehydrogenase,22402,2142,1.36 [1.29-1.44],3.513195261170237e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SORT1,Sortilin,22288,2136,1.39 [1.26-1.54],9.740997978513751e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SOST,Sclerostin,22288,2136,1.24 [1.12-1.36],2.4319548076774712e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,18933,1813,1.03 [0.95-1.13],0.4736640873037655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SOX2,Transcription factor SOX-2,19376,1838,1.08 [0.90-1.30],0.4142813000824892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SOX9,Transcription factor SOX-9,18933,1813,1.07 [0.91-1.27],0.4109603982177942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,19419,1844,0.97 [0.83-1.13],0.6687628387201696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPAG1,Sperm-associated antigen 1,19419,1844,1.01 [0.94-1.10],0.7327223754485683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPARC,SPARC,22422,2149,1.04 [0.99-1.10],0.1389927008199885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPARCL1,SPARC-like protein 1,22387,2137,0.74 [0.64-0.85],2.321642964051975e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPART,Spartin,19045,1813,1.03 [0.97-1.09],0.4036193735269261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPESP1,Sperm equatorial segment protein 1,19462,1849,0.91 [0.80-1.05],0.202460918491562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINK1,Serine protease inhibitor Kazal-type 1,22355,2147,1.62 [1.50-1.74],3.488216951471037e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINK2,Serine protease inhibitor Kazal-type 2,19045,1813,0.81 [0.72-0.92],0.0007925178011389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINK4,Serine protease inhibitor Kazal-type 4,22279,2137,1.40 [1.33-1.48],2.7161157886672203e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINK5,Serine protease inhibitor Kazal-type 5,22355,2147,0.86 [0.77-0.96],0.0075300872110276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINK6,Serine protease inhibitor Kazal-type 6,22508,2152,1.12 [1.04-1.20],0.0026985129992124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINK8,Serine protease inhibitor Kazal-type 8,18799,1796,0.93 [0.82-1.06],0.286297318284565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINT1,Kunitz-type protease inhibitor 1,22287,2141,1.73 [1.51-1.97],5.59136176824987e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINT2,Kunitz-type protease inhibitor 2,22429,2152,1.34 [1.21-1.47],3.0304139084636203e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINT3,Kunitz-type protease inhibitor 3,19369,1846,0.96 [0.93-0.99],0.0088709282445065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPOCK1,Testican-1,22137,2130,0.82 [0.70-0.95],0.0076829321305066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPON1,Spondin-1,22359,2146,1.61 [1.46-1.78],4.997679031927407e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPON2,Spondin-2,22224,2131,1.89 [1.70-2.10],1.8400409395908714e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPP1,Osteopontin,22580,2163,0.91 [0.84-0.99],0.022133724266521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",18885,1799,0.98 [0.88-1.10],0.7295343651629052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPRING1,SREBP regulating gene protein,18754,1788,0.97 [0.89-1.05],0.3949573663221059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPRR1B,Cornifin-B,19109,1826,0.98 [0.93-1.04],0.5736169771788022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPRR3,Small proline-rich protein 3,19425,1849,1.03 [0.96-1.10],0.392198765672808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPRY2,Protein sprouty homolog 2,21900,2081,1.00 [0.96-1.05],0.8331154402473565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",18824,1792,1.00 [0.87-1.16],0.9623587772804368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPTLC1,Serine palmitoyltransferase 1,19425,1849,1.07 [0.96-1.20],0.2213665082391112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SRC,Proto-oncogene tyrosine-protein kinase Src,22383,2147,1.03 [1.00-1.06],0.0911805751093947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SRP14,Signal recognition particle 14 kDa protein,22222,2129,1.15 [1.08-1.22],1.5712735271541695e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SRPK2,SRSF protein kinase 2,22279,2137,1.07 [1.02-1.12],0.0038254259927799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SRPX,Sushi repeat-containing protein SRPX,19462,1849,1.05 [0.93-1.18],0.4270083720068274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SSB,Lupus La protein,21826,2083,1.03 [0.96-1.10],0.4473826122525143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",18885,1799,1.05 [0.92-1.19],0.4721972772800809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,22288,2136,1.17 [1.14-1.21],2.8840778783924554e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,22460,2144,1.80 [1.64-1.96],8.299367995449601e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SSH3,Protein phosphatase Slingshot homolog 3,18754,1788,0.89 [0.75-1.04],0.1503102480350751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SSNA1,Sjoegren syndrome nuclear autoantigen 1,19369,1846,1.07 [0.98-1.16],0.1149567207237723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ST13,Hsc70-interacting protein,19045,1813,1.05 [0.97-1.14],0.2322643105637895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",22222,2129,0.87 [0.79-0.96],0.0052734006216938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",22606,2166,1.55 [1.38-1.73],7.51402027501092e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",18885,1799,0.93 [0.84-1.03],0.160072515374469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STAB2,Stabilin-2,19475,1856,1.93 [1.65-2.26],2.2327843467098913e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STAM,Signal transducing adapter molecule 1,19371,1841,0.95 [0.84-1.08],0.4638289675003414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STAMBP,STAM-binding protein,22104,2129,1.04 [0.98-1.11],0.1664134400434198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STAT2,Signal transducer and activator of transcription 2,18885,1799,1.05 [0.99-1.11],0.1203245213739071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STAT5B,Signal transducer and activator of transcription 5B,22222,2129,1.02 [0.99-1.05],0.2372942975227097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,18754,1788,1.01 [0.94-1.09],0.7729179451413422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STC1,Stanniocalcin-1,22509,2156,1.45 [1.34-1.57],5.506604772257279e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STC2,Stanniocalcin-2,22328,2144,1.43 [1.22-1.67],1.1198992370959574e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STEAP4,Metalloreductase STEAP4,18824,1792,0.99 [0.93-1.05],0.7024216226220874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STIP1,Stress-induced-phosphoprotein 1,22319,2142,1.06 [1.00-1.12],0.0505025237616808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STK11,Serine/threonine-protein kinase STK11,21913,2105,1.08 [1.02-1.14],0.004838921830843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STK24,Serine/threonine-protein kinase 24,21826,2083,1.05 [0.99-1.12],0.1041568598024502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STK4,Serine/threonine-protein kinase 4,22331,2138,1.04 [0.99-1.08],0.1040531949904153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STOML2,"Stomatin-like protein 2, mitochondrial",18754,1788,0.99 [0.94-1.04],0.6593317089834405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STX16,Syntaxin-16,21834,2088,1.10 [1.03-1.17],0.0071221195056625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STX1B,Syntaxin-1B,18933,1813,0.82 [0.72-0.93],0.0017854831291315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STX3,Syntaxin-3,19425,1849,1.06 [0.95-1.19],0.2694472535213422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STX4,Syntaxin-4,22222,2129,1.13 [1.07-1.20],5.06290791459729e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STX5,Syntaxin-5,18885,1799,0.99 [0.88-1.11],0.8402442744504859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STX6,Syntaxin-6,21834,2088,1.06 [0.99-1.12],0.0789781676938015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STX7,Syntaxin-7,18885,1799,1.09 [0.99-1.19],0.0843584390840519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STX8,Syntaxin-8,22279,2137,1.12 [1.04-1.22],0.0045915473216544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STXBP1,Syntaxin-binding protein 1,19419,1844,1.02 [0.96-1.08],0.61298608401519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STXBP3,Syntaxin-binding protein 3,21834,2088,1.01 [0.92-1.10],0.8614662595776859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUGP1,SURP and G-patch domain-containing protein 1,19369,1846,1.05 [0.94-1.17],0.397120086102024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUGT1,Protein SGT1 homolog,21834,2088,1.01 [0.96-1.06],0.8273074508757927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SULT1A1,Sulfotransferase 1A1,22509,2156,1.02 [0.99-1.05],0.2232511015248787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SULT2A1,Bile salt sulfotransferase,22279,2137,1.40 [1.33-1.48],1.340910651602585e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUMF1,Formylglycine-generating enzyme,18885,1799,1.01 [0.94-1.09],0.7221902754160431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,22509,2156,1.25 [1.16-1.34],8.353704666667118e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUOX,"Sulfite oxidase, mitochondrial",19419,1844,1.33 [1.25-1.42],1.0583906317041909e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUSD1,Sushi domain-containing protein 1,21913,2105,1.08 [1.00-1.17],0.0483008983699779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUSD2,Sushi domain-containing protein 2,22355,2147,1.19 [1.05-1.36],0.0080710067633014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUSD4,Sushi domain-containing protein 4,19371,1841,1.08 [0.97-1.20],0.1619689566651129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUSD5,Sushi domain-containing protein 5,18934,1805,0.57 [0.50-0.65],4.72074997140161e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SV2A,Synaptic vesicle glycoprotein 2A,18933,1813,1.10 [1.02-1.17],0.0102069453600366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SWAP70,Switch-associated protein 70,19369,1846,0.95 [0.83-1.08],0.3977838034674552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SYAP1,Synapse-associated protein 1,19045,1813,1.00 [0.93-1.08],0.9638956271995204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,18824,1792,1.02 [0.94-1.10],0.6439864611296842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SYT1,Synaptotagmin-1,19425,1849,0.86 [0.76-0.97],0.0156059635099483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SYTL4,Synaptotagmin-like protein 4,19462,1849,1.07 [1.01-1.13],0.0299992844965735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,19109,1826,1.01 [0.97-1.05],0.6521222834322269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TACC3,Transforming acidic coiled-coil-containing protein 3,22222,2129,1.01 [0.98-1.05],0.3819562375788435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TACSTD2,Tumor-associated calcium signal transducer 2,19708,1874,1.05 [0.91-1.20],0.5374874948405335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TADA3,Transcriptional adapter 3,19371,1841,1.11 [0.99-1.24],0.0799506469088711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TAFA5,Chemokine-like protein TAFA-5,22222,2129,1.11 [1.00-1.22],0.0517012550242214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TAGLN3,Transgelin-3,18754,1788,1.03 [0.95-1.11],0.4587313278600557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TALDO1,Transaldolase,19389,1850,1.33 [1.21-1.47],1.2112664787722009e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TANK,TRAF family member-associated NF-kappa-B activator,21900,2081,1.11 [1.05-1.17],0.0004759323914176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TAP1,Antigen peptide transporter 1,19109,1826,1.05 [0.97-1.13],0.2148482085321244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TARBP2,RISC-loading complex subunit TARBP2,21826,2083,1.07 [1.01-1.12],0.0116198600813946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",18933,1813,0.92 [0.86-0.98],0.0064920524503397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",19371,1841,1.10 [0.98-1.23],0.1212115066308062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TAX1BP1,Tax1-binding protein 1,19425,1849,1.14 [1.07-1.22],0.0001787954499292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TBC1D17,TBC1 domain family member 17,21826,2083,1.08 [0.99-1.17],0.0840975672644947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TBC1D23,TBC1 domain family member 23,22222,2129,1.04 [1.00-1.08],0.0781025121729959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TBC1D5,TBC1 domain family member 5,22279,2137,1.05 [1.00-1.10],0.0474816406458406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TBCA,Tubulin-specific chaperone A,19045,1813,1.02 [0.97-1.08],0.4065312022091278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TBCB,Tubulin-folding cofactor B,22137,2130,1.03 [0.99-1.07],0.1985945971459533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TBCC,Tubulin-specific chaperone C,22137,2130,1.03 [0.98-1.08],0.2746336146589114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TBL1X,F-box-like/WD repeat-containing protein TBL1X,21834,2088,1.01 [0.96-1.06],0.6544686535801969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TBR1,T-box brain protein 1,18933,1813,0.99 [0.90-1.09],0.8293170329797607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCL1A,T-cell leukemia/lymphoma protein 1A,22114,2127,1.02 [0.99-1.06],0.2438348151997965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCL1B,T-cell leukemia/lymphoma protein 1B,21913,2105,1.05 [1.00-1.10],0.0295890199316156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCN1,Transcobalamin-1,19068,1809,1.18 [1.05-1.33],0.0065882076706373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCN2,Transcobalamin-2,22580,2163,1.68 [1.50-1.87],7.930799874093805e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCOF1,Treacle protein,19462,1849,1.50 [1.33-1.68],1.0935357515007532e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCP11,T-complex protein 11 homolog,19109,1826,0.97 [0.89-1.05],0.444033002695778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCTN3,Tectonic-3,19462,1849,1.56 [1.35-1.81],3.4142952095471803e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TDGF1,Teratocarcinoma-derived growth factor 1,21826,2083,1.02 [1.00-1.05],0.0705745076689772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TDO2,"Tryptophan 2,3-dioxygenase",18933,1813,1.07 [0.96-1.20],0.2416629813568267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TDP1,Tyrosyl-DNA phosphodiesterase 1,19371,1841,1.04 [0.98-1.11],0.2150633081672237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TDRKH,Tudor and KH domain-containing protein,21826,2083,1.10 [1.05-1.15],4.501351422071729e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TEF,Thyrotroph embryonic factor,18799,1796,1.00 [0.90-1.11],0.9557065956975188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TEK,Angiopoietin-1 receptor,22422,2149,2.33 [1.97-2.76],1.951721201741788e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TERF1,Telomeric repeat-binding factor 1,18885,1799,1.03 [0.88-1.20],0.7021828291278448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TET2,Methylcytosine dioxygenase TET2,19064,1820,1.00 [0.95-1.04],0.8527728675875317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TEX101,Testis-expressed protein 101,18933,1813,1.00 [0.92-1.09],0.998328673298483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TEX33,Testis-expressed protein 33,19109,1826,1.05 [0.94-1.17],0.3787929177808549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TF,Serotransferrin,19494,1852,2.01 [1.64-2.47],1.9345759926015168e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFAP2A,Transcription factor AP-2-alpha,18824,1792,0.98 [0.90-1.06],0.5457030918219767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFF1,Trefoil factor 1,22238,2137,1.26 [1.20-1.31],3.3222935372269486e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFF2,Trefoil factor 2,22391,2150,1.45 [1.37-1.54],3.699953956196583e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFF3,Trefoil factor 3,22336,2127,1.47 [1.36-1.58],4.27408346745122e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFPI,Tissue factor pathway inhibitor,22310,2134,0.84 [0.74-0.96],0.0080680039038005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFPI2,Tissue factor pathway inhibitor 2,22363,2144,1.18 [1.09-1.28],7.404493515631676e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFRC,Transferrin receptor protein 1,22447,2142,1.17 [1.06-1.29],0.0021586400964282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TG,Thyroglobulin,19371,1841,0.92 [0.88-0.96],3.860408783300313e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFA,Protransforming growth factor alpha,22279,2137,1.51 [1.40-1.63],6.173245812033746e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFB1,Transforming growth factor beta-1 proprotein,22519,2155,1.43 [1.30-1.56],5.513756589282063e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFB2,Transforming growth factor beta-2 proprotein,19371,1841,1.04 [0.96-1.13],0.3547818233501074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFBI,Transforming growth factor-beta-induced protein ig-h3,22237,2125,1.23 [1.07-1.41],0.0040587089363605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFBR1,TGF-beta receptor type-1,18885,1799,1.21 [0.98-1.49],0.0709295813178866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFBR2,TGF-beta receptor type-2,22422,2149,1.34 [1.21-1.48],2.164808932478856e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFBR3,Transforming growth factor beta receptor type 3,22606,2166,0.71 [0.63-0.79],1.915000710917941e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGM2,Protein-glutamine gamma-glutamyltransferase 2,22303,2134,1.02 [0.97-1.07],0.4758075665128111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGOLN2,Trans-Golgi network integral membrane protein 2,19470,1855,0.90 [0.76-1.06],0.1964482998398051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THAP12,52 kDa repressor of the inhibitor of the protein kinase,18726,1786,1.01 [0.96-1.07],0.5860125067574617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THBD,Thrombomodulin,22331,2138,1.21 [1.07-1.38],0.002862834175886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THBS2,Thrombospondin-2,22355,2147,2.00 [1.85-2.16],3.605899983443677e-66
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THBS4,Thrombospondin-4,22375,2141,1.22 [1.13-1.33],1.876011928225004e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THOP1,Thimet oligopeptidase,22210,2133,1.53 [1.36-1.71],4.682308820754152e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THPO,Thrombopoietin,21913,2105,0.84 [0.76-0.93],0.00056603320343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THRAP3,Thyroid hormone receptor-associated protein 3,18799,1796,1.01 [0.97-1.05],0.551814981749007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THSD1,Thrombospondin type-1 domain-containing protein 1,18739,1783,0.98 [0.86-1.12],0.780056030294263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THTPA,Thiamine-triphosphatase,19340,1837,0.98 [0.93-1.04],0.5079305668993046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THY1,Thy-1 membrane glycoprotein,22509,2156,1.33 [1.17-1.51],8.615783450087895e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIA1,Nucleolysin TIA-1 isoform p40,21657,2082,1.03 [1.00-1.06],0.0905497799458455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIE1,Tyrosine-protein kinase receptor Tie-1,22606,2166,1.20 [1.09-1.32],0.0003218014017115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",21793,2082,1.13 [1.04-1.23],0.002970939368025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,19109,1826,1.17 [1.05-1.31],0.0060845743753622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,22460,2144,0.96 [0.88-1.04],0.3048900584481005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,19462,1849,1.08 [0.97-1.21],0.1685004744043634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,19425,1849,1.04 [0.98-1.09],0.1989594209109583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIMP1,Metalloproteinase inhibitor 1,22127,2107,1.87 [1.66-2.11],1.9822759767256124e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIMP2,Metalloproteinase inhibitor 2,19462,1849,0.91 [0.76-1.09],0.3254112406063073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIMP3,Metalloproteinase inhibitor 3,22429,2152,1.07 [1.04-1.10],6.689983034533094e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIMP4,Metalloproteinase inhibitor 4,22355,2147,0.67 [0.61-0.74],1.1789807382673464e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TINAGL1,Tubulointerstitial nephritis antigen-like,22255,2133,1.12 [0.94-1.33],0.2047147242818076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TJAP1,Tight junction-associated protein 1,22422,2149,1.05 [1.00-1.10],0.0379727042085225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TJP3,Tight junction protein ZO-3,18824,1792,1.00 [0.90-1.12],0.9901816115682198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TK1,"Thymidine kinase, cytosolic",19109,1826,1.08 [0.98-1.19],0.1053209541904331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TLR1,Toll-like receptor 1,18885,1799,1.36 [1.16-1.59],0.0001867119013143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TLR2,Toll-like receptor 2,19109,1826,1.20 [0.99-1.46],0.0607069226166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TLR3,Toll-like receptor 3,22551,2158,1.29 [1.21-1.38],6.819276514230061e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TLR4,Toll-like receptor 4,18885,1799,1.08 [0.92-1.26],0.3680970678589512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,18933,1813,1.00 [0.91-1.08],0.924241369741188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMED1,Transmembrane emp24 domain-containing protein 1,19109,1826,0.93 [0.86-1.02],0.1063457331448871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMED10,Transmembrane emp24 domain-containing protein 10,18799,1796,0.96 [0.88-1.06],0.4442793890453251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMED4,Transmembrane emp24 domain-containing protein 4,18799,1796,0.97 [0.90-1.05],0.4769497805805922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMED8,Protein TMED8,19369,1846,1.03 [0.99-1.08],0.1786967712478279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMEM106A,Transmembrane protein 106A,19371,1841,1.05 [0.99-1.12],0.1171794787768297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMEM132A,Transmembrane protein 132A,18968,1809,0.98 [0.91-1.06],0.6504131425104639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMEM25,Transmembrane protein 25,19419,1844,1.05 [0.96-1.15],0.3150604390834279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMOD4,Tropomodulin-4,18754,1788,1.00 [0.89-1.12],0.9895740270322284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMPRSS11B,Transmembrane protease serine 11B,18824,1792,0.96 [0.90-1.03],0.2340459008570839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMPRSS11D,Transmembrane protease serine 11D,19397,1848,1.04 [0.93-1.17],0.4427453452479202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMPRSS15,Enteropeptidase,22222,2129,1.30 [1.25-1.36],1.6320943178636827e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMPRSS5,Transmembrane protease serine 5,22039,2122,0.85 [0.77-0.94],0.0015287646903386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMSB10,Thymosin beta-10,22355,2147,1.07 [1.01-1.13],0.0123272355560699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNC,Tenascin,22460,2144,0.84 [0.77-0.90],6.8841569881910994e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNF,Tumor necrosis factor,21885,2103,1.31 [1.21-1.42],2.7263404756572888e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,19369,1846,0.99 [0.90-1.09],0.7872329799598435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,21900,2081,1.01 [0.90-1.12],0.919642034197446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,19045,1813,1.00 [0.93-1.07],0.9118986476958963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,22137,2130,1.98 [1.83-2.14],1.5500439557444015e-67
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,22137,2130,1.37 [1.31-1.44],4.591111005461066e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,22412,2148,1.15 [1.07-1.25],0.0004156727656381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,22551,2158,1.91 [1.76-2.08],1.9406717346617734e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,22325,2139,2.16 [1.92-2.43],1.987852791481956e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,22422,2149,1.77 [1.61-1.95],1.3942357968014668e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,22359,2146,1.18 [1.07-1.31],0.0011206568826471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,21900,2081,1.09 [1.00-1.19],0.0532631406199655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,22359,2146,1.60 [1.43-1.80],1.2965650195944644e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,19045,1813,0.89 [0.80-0.99],0.0279854901509535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,22508,2152,1.00 [0.89-1.12],0.9929397903799068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,22355,2147,1.90 [1.70-2.12],8.908878351666518e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,22355,2147,1.41 [1.31-1.51],1.667979484937558e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,22509,2156,1.03 [0.90-1.18],0.6417323027250006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,22519,2155,1.44 [1.32-1.58],1.6322042692878213e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,22137,2130,1.27 [1.20-1.35],7.760481649979837e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,22509,2156,1.04 [0.95-1.13],0.3865810245091781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,22137,2130,1.25 [1.15-1.35],8.488266812293159e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF10,Tumor necrosis factor ligand superfamily member 10,22551,2158,0.49 [0.43-0.57],5.954209790045877e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF11,Tumor necrosis factor ligand superfamily member 11,22279,2137,0.77 [0.72-0.82],6.017812777335185e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF12,Tumor necrosis factor ligand superfamily member 12,22551,2158,0.48 [0.42-0.55],1.3893480447401207e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,22429,2152,1.53 [1.34-1.76],6.610860797422885e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,22577,2164,1.47 [1.29-1.66],3.047113770472379e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF14,Tumor necrosis factor ligand superfamily member 14,22137,2130,1.16 [1.08-1.24],1.5780660357808282e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,19475,1856,1.39 [1.24-1.57],2.5400344834740745e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNIP1,TNFAIP3-interacting protein 1,19425,1849,1.07 [1.02-1.12],0.0101398267494291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNN,Tenascin-N,19475,1856,1.39 [1.25-1.53],3.1700306160236525e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNNI3,"Troponin I, cardiac muscle",21913,2105,1.04 [1.00-1.10],0.0707210719748788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNPO1,Transportin-1,19109,1826,0.97 [0.85-1.10],0.6271643261581255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNR,Tenascin-R,22137,2130,1.00 [0.91-1.09],0.9185190708600516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNXB,Tenascin-X,22355,2147,0.72 [0.62-0.83],1.0307419023980417e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,19462,1849,1.13 [1.06-1.19],3.4516954667788554e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TOP1,DNA topoisomerase 1,19369,1846,1.07 [1.03-1.11],0.000730047000624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TOP1MT,"DNA topoisomerase I, mitochondrial",18754,1788,1.01 [0.92-1.11],0.8637841862895258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TOP2B,DNA topoisomerase 2-beta,18885,1799,1.09 [1.03-1.16],0.0023812873405896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TOR1AIP1,Torsin-1A-interacting protein 1,18968,1809,1.12 [1.04-1.22],0.0050201514715184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TP53,Cellular tumor antigen p53,21834,2088,1.06 [0.97-1.16],0.18952406911408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TP53BP1,TP53-binding protein 1,18885,1799,0.99 [0.94-1.05],0.7436019313021917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TP53I3,Quinone oxidoreductase PIG3,18635,1766,1.28 [1.17-1.39],1.4540209504982976e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TP53INP1,Tumor protein p53-inducible nuclear protein 1,21913,2105,0.99 [0.87-1.13],0.9210264206570596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TP73,Tumor protein p73,18933,1813,0.99 [0.87-1.13],0.8558503397069743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPBGL,Trophoblast glycoprotein-like,18933,1813,0.95 [0.85-1.06],0.3211839261503303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPD52L2,Tumor protein D54,19045,1813,1.03 [0.98-1.07],0.2305216570936467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPK1,Thiamin pyrophosphokinase 1,19462,1849,0.47 [0.40-0.55],1.6600946542304261e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPM3,Tropomyosin alpha-3 chain,18799,1796,1.02 [0.92-1.13],0.6892420473893881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPMT,Thiopurine S-methyltransferase,21834,2088,0.95 [0.90-1.00],0.0674121486528209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPP1,Tripeptidyl-peptidase 1,22170,2126,1.50 [1.40-1.61],5.405678685752478e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPPP2,Tubulin polymerization-promoting protein family member 2,19109,1826,0.99 [0.94-1.05],0.8238936006045623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPPP3,Tubulin polymerization-promoting protein family member 3,21826,2083,0.85 [0.76-0.95],0.0036584877123316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPR,Nucleoprotein TPR,18799,1796,1.16 [1.07-1.26],0.000279795026105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPRKB,EKC/KEOPS complex subunit TPRKB,18754,1788,0.98 [0.91-1.05],0.5934280869868096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPSAB1,Tryptase alpha/beta-1,22518,2157,1.12 [1.04-1.20],0.002810310968332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPSD1,Tryptase delta,19419,1844,1.04 [0.93-1.17],0.4715697046612033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPSG1,Tryptase gamma,18885,1799,0.99 [0.83-1.18],0.9093033615675498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPT1,Translationally-controlled tumor protein,21900,2081,0.99 [0.93-1.05],0.7218033480094912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRAF2,TNF receptor-associated factor 2,22279,2137,1.05 [0.99-1.11],0.1006611188444772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRAF3,"TNF receptor-associated factor 3, Isoform 2",18885,1799,1.08 [0.96-1.21],0.1907096299633475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,18799,1796,1.03 [0.94-1.13],0.5093138033346897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,19109,1826,1.02 [0.97-1.07],0.5045840069154248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TREH,Trehalase,19475,1856,1.53 [1.44-1.63],1.3484723851304843e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TREM2,Triggering receptor expressed on myeloid cells 2,22325,2139,1.29 [1.21-1.38],2.1825707399908866e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TREML1,Trem-like transcript 1 protein,19470,1855,0.98 [0.90-1.07],0.6702708750147442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TREML2,Trem-like transcript 2 protein,22355,2147,1.03 [0.92-1.15],0.5900562458355251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRIAP1,TP53-regulated inhibitor of apoptosis 1,22508,2152,1.07 [1.00-1.14],0.0395944079460847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRIM21,E3 ubiquitin-protein ligase TRIM21,22279,2137,1.03 [0.98-1.08],0.3061730777599636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRIM24,Transcription intermediary factor 1-alpha,19079,1824,1.07 [1.00-1.15],0.0493354625736635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,19369,1846,1.03 [0.99-1.08],0.1500134049777546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRIM26,Tripartite motif-containing protein 26,18754,1788,1.05 [0.97-1.14],0.186383771398959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRIM40,E3 ubiquitin ligase TRIM40,18933,1813,1.04 [0.97-1.11],0.2497165508332994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRIM5,Tripartite motif-containing protein 5,22279,2137,1.06 [1.01-1.11],0.0091707913315579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRIM58,E3 ubiquitin-protein ligase TRIM58,19371,1841,1.07 [1.02-1.13],0.0102719016799197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TRPV3,Transient receptor potential cation channel subfamily V member 3,18799,1796,0.98 [0.89-1.08],0.7114403542383898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TSC1,Hamartin,18885,1799,0.98 [0.91-1.05],0.5277618439118978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TSC22D1,TSC22 domain family protein 1,19419,1844,1.04 [0.97-1.11],0.3018725304980744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TSHB,Thyrotropin subunit beta,22331,2138,0.93 [0.89-0.98],0.0047493132680324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TSLP,Thymic stromal lymphopoietin,21913,2105,0.95 [0.89-1.02],0.1650454496785554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TSNAX,Translin-associated protein X,18799,1796,1.01 [0.90-1.14],0.8230091377252853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TSPAN1,Tetraspanin-1,21913,2105,1.04 [0.99-1.09],0.1003006938980149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TSPAN15,Tetraspanin-15,18799,1796,0.97 [0.89-1.06],0.4859208983748601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TSPAN7,Tetraspanin-7,18824,1792,0.97 [0.92-1.02],0.2580765784349299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TSPAN8,Tetraspanin-8,19369,1846,1.07 [1.03-1.12],0.0022963232031487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TSPYL1,Testis-specific Y-encoded-like protein 1,18885,1799,0.99 [0.89-1.12],0.9255328477529616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TST,Thiosulfate sulfurtransferase,21783,2082,1.03 [0.98-1.09],0.2074653657889539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TTF2,Transcription termination factor 2,18933,1813,1.00 [0.91-1.09],0.9613716925295178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TTN,Titin,18799,1796,1.01 [0.94-1.08],0.8528855983887497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TTR,Transthyretin,19279,1829,1.03 [0.86-1.23],0.7668221095133191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TUBB3,Tubulin beta-3 chain,18824,1792,0.97 [0.82-1.14],0.6747748863745227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TWF2,Twinfilin-2,19475,1856,1.02 [0.97-1.08],0.3774848293267604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TXK,Tyrosine-protein kinase TXK,19109,1826,0.96 [0.90-1.02],0.2284498735474411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TXLNA,Alpha-taxilin,22137,2130,1.10 [1.05-1.15],1.992636975913848e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TXN,Thioredoxin,19143,1825,0.95 [0.85-1.05],0.3159121282318475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TXNDC15,Thioredoxin domain-containing protein 15,22422,2149,1.09 [0.95-1.26],0.2066751151124606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TXNDC5,Thioredoxin domain-containing protein 5,22509,2156,1.11 [1.05-1.18],0.0001299926177976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TXNDC9,Thioredoxin domain-containing protein 9,19425,1849,1.03 [0.95-1.13],0.4327532107197214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TXNL1,Thioredoxin-like protein 1,18786,1789,0.96 [0.91-1.00],0.074677616662385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",22355,2147,1.27 [1.17-1.37],1.3856871382714996e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TYMP,Thymidine phosphorylase,22182,2121,1.11 [1.05-1.18],0.0006081831150631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TYRO3,Tyrosine-protein kinase receptor TYRO3,22331,2138,1.12 [0.98-1.28],0.1072839342637558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",18885,1799,1.13 [1.05-1.21],0.000754253653881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UBAC1,Ubiquitin-associated domain-containing protein 1,22222,2129,0.99 [0.89-1.11],0.9247291288870306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UBE2B,Ubiquitin-conjugating enzyme E2 B,19371,1841,1.01 [0.86-1.17],0.9413030855682872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,19462,1849,1.05 [0.98-1.13],0.1744778445039741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,18885,1799,0.94 [0.86-1.02],0.1137882594612243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UBQLN3,Ubiquilin-3,18799,1796,1.06 [0.99-1.15],0.1036282752716324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UBXN1,UBX domain-containing protein 1,19045,1813,1.01 [0.95-1.08],0.6880901963507651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,19369,1846,1.02 [0.99-1.05],0.1975844010744642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UGDH,UDP-glucose 6-dehydrogenase,18799,1796,0.96 [0.91-1.01],0.1140763540647581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UHRF2,E3 ubiquitin-protein ligase UHRF2,18799,1796,0.94 [0.83-1.08],0.3949718127815264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ULBP2,UL16-binding protein 2,22137,2130,1.46 [1.33-1.60],3.043063411988817e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UMOD,Uromodulin,22546,2156,0.70 [0.65-0.74],1.4601369476057702e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UNC5D,Netrin receptor UNC5D,18885,1799,0.99 [0.83-1.17],0.8735766999778666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UNC79,Protein unc-79 homolog,18754,1788,1.01 [0.93-1.10],0.7770903117097263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UNG,Uracil-DNA glycosylase,19371,1841,0.91 [0.79-1.04],0.1726150466426374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UPB1,Beta-ureidopropionase,19462,1849,1.48 [1.42-1.54],2.6108924286245368e-77
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UPK3A,Uroplakin-3a,18824,1792,0.95 [0.86-1.04],0.2472646968668372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UPK3BL1,Uroplakin-3b-like protein 1,19065,1820,0.96 [0.88-1.04],0.3133471186306488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UROD,Uroporphyrinogen decarboxylase,19045,1813,1.10 [1.03-1.17],0.005957778685066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UROS,Uroporphyrinogen-III synthase,18933,1813,0.96 [0.89-1.03],0.2131044411765824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,USO1,General vesicular transport factor p115,22222,2129,1.04 [1.00-1.09],0.0460487723378939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,USP25,Ubiquitin carboxyl-terminal hydrolase 25,19371,1841,1.08 [1.01-1.15],0.0196987936777751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,USP28,Ubiquitin carboxyl-terminal hydrolase 28,19425,1849,1.08 [0.96-1.21],0.2113283587839084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,USP47,Ubiquitin carboxyl-terminal hydrolase 47,18799,1796,1.01 [0.95-1.06],0.811940171139925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,USP8,Ubiquitin carboxyl-terminal hydrolase 8,21913,2105,1.05 [1.01-1.10],0.015175698865236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UXS1,UDP-glucuronic acid decarboxylase 1,21834,2088,1.07 [1.00-1.15],0.0616109762072557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VAMP5,Vesicle-associated membrane protein 5,21913,2105,1.10 [1.03-1.18],0.0039912849279382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VAMP8,Vesicle-associated membrane protein 8,18885,1799,1.04 [0.98-1.09],0.188930627861293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VASH1,Tubulinyl-Tyr carboxypeptidase 1,22279,2137,1.05 [1.00-1.10],0.0497032407230128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VASN,Vasorin,22009,2103,0.92 [0.80-1.06],0.2680333980654487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VASP,Vasodilator-stimulated phosphoprotein,19470,1855,1.00 [0.94-1.07],0.8938418435217621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,22222,2129,0.45 [0.37-0.55],7.446401711518236e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VAV3,Guanine nucleotide exchange factor VAV3,18824,1792,1.02 [0.98-1.07],0.3588904932081588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VCAM1,Vascular cell adhesion protein 1,22412,2141,1.54 [1.35-1.76],2.153088636817708e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VCAN,Versican core protein,22509,2156,0.72 [0.63-0.81],3.172197635696066e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VCPKMT,Protein-lysine methyltransferase METTL21D,18754,1788,0.99 [0.94-1.05],0.7484469017098694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VEGFA,Vascular endothelial growth factor A,22480,2150,1.24 [1.17-1.33],1.2547300794859496e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VEGFB,Vascular endothelial growth factor B,18885,1799,0.93 [0.80-1.09],0.3751394139497944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VEGFC,Vascular endothelial growth factor C,22422,2149,1.07 [1.00-1.14],0.056754727339947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VEGFD,Vascular endothelial growth factor D,22516,2155,1.14 [1.02-1.26],0.0156606121881595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VGF,Neurosecretory protein VGF,19419,1844,0.78 [0.67-0.90],0.0007474173849335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VIM,Vimentin,21913,2105,1.00 [0.96-1.03],0.8688019999997143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VIPR1,Vasoactive intestinal polypeptide receptor 1,18968,1809,1.02 [0.84-1.24],0.8668325880687171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VIT,Vitrin,19462,1849,0.92 [0.82-1.03],0.1487547785095359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VMO1,Vitelline membrane outer layer protein 1 homolog,22222,2129,1.31 [1.23-1.39],1.5242595615977265e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VNN1,Pantetheinase,19470,1855,1.35 [1.26-1.44],2.745715844845212e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VNN2,Vascular non-inflammatory molecule 2,22222,2129,1.30 [1.19-1.42],2.9290980253583193e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VPS28,Vacuolar protein sorting-associated protein 28 homolog,19109,1826,1.04 [0.97-1.11],0.3109190498703004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VPS37A,Vacuolar protein sorting-associated protein 37A,22222,2129,1.08 [1.03-1.13],0.0016706765231653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VPS4B,Vacuolar protein sorting-associated protein 4B,19371,1841,1.00 [0.95-1.05],0.9584333314402292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VPS53,Vacuolar protein sorting-associated protein 53 homolog,22222,2129,1.05 [1.00-1.11],0.0370827572334165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSIG10,V-set and immunoglobulin domain-containing protein 10,19371,1841,1.11 [0.98-1.26],0.1090017535778554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,18799,1796,1.12 [0.98-1.27],0.0942185695100937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,19371,1841,1.42 [1.34-1.51],1.4451861381350286e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,22328,2144,1.52 [1.40-1.66],8.770876840996837e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,22292,2135,1.12 [1.05-1.19],0.0002376424538222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSNL1,Visinin-like protein 1,19425,1849,1.42 [1.28-1.58],7.535672964894647e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSTM1,V-set and transmembrane domain-containing protein 1,21826,2083,1.03 [0.96-1.12],0.3881243093865751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSTM2B,V-set and transmembrane domain-containing protein 2B,19109,1826,0.91 [0.81-1.02],0.1016212327858272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,21913,2105,1.25 [1.18-1.32],4.209154088892692e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,22509,2156,1.02 [0.97-1.07],0.5144803799438629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VTCN1,V-set domain-containing T-cell activation inhibitor 1,21834,2088,1.22 [1.08-1.37],0.0011468313250493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,19045,1813,1.08 [1.00-1.17],0.0476465951553235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VWA1,von Willebrand factor A domain-containing protein 1,22470,2148,1.29 [1.18-1.41],5.912727166590446e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VWA5A,von Willebrand factor A domain-containing protein 5A,18754,1788,1.03 [0.97-1.09],0.325080668145878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VWC2,Brorin,22068,2128,1.16 [1.06-1.27],0.0019219645561178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VWC2L,von Willebrand factor C domain-containing protein 2-like,19419,1844,0.74 [0.65-0.83],1.0347832308469211e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VWF,von Willebrand factor,22606,2166,1.12 [1.07-1.18],1.2919576165358389e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WARS,"Tryptophan--tRNA ligase, cytoplasmic",22355,2147,1.15 [1.04-1.27],0.0082610662765965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WAS,Wiskott-Aldrich syndrome protein,21900,2081,1.03 [0.97-1.09],0.4132996614062513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WASF1,Wiskott-Aldrich syndrome protein family member 1,21913,2105,1.05 [1.01-1.10],0.0136740111346662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WASF3,Wiskott-Aldrich syndrome protein family member 3,21826,2083,0.98 [0.93-1.03],0.3741501810099988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WASHC3,WASH complex subunit 3,19425,1849,1.07 [1.01-1.14],0.0194930443602268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WASL,Neural Wiskott-Aldrich syndrome protein,18885,1799,0.92 [0.85-1.00],0.0400223488291823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WDR46,WD repeat-containing protein 46,19371,1841,1.03 [0.91-1.16],0.6635280500635392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WFDC1,WAP four-disulfide core domain protein 1,18973,1804,1.12 [1.04-1.20],0.0033001415645681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WFDC12,WAP four-disulfide core domain protein 12,22477,2150,0.96 [0.91-1.02],0.190549365631772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WFDC2,WAP four-disulfide core domain protein 2,21224,2030,1.41 [1.29-1.53],6.8956420638011876e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",22060,2123,0.93 [0.84-1.02],0.1173915647056599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",22359,2146,0.68 [0.61-0.77],4.592071681645842e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WIF1,Wnt inhibitory factor 1,22508,2152,0.56 [0.50-0.63],4.647658687685578e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WNT9A,Protein Wnt-9a,21900,2081,0.95 [0.83-1.09],0.4582734887861273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,22137,2130,1.11 [1.03-1.19],0.0059772969190901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,XCL1,Lymphotactin,22508,2152,1.13 [1.06-1.21],0.0001223610931654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,XG,Glycoprotein Xg,22510,2157,0.99 [0.88-1.10],0.7970959550137405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,XIAP,E3 ubiquitin-protein ligase XIAP,18885,1799,1.08 [0.99-1.17],0.0679115356646878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,XPNPEP2,Xaa-Pro aminopeptidase 2,22422,2149,0.93 [0.90-0.97],0.0002385815541042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,XRCC4,DNA repair protein XRCC4,21826,2083,1.13 [1.02-1.25],0.0167165071302849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,YAP1,Transcriptional coactivator YAP1,19425,1849,1.29 [1.11-1.50],0.0011889018573314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",19369,1846,1.04 [1.01-1.08],0.009144261572138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,YES1,Tyrosine-protein kinase Yes,22222,2129,1.06 [1.02-1.09],0.0013592380323343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,YJU2,Splicing factor YJU2,19371,1841,1.03 [0.90-1.19],0.6371089146304848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,YOD1,Ubiquitin thioesterase OTU1,18799,1796,1.06 [0.98-1.14],0.1242441753913339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,YTHDF3,YTH domain-containing family protein 3,21900,2081,1.06 [1.01-1.11],0.009322665730727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,YWHAQ,14-3-3 protein theta,19045,1813,1.04 [0.98-1.11],0.1936003517544642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,YY1,Transcriptional repressor protein YY1,18885,1799,0.98 [0.83-1.16],0.8433297564551614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZBP1,Z-DNA-binding protein 1,18885,1799,1.01 [0.89-1.13],0.9045745212306544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZBTB16,Zinc finger and BTB domain-containing protein 16,21834,2088,1.08 [1.03-1.14],0.0030699990496349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZBTB17,Zinc finger and BTB domain-containing protein 17,21913,2105,1.18 [1.09-1.28],4.027007861638249e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZCCHC8,Zinc finger CCHC domain-containing protein 8,18799,1796,1.02 [0.95-1.10],0.5605928078598219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZFYVE19,Abscission/NoCut checkpoint regulator,19369,1846,1.01 [0.96-1.06],0.760943151642284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZHX2,Zinc fingers and homeoboxes protein 2,19425,1849,1.22 [1.09-1.37],0.0005737399658825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZNF174,Zinc finger protein 174,18885,1799,1.02 [0.91-1.15],0.7227738499128021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZNF75D,Zinc finger protein 75D,19109,1826,1.03 [0.96-1.11],0.3875906202194398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZNF830,Zinc finger protein 830,19371,1841,0.99 [0.93-1.05],0.7640903499753945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZNRD2,Protein ZNRD2,19369,1846,1.16 [1.09-1.23],3.5893600942467748e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,19371,1841,1.03 [0.95-1.11],0.5371270786612783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZP3,Zona pellucida sperm-binding protein 3,18968,1809,1.01 [0.99-1.02],0.5015419170720012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZP4,Zona pellucida sperm-binding protein 4,18754,1788,0.98 [0.85-1.13],0.7570153928645657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZPR1,Zinc finger protein ZPR1,18824,1792,0.99 [0.94-1.03],0.5563541129895584
